CN110914430B - 抗bril抗体以及使用了该抗体的bril融合蛋白质的稳定化方法 - Google Patents
抗bril抗体以及使用了该抗体的bril融合蛋白质的稳定化方法 Download PDFInfo
- Publication number
- CN110914430B CN110914430B CN201880046011.XA CN201880046011A CN110914430B CN 110914430 B CN110914430 B CN 110914430B CN 201880046011 A CN201880046011 A CN 201880046011A CN 110914430 B CN110914430 B CN 110914430B
- Authority
- CN
- China
- Prior art keywords
- bril
- antibody
- leu
- amino acid
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 101001034831 Homo sapiens Interferon-induced transmembrane protein 5 Proteins 0.000 title claims abstract description 324
- 102100039731 Interferon-induced transmembrane protein 5 Human genes 0.000 title claims abstract description 324
- 108020001507 fusion proteins Proteins 0.000 title claims abstract description 147
- 102000037865 fusion proteins Human genes 0.000 title claims abstract description 147
- 238000000034 method Methods 0.000 title claims abstract description 139
- 230000000087 stabilizing effect Effects 0.000 title claims abstract description 22
- 230000027455 binding Effects 0.000 claims abstract description 161
- 239000000427 antigen Substances 0.000 claims abstract description 156
- 108091007433 antigens Proteins 0.000 claims abstract description 154
- 102000036639 antigens Human genes 0.000 claims abstract description 154
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 131
- 239000012634 fragment Substances 0.000 claims abstract description 125
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 104
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 132
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 claims description 48
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 claims description 26
- 108010078791 Carrier Proteins Proteins 0.000 claims description 10
- 102000004310 Ion Channels Human genes 0.000 claims description 7
- 239000013598 vector Substances 0.000 abstract description 37
- 238000012916 structural analysis Methods 0.000 abstract description 30
- 210000000628 antibody-producing cell Anatomy 0.000 abstract description 11
- 108020004707 nucleic acids Proteins 0.000 abstract description 6
- 102000039446 nucleic acids Human genes 0.000 abstract description 6
- 150000007523 nucleic acids Chemical class 0.000 abstract description 6
- 210000004027 cell Anatomy 0.000 description 86
- 241000282414 Homo sapiens Species 0.000 description 85
- 235000018102 proteins Nutrition 0.000 description 44
- 238000002425 crystallisation Methods 0.000 description 39
- 230000008025 crystallization Effects 0.000 description 38
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 33
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 31
- 239000013078 crystal Substances 0.000 description 29
- 239000000523 sample Substances 0.000 description 29
- 125000000539 amino acid group Chemical group 0.000 description 28
- 210000004408 hybridoma Anatomy 0.000 description 28
- 239000013604 expression vector Substances 0.000 description 27
- 238000004519 manufacturing process Methods 0.000 description 26
- 102100033049 G-protein coupled receptor 42 Human genes 0.000 description 25
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 24
- 241000699666 Mus <mouse, genus> Species 0.000 description 24
- 239000004475 Arginine Substances 0.000 description 23
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 23
- 241000699670 Mus sp. Species 0.000 description 23
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 23
- -1 clC-1 Proteins 0.000 description 23
- 239000000243 solution Substances 0.000 description 22
- 108091006112 ATPases Proteins 0.000 description 21
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 21
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 21
- 108020004414 DNA Proteins 0.000 description 20
- 239000002299 complementary DNA Substances 0.000 description 20
- 108090000765 processed proteins & peptides Proteins 0.000 description 20
- 241000588724 Escherichia coli Species 0.000 description 19
- 102000011731 Vacuolar Proton-Translocating ATPases Human genes 0.000 description 19
- 108010037026 Vacuolar Proton-Translocating ATPases Proteins 0.000 description 19
- 238000004458 analytical method Methods 0.000 description 19
- 230000003053 immunization Effects 0.000 description 19
- 239000002502 liposome Substances 0.000 description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 18
- 241001465754 Metazoa Species 0.000 description 17
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 17
- 210000004102 animal cell Anatomy 0.000 description 17
- 238000003018 immunoassay Methods 0.000 description 16
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 16
- 239000002609 medium Substances 0.000 description 16
- 241000699660 Mus musculus Species 0.000 description 15
- 238000002649 immunization Methods 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 15
- 230000004927 fusion Effects 0.000 description 14
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 13
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 13
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 13
- 239000000872 buffer Substances 0.000 description 13
- 235000002639 sodium chloride Nutrition 0.000 description 13
- 210000000170 cell membrane Anatomy 0.000 description 12
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 206010035226 Plasma cell myeloma Diseases 0.000 description 11
- 241000700159 Rattus Species 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- 201000000050 myeloid neoplasm Diseases 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 238000002965 ELISA Methods 0.000 description 10
- 239000004472 Lysine Substances 0.000 description 10
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 description 10
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 10
- 229940024606 amino acid Drugs 0.000 description 10
- 102000004196 processed proteins & peptides Human genes 0.000 description 10
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 9
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 9
- 238000012216 screening Methods 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 8
- 239000007995 HEPES buffer Substances 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 8
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 8
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 8
- 230000001900 immune effect Effects 0.000 description 8
- 230000037427 ion transport Effects 0.000 description 8
- 229910001414 potassium ion Inorganic materials 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 238000010186 staining Methods 0.000 description 8
- 241000283973 Oryctolagus cuniculus Species 0.000 description 7
- 235000004279 alanine Nutrition 0.000 description 7
- 238000012258 culturing Methods 0.000 description 7
- 230000003834 intracellular effect Effects 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 229910001415 sodium ion Inorganic materials 0.000 description 7
- 230000006641 stabilisation Effects 0.000 description 7
- 238000011105 stabilization Methods 0.000 description 7
- 238000005199 ultracentrifugation Methods 0.000 description 7
- 241000024188 Andala Species 0.000 description 6
- 108090000862 Ion Channels Proteins 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- 101100426590 Schizosaccharomyces pombe (strain 972 / ATCC 24843) trp2 gene Proteins 0.000 description 6
- 238000002441 X-ray diffraction Methods 0.000 description 6
- WLNARFZDISHUGS-MIXBDBMTSA-N cholesteryl hemisuccinate Chemical compound C1C=C2C[C@@H](OC(=O)CCC(O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 WLNARFZDISHUGS-MIXBDBMTSA-N 0.000 description 6
- 239000011549 crystallization solution Substances 0.000 description 6
- 239000012228 culture supernatant Substances 0.000 description 6
- 238000010828 elution Methods 0.000 description 6
- OFKDAAIKGIBASY-VFGNJEKYSA-N ergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C3=CC=CC4=NC=C([C]34)C2)=C1)C)C1=CC=CC=C1 OFKDAAIKGIBASY-VFGNJEKYSA-N 0.000 description 6
- 229960004943 ergotamine Drugs 0.000 description 6
- XCGSFFUVFURLIX-UHFFFAOYSA-N ergotaminine Natural products C1=C(C=2C=CC=C3NC=C(C=23)C2)C2N(C)CC1C(=O)NC(C(N12)=O)(C)OC1(O)C1CCCN1C(=O)C2CC1=CC=CC=C1 XCGSFFUVFURLIX-UHFFFAOYSA-N 0.000 description 6
- 239000002773 nucleotide Substances 0.000 description 6
- 125000003729 nucleotide group Chemical group 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 6
- 101150079396 trpC2 gene Proteins 0.000 description 6
- 206010003445 Ascites Diseases 0.000 description 5
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 5
- 102100022718 Atypical chemokine receptor 2 Human genes 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- 108020004635 Complementary DNA Proteins 0.000 description 5
- 101000678892 Homo sapiens Atypical chemokine receptor 2 Proteins 0.000 description 5
- 241000235058 Komagataella pastoris Species 0.000 description 5
- 108010076504 Protein Sorting Signals Proteins 0.000 description 5
- 101100100680 Schizosaccharomyces pombe (strain 972 / ATCC 24843) trp4 gene Proteins 0.000 description 5
- 229920002684 Sepharose Polymers 0.000 description 5
- 108010076818 TEV protease Proteins 0.000 description 5
- 102000003622 TRPC4 Human genes 0.000 description 5
- 102000027545 TRPM Human genes 0.000 description 5
- 108091008847 TRPM Proteins 0.000 description 5
- 108060008547 TRPM3 Proteins 0.000 description 5
- 102000003620 TRPM3 Human genes 0.000 description 5
- 101150099990 Trpc4 gene Proteins 0.000 description 5
- 150000001413 amino acids Chemical group 0.000 description 5
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 5
- 235000009582 asparagine Nutrition 0.000 description 5
- 229960001230 asparagine Drugs 0.000 description 5
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 5
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 5
- 229940098773 bovine serum albumin Drugs 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 5
- 239000003446 ligand Substances 0.000 description 5
- 230000002438 mitochondrial effect Effects 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 108020003175 receptors Proteins 0.000 description 5
- 102000005962 receptors Human genes 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 108010073969 valyllysine Proteins 0.000 description 5
- 239000011534 wash buffer Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- 101000919756 Homo sapiens Chemerin-like receptor 1 Proteins 0.000 description 4
- 101000818546 Homo sapiens N-formyl peptide receptor 2 Proteins 0.000 description 4
- 241000880493 Leptailurus serval Species 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- 102100021126 N-formyl peptide receptor 2 Human genes 0.000 description 4
- 239000004365 Protease Substances 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 4
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 4
- 239000004473 Threonine Substances 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 210000003719 b-lymphocyte Anatomy 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 108010050848 glycylleucine Proteins 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 102000049854 human CMKLR1 Human genes 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000001103 potassium chloride Substances 0.000 description 4
- 235000011164 potassium chloride Nutrition 0.000 description 4
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 4
- 235000013930 proline Nutrition 0.000 description 4
- 108010029020 prolylglycine Proteins 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 108010026333 seryl-proline Proteins 0.000 description 4
- 238000001542 size-exclusion chromatography Methods 0.000 description 4
- 239000012128 staining reagent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 4
- 230000009261 transgenic effect Effects 0.000 description 4
- 241000701447 unidentified baculovirus Species 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- IOFVWPYSRSCWHI-JXUBOQSCSA-N Ala-Thr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)N IOFVWPYSRSCWHI-JXUBOQSCSA-N 0.000 description 3
- 102100031301 Brain mitochondrial carrier protein 1 Human genes 0.000 description 3
- 101710149863 C-C chemokine receptor type 4 Proteins 0.000 description 3
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 3
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 description 3
- 102100036301 C-C chemokine receptor type 7 Human genes 0.000 description 3
- 102100025074 C-C chemokine receptor-like 2 Human genes 0.000 description 3
- 102100036846 C-C motif chemokine 21 Human genes 0.000 description 3
- 102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 description 3
- 102100039196 CX3C chemokine receptor 1 Human genes 0.000 description 3
- 241000699800 Cricetinae Species 0.000 description 3
- 101100295889 Drosophila melanogaster Orct gene Proteins 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 102100031780 Endonuclease Human genes 0.000 description 3
- 108010042407 Endonucleases Proteins 0.000 description 3
- 108091006020 Fc-tagged proteins Proteins 0.000 description 3
- BYYNJRSNDARRBX-YFKPBYRVSA-N Gly-Gln-Gly Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O BYYNJRSNDARRBX-YFKPBYRVSA-N 0.000 description 3
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 3
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 101000777114 Homo sapiens Brain mitochondrial carrier protein 1 Proteins 0.000 description 3
- 101000716068 Homo sapiens C-C chemokine receptor type 6 Proteins 0.000 description 3
- 101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 description 3
- 101000716070 Homo sapiens C-C chemokine receptor type 9 Proteins 0.000 description 3
- 101000713085 Homo sapiens C-C motif chemokine 21 Proteins 0.000 description 3
- 101000871098 Homo sapiens G-protein coupled receptor 42 Proteins 0.000 description 3
- 101000777117 Homo sapiens Mitochondrial uncoupling protein 4 Proteins 0.000 description 3
- 101000844504 Homo sapiens Transient receptor potential cation channel subfamily M member 4 Proteins 0.000 description 3
- AXNGDPAKKCEKGY-QPHKQPEJSA-N Ile-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N AXNGDPAKKCEKGY-QPHKQPEJSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 102100033588 Kidney mitochondrial carrier protein 1 Human genes 0.000 description 3
- 108010052285 Membrane Proteins Proteins 0.000 description 3
- 102100031307 Mitochondrial uncoupling protein 4 Human genes 0.000 description 3
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000012980 RPMI-1640 medium Substances 0.000 description 3
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 3
- YXEYTHXDRDAIOJ-CWRNSKLLSA-N Ser-Trp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CO)N)C(=O)O YXEYTHXDRDAIOJ-CWRNSKLLSA-N 0.000 description 3
- 101150098781 Slc25a30 gene Proteins 0.000 description 3
- 101150095096 TRPM2 gene Proteins 0.000 description 3
- 102000003618 TRPM4 Human genes 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 102000030619 alpha-1 Adrenergic Receptor Human genes 0.000 description 3
- 108020004102 alpha-1 Adrenergic Receptor Proteins 0.000 description 3
- 102000030484 alpha-2 Adrenergic Receptor Human genes 0.000 description 3
- 108020004101 alpha-2 Adrenergic Receptor Proteins 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004899 c-terminal region Anatomy 0.000 description 3
- 230000007910 cell fusion Effects 0.000 description 3
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000010218 electron microscopic analysis Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 3
- 239000005090 green fluorescent protein Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 108010034529 leucyl-lysine Proteins 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000012268 protein inhibitor Substances 0.000 description 3
- 229940121649 protein inhibitor Drugs 0.000 description 3
- 239000003725 proteoliposome Substances 0.000 description 3
- 239000000941 radioactive substance Substances 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 238000010257 thawing Methods 0.000 description 3
- 230000005030 transcription termination Effects 0.000 description 3
- ARLKVQYMFRECLV-JSGCOSHPSA-N (2s)-2-[[(2s)-2-amino-3-(1h-indol-3-yl)propanoyl]amino]-4-methylsulfanylbutanamide Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCSC)C(N)=O)=CNC2=C1 ARLKVQYMFRECLV-JSGCOSHPSA-N 0.000 description 2
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 description 2
- ZIWWTZWAKYBUOB-CIUDSAMLSA-N Ala-Asp-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O ZIWWTZWAKYBUOB-CIUDSAMLSA-N 0.000 description 2
- YEELWQSXYBJVSV-UWJYBYFXSA-N Ala-Cys-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YEELWQSXYBJVSV-UWJYBYFXSA-N 0.000 description 2
- YIGLXQRFQVWFEY-NRPADANISA-N Ala-Gln-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O YIGLXQRFQVWFEY-NRPADANISA-N 0.000 description 2
- OINVDEKBKBCPLX-JXUBOQSCSA-N Ala-Lys-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OINVDEKBKBCPLX-JXUBOQSCSA-N 0.000 description 2
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 102100035263 Anion exchange transporter Human genes 0.000 description 2
- 102100029406 Aquaporin-7 Human genes 0.000 description 2
- AOHKLEBWKMKITA-IHRRRGAJSA-N Arg-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N AOHKLEBWKMKITA-IHRRRGAJSA-N 0.000 description 2
- RLHANKIRBONJBK-IHRRRGAJSA-N Asn-Met-Phe Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC(=O)N)N RLHANKIRBONJBK-IHRRRGAJSA-N 0.000 description 2
- MKJBPDLENBUHQU-CIUDSAMLSA-N Asn-Ser-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O MKJBPDLENBUHQU-CIUDSAMLSA-N 0.000 description 2
- YNQIDCRRTWGHJD-ZLUOBGJFSA-N Asp-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(O)=O YNQIDCRRTWGHJD-ZLUOBGJFSA-N 0.000 description 2
- WMLFFCRUSPNENW-ZLUOBGJFSA-N Asp-Ser-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O WMLFFCRUSPNENW-ZLUOBGJFSA-N 0.000 description 2
- 101710150960 Bacterial non-heme ferritin Proteins 0.000 description 2
- 102100039705 Beta-2 adrenergic receptor Human genes 0.000 description 2
- 102100034159 Beta-3 adrenergic receptor Human genes 0.000 description 2
- 102100031172 C-C chemokine receptor type 1 Human genes 0.000 description 2
- 101710149814 C-C chemokine receptor type 1 Proteins 0.000 description 2
- 102100031151 C-C chemokine receptor type 2 Human genes 0.000 description 2
- 101710149815 C-C chemokine receptor type 2 Proteins 0.000 description 2
- 102100024167 C-C chemokine receptor type 3 Human genes 0.000 description 2
- 101710149862 C-C chemokine receptor type 3 Proteins 0.000 description 2
- 102100036305 C-C chemokine receptor type 8 Human genes 0.000 description 2
- 102100036166 C-X-C chemokine receptor type 1 Human genes 0.000 description 2
- 102100028989 C-X-C chemokine receptor type 2 Human genes 0.000 description 2
- 102100028990 C-X-C chemokine receptor type 3 Human genes 0.000 description 2
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 2
- 102100031658 C-X-C chemokine receptor type 5 Human genes 0.000 description 2
- 102100025618 C-X-C chemokine receptor type 6 Human genes 0.000 description 2
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 2
- 102100032996 C5a anaphylatoxin chemotactic receptor 2 Human genes 0.000 description 2
- 108091005932 CCKBR Proteins 0.000 description 2
- 108090000835 CX3C Chemokine Receptor 1 Proteins 0.000 description 2
- 101100496114 Caenorhabditis elegans clc-2 gene Proteins 0.000 description 2
- 102100036289 Calcium-binding mitochondrial carrier protein SCaMC-2 Human genes 0.000 description 2
- 101710161843 Calcium-independent mitochondrial carrier protein SCaMC-3L Proteins 0.000 description 2
- 102100033868 Cannabinoid receptor 1 Human genes 0.000 description 2
- 101710187010 Cannabinoid receptor 1 Proteins 0.000 description 2
- 102100036214 Cannabinoid receptor 2 Human genes 0.000 description 2
- 101710187022 Cannabinoid receptor 2 Proteins 0.000 description 2
- 102100035294 Chemokine XC receptor 1 Human genes 0.000 description 2
- 102100022133 Complement C3 Human genes 0.000 description 2
- 101710205889 Cytochrome b562 Proteins 0.000 description 2
- 102100034274 Diamine acetyltransferase 1 Human genes 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 102100040611 Endothelin receptor type B Human genes 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 101150050349 FFAR2 gene Proteins 0.000 description 2
- 108050000784 Ferritin Proteins 0.000 description 2
- 102000008857 Ferritin Human genes 0.000 description 2
- 238000008416 Ferritin Methods 0.000 description 2
- 101150108864 Ffar1 gene Proteins 0.000 description 2
- 101150008543 Ffar3 gene Proteins 0.000 description 2
- 102100040133 Free fatty acid receptor 2 Human genes 0.000 description 2
- 102100028461 Frizzled-9 Human genes 0.000 description 2
- 102100023328 G-protein coupled estrogen receptor 1 Human genes 0.000 description 2
- 102100033062 G-protein coupled receptor 61 Human genes 0.000 description 2
- 101150094690 GAL1 gene Proteins 0.000 description 2
- 102100028501 Galanin peptides Human genes 0.000 description 2
- YJIUYQKQBBQYHZ-ACZMJKKPSA-N Gln-Ala-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O YJIUYQKQBBQYHZ-ACZMJKKPSA-N 0.000 description 2
- XOKGKOQWADCLFQ-GARJFASQSA-N Gln-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)N)N)C(=O)O XOKGKOQWADCLFQ-GARJFASQSA-N 0.000 description 2
- RBWKVOSARCFSQQ-FXQIFTODSA-N Gln-Gln-Ser Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O RBWKVOSARCFSQQ-FXQIFTODSA-N 0.000 description 2
- GQZDDFRXSDGUNG-YVNDNENWSA-N Gln-Ile-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O GQZDDFRXSDGUNG-YVNDNENWSA-N 0.000 description 2
- SXFPZRRVWSUYII-KBIXCLLPSA-N Gln-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)N SXFPZRRVWSUYII-KBIXCLLPSA-N 0.000 description 2
- NTBDVNJIWCKURJ-ACZMJKKPSA-N Glu-Asp-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O NTBDVNJIWCKURJ-ACZMJKKPSA-N 0.000 description 2
- HJIFPJUEOGZWRI-GUBZILKMSA-N Glu-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N HJIFPJUEOGZWRI-GUBZILKMSA-N 0.000 description 2
- KRGZZKWSBGPLKL-IUCAKERBSA-N Glu-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)N KRGZZKWSBGPLKL-IUCAKERBSA-N 0.000 description 2
- GJBUAAAIZSRCDC-GVXVVHGQSA-N Glu-Leu-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O GJBUAAAIZSRCDC-GVXVVHGQSA-N 0.000 description 2
- MFNUFCFRAZPJFW-JYJNAYRXSA-N Glu-Lys-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MFNUFCFRAZPJFW-JYJNAYRXSA-N 0.000 description 2
- FFJQHWKSGAWSTJ-BFHQHQDPSA-N Gly-Thr-Ala Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O FFJQHWKSGAWSTJ-BFHQHQDPSA-N 0.000 description 2
- WTUSRDZLLWGYAT-KCTSRDHCSA-N Gly-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)CN WTUSRDZLLWGYAT-KCTSRDHCSA-N 0.000 description 2
- GBYYQVBXFVDJPJ-WLTAIBSBSA-N Gly-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)CN)O GBYYQVBXFVDJPJ-WLTAIBSBSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- CNHSMSFYVARZLI-YJRXYDGGSA-N His-His-Thr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CNHSMSFYVARZLI-YJRXYDGGSA-N 0.000 description 2
- 101000771402 Homo sapiens Aquaporin-7 Proteins 0.000 description 2
- 101000777558 Homo sapiens C-C chemokine receptor type 10 Proteins 0.000 description 2
- 101000716063 Homo sapiens C-C chemokine receptor type 8 Proteins 0.000 description 2
- 101000947174 Homo sapiens C-X-C chemokine receptor type 1 Proteins 0.000 description 2
- 101000916050 Homo sapiens C-X-C chemokine receptor type 3 Proteins 0.000 description 2
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 2
- 101000922405 Homo sapiens C-X-C chemokine receptor type 5 Proteins 0.000 description 2
- 101000856683 Homo sapiens C-X-C chemokine receptor type 6 Proteins 0.000 description 2
- 101000868001 Homo sapiens C5a anaphylatoxin chemotactic receptor 2 Proteins 0.000 description 2
- 101000804783 Homo sapiens Chemokine XC receptor 1 Proteins 0.000 description 2
- 101000901154 Homo sapiens Complement C3 Proteins 0.000 description 2
- 101000641077 Homo sapiens Diamine acetyltransferase 1 Proteins 0.000 description 2
- 101000967299 Homo sapiens Endothelin receptor type B Proteins 0.000 description 2
- 101001061405 Homo sapiens Frizzled-9 Proteins 0.000 description 2
- 101000829902 Homo sapiens G-protein coupled estrogen receptor 1 Proteins 0.000 description 2
- 101000871155 Homo sapiens G-protein coupled receptor 61 Proteins 0.000 description 2
- 101100121078 Homo sapiens GAL gene Proteins 0.000 description 2
- 101001080225 Homo sapiens Hematopoietic SH2 domain-containing protein Proteins 0.000 description 2
- 101001034207 Homo sapiens Mitochondrial folate transporter/carrier Proteins 0.000 description 2
- 101000577126 Homo sapiens Monocarboxylate transporter 4 Proteins 0.000 description 2
- 101000577129 Homo sapiens Monocarboxylate transporter 5 Proteins 0.000 description 2
- 101000577131 Homo sapiens Monocarboxylate transporter 6 Proteins 0.000 description 2
- 101000577033 Homo sapiens Monocarboxylate transporter 7 Proteins 0.000 description 2
- 101000987117 Homo sapiens Monocarboxylate transporter 8 Proteins 0.000 description 2
- 101001059802 Homo sapiens N-formyl peptide receptor 3 Proteins 0.000 description 2
- 101000821902 Homo sapiens Solute carrier family 22 member 11 Proteins 0.000 description 2
- 101000727802 Homo sapiens Sulfate transporter Proteins 0.000 description 2
- 101000889890 Homo sapiens Testis-expressed protein 11 Proteins 0.000 description 2
- 101000844510 Homo sapiens Transient receptor potential cation channel subfamily M member 1 Proteins 0.000 description 2
- 101000844518 Homo sapiens Transient receptor potential cation channel subfamily M member 7 Proteins 0.000 description 2
- 101000685830 Homo sapiens Zinc transporter ZIP4 Proteins 0.000 description 2
- 101000818522 Homo sapiens fMet-Leu-Phe receptor Proteins 0.000 description 2
- HVWXAQVMRBKKFE-UGYAYLCHSA-N Ile-Asp-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N HVWXAQVMRBKKFE-UGYAYLCHSA-N 0.000 description 2
- DFJJAVZIHDFOGQ-MNXVOIDGSA-N Ile-Glu-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N DFJJAVZIHDFOGQ-MNXVOIDGSA-N 0.000 description 2
- PWUMCBLVWPCKNO-MGHWNKPDSA-N Ile-Leu-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PWUMCBLVWPCKNO-MGHWNKPDSA-N 0.000 description 2
- FBGXMKUWQFPHFB-JBDRJPRFSA-N Ile-Ser-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N FBGXMKUWQFPHFB-JBDRJPRFSA-N 0.000 description 2
- ZLFNNVATRMCAKN-ZKWXMUAHSA-N Ile-Ser-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N ZLFNNVATRMCAKN-ZKWXMUAHSA-N 0.000 description 2
- BCISUQVFDGYZBO-QSFUFRPTSA-N Ile-Val-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(O)=O BCISUQVFDGYZBO-QSFUFRPTSA-N 0.000 description 2
- 206010061598 Immunodeficiency Diseases 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
- 108010018951 Interleukin-8B Receptors Proteins 0.000 description 2
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- SUPVSFFZWVOEOI-CQDKDKBSSA-N Leu-Ala-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 SUPVSFFZWVOEOI-CQDKDKBSSA-N 0.000 description 2
- SUPVSFFZWVOEOI-UHFFFAOYSA-N Leu-Ala-Tyr Natural products CC(C)CC(N)C(=O)NC(C)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 SUPVSFFZWVOEOI-UHFFFAOYSA-N 0.000 description 2
- JKGHDYGZRDWHGA-SRVKXCTJSA-N Leu-Asn-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JKGHDYGZRDWHGA-SRVKXCTJSA-N 0.000 description 2
- KAFOIVJDVSZUMD-DCAQKATOSA-N Leu-Gln-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-DCAQKATOSA-N 0.000 description 2
- KAFOIVJDVSZUMD-UHFFFAOYSA-N Leu-Gln-Gln Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-UHFFFAOYSA-N 0.000 description 2
- QVFGXCVIXXBFHO-AVGNSLFASA-N Leu-Glu-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O QVFGXCVIXXBFHO-AVGNSLFASA-N 0.000 description 2
- JFSGIJSCJFQGSZ-MXAVVETBSA-N Leu-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(C)C)N JFSGIJSCJFQGSZ-MXAVVETBSA-N 0.000 description 2
- KWLWZYMNUZJKMZ-IHRRRGAJSA-N Leu-Pro-Leu Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O KWLWZYMNUZJKMZ-IHRRRGAJSA-N 0.000 description 2
- UWKNTTJNVSYXPC-CIUDSAMLSA-N Lys-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN UWKNTTJNVSYXPC-CIUDSAMLSA-N 0.000 description 2
- GJJQCBVRWDGLMQ-GUBZILKMSA-N Lys-Glu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O GJJQCBVRWDGLMQ-GUBZILKMSA-N 0.000 description 2
- NKKFVJRLCCUJNA-QWRGUYRKSA-N Lys-Gly-Lys Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN NKKFVJRLCCUJNA-QWRGUYRKSA-N 0.000 description 2
- PRSBSVAVOQOAMI-BJDJZHNGSA-N Lys-Ile-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCCCN PRSBSVAVOQOAMI-BJDJZHNGSA-N 0.000 description 2
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 2
- MIMXMVDLMDMOJD-BZSNNMDCSA-N Lys-Tyr-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O MIMXMVDLMDMOJD-BZSNNMDCSA-N 0.000 description 2
- 102000018697 Membrane Proteins Human genes 0.000 description 2
- IYXDSYWCVVXSKB-CIUDSAMLSA-N Met-Asn-Glu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O IYXDSYWCVVXSKB-CIUDSAMLSA-N 0.000 description 2
- IHITVQKJXQQGLJ-LPEHRKFASA-N Met-Asn-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N IHITVQKJXQQGLJ-LPEHRKFASA-N 0.000 description 2
- VOOINLQYUZOREH-SRVKXCTJSA-N Met-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCSC)N VOOINLQYUZOREH-SRVKXCTJSA-N 0.000 description 2
- 108010050258 Mitochondrial Uncoupling Proteins Proteins 0.000 description 2
- 102100029820 Mitochondrial brown fat uncoupling protein 1 Human genes 0.000 description 2
- 102100032415 Mitochondrial carrier protein SCaMC-3L Human genes 0.000 description 2
- 101710101793 Mitochondrial carrier protein SCaMC-3L Proteins 0.000 description 2
- 102100039811 Mitochondrial folate transporter/carrier Human genes 0.000 description 2
- 102100032118 Mitochondrial outer membrane protein SLC25A46 Human genes 0.000 description 2
- 102100040200 Mitochondrial uncoupling protein 2 Human genes 0.000 description 2
- 102100040216 Mitochondrial uncoupling protein 3 Human genes 0.000 description 2
- 102100025273 Monocarboxylate transporter 5 Human genes 0.000 description 2
- 102100028130 N-formyl peptide receptor 3 Human genes 0.000 description 2
- 108010079364 N-glycylalanine Proteins 0.000 description 2
- 101000610236 Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576) Protein PatA Proteins 0.000 description 2
- 108010067244 Origin Recognition Complex Proteins 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- 102100035278 Pendrin Human genes 0.000 description 2
- 108050001616 Pendrin Proteins 0.000 description 2
- 102100037882 Perilipin-5 Human genes 0.000 description 2
- IUVYJBMTHARMIP-PCBIJLKTSA-N Phe-Asp-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O IUVYJBMTHARMIP-PCBIJLKTSA-N 0.000 description 2
- CUMXHKAOHNWRFQ-BZSNNMDCSA-N Phe-Asp-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 CUMXHKAOHNWRFQ-BZSNNMDCSA-N 0.000 description 2
- AXIOGMQCDYVTNY-ACRUOGEOSA-N Phe-Phe-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 AXIOGMQCDYVTNY-ACRUOGEOSA-N 0.000 description 2
- MMJJFXWMCMJMQA-STQMWFEESA-N Phe-Pro-Gly Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)C1=CC=CC=C1 MMJJFXWMCMJMQA-STQMWFEESA-N 0.000 description 2
- ZCXQTRXYZOSGJR-FXQIFTODSA-N Pro-Asp-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O ZCXQTRXYZOSGJR-FXQIFTODSA-N 0.000 description 2
- PTLOFJZJADCNCD-DCAQKATOSA-N Pro-Glu-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1 PTLOFJZJADCNCD-DCAQKATOSA-N 0.000 description 2
- DXTOOBDIIAJZBJ-BQBZGAKWSA-N Pro-Gly-Ser Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(O)=O DXTOOBDIIAJZBJ-BQBZGAKWSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 102100032018 Putative solute carrier family 35 member G4 Human genes 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 108091006455 SLC25A25 Proteins 0.000 description 2
- 108091006473 SLC25A33 Proteins 0.000 description 2
- 108091006467 SLC25A36 Proteins 0.000 description 2
- 108091006481 SLC25A46 Proteins 0.000 description 2
- 108091006503 SLC26A1 Proteins 0.000 description 2
- 108091006516 SLC26A7 Proteins 0.000 description 2
- 108091006518 SLC26A9 Proteins 0.000 description 2
- 108091006269 SLC5A2 Proteins 0.000 description 2
- FMDHKPRACUXATF-ACZMJKKPSA-N Ser-Gln-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O FMDHKPRACUXATF-ACZMJKKPSA-N 0.000 description 2
- BPMRXBZYPGYPJN-WHFBIAKZSA-N Ser-Gly-Asn Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O BPMRXBZYPGYPJN-WHFBIAKZSA-N 0.000 description 2
- KDGARKCAKHBEDB-NKWVEPMBSA-N Ser-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CO)N)C(=O)O KDGARKCAKHBEDB-NKWVEPMBSA-N 0.000 description 2
- BEBVVQPDSHHWQL-NRPADANISA-N Ser-Val-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O BEBVVQPDSHHWQL-NRPADANISA-N 0.000 description 2
- LGIMRDKGABDMBN-DCAQKATOSA-N Ser-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N LGIMRDKGABDMBN-DCAQKATOSA-N 0.000 description 2
- 108010087132 Sodium-Bicarbonate Symporters Proteins 0.000 description 2
- 102100020888 Sodium/glucose cotransporter 2 Human genes 0.000 description 2
- 102100039667 Solute carrier family 2, facilitated glucose transporter member 11 Human genes 0.000 description 2
- 102100039671 Solute carrier family 2, facilitated glucose transporter member 12 Human genes 0.000 description 2
- 102100022720 Solute carrier family 2, facilitated glucose transporter member 6 Human genes 0.000 description 2
- 102100021493 Solute carrier family 22 member 11 Human genes 0.000 description 2
- 102100021543 Solute carrier family 22 member 16 Human genes 0.000 description 2
- 102100033827 Solute carrier family 25 member 33 Human genes 0.000 description 2
- 102100030106 Solute carrier family 25 member 36 Human genes 0.000 description 2
- 102100035267 Solute carrier family 26 member 9 Human genes 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 101000757768 Strongylocentrotus purpuratus Aristaless homeobox protein Proteins 0.000 description 2
- 102100030113 Sulfate transporter Human genes 0.000 description 2
- 102000003627 TRPC1 Human genes 0.000 description 2
- 101150017559 TRPC1 gene Proteins 0.000 description 2
- 102000003617 TRPM1 Human genes 0.000 description 2
- 102000003615 TRPM2 Human genes 0.000 description 2
- 102000003611 TRPM7 Human genes 0.000 description 2
- JMZKMSTYXHFYAK-VEVYYDQMSA-N Thr-Arg-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O JMZKMSTYXHFYAK-VEVYYDQMSA-N 0.000 description 2
- GZYNMZQXFRWDFH-YTWAJWBKSA-N Thr-Arg-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N)O GZYNMZQXFRWDFH-YTWAJWBKSA-N 0.000 description 2
- YDWLCDQXLCILCZ-BWAGICSOSA-N Thr-His-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YDWLCDQXLCILCZ-BWAGICSOSA-N 0.000 description 2
- XHWCDRUPDNSDAZ-XKBZYTNZSA-N Thr-Ser-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N)O XHWCDRUPDNSDAZ-XKBZYTNZSA-N 0.000 description 2
- WPSKTVVMQCXPRO-BWBBJGPYSA-N Thr-Ser-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WPSKTVVMQCXPRO-BWBBJGPYSA-N 0.000 description 2
- IEZVHOULSUULHD-XGEHTFHBSA-N Thr-Ser-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O IEZVHOULSUULHD-XGEHTFHBSA-N 0.000 description 2
- BBPCSGKKPJUYRB-UVOCVTCTSA-N Thr-Thr-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O BBPCSGKKPJUYRB-UVOCVTCTSA-N 0.000 description 2
- MNYNCKZAEIAONY-XGEHTFHBSA-N Thr-Val-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O MNYNCKZAEIAONY-XGEHTFHBSA-N 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- SNJAPSVIPKUMCK-NWLDYVSISA-N Trp-Glu-Thr Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SNJAPSVIPKUMCK-NWLDYVSISA-N 0.000 description 2
- FBGDDUKYOBNZJL-WDSOQIARSA-N Trp-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N FBGDDUKYOBNZJL-WDSOQIARSA-N 0.000 description 2
- LGEYOIQBBIPHQN-UWJYBYFXSA-N Tyr-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 LGEYOIQBBIPHQN-UWJYBYFXSA-N 0.000 description 2
- NXRGXTBPMOGFID-CFMVVWHZSA-N Tyr-Ile-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O NXRGXTBPMOGFID-CFMVVWHZSA-N 0.000 description 2
- AXWBYOVVDRBOGU-SIUGBPQLSA-N Tyr-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N AXWBYOVVDRBOGU-SIUGBPQLSA-N 0.000 description 2
- UPODKYBYUBTWSV-BZSNNMDCSA-N Tyr-Phe-Cys Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CS)C(O)=O)C1=CC=C(O)C=C1 UPODKYBYUBTWSV-BZSNNMDCSA-N 0.000 description 2
- OJCISMMNNUNNJA-BZSNNMDCSA-N Tyr-Tyr-Asp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CC=C(O)C=C1 OJCISMMNNUNNJA-BZSNNMDCSA-N 0.000 description 2
- 108010021111 Uncoupling Protein 2 Proteins 0.000 description 2
- 108010021098 Uncoupling Protein 3 Proteins 0.000 description 2
- BEGDZYNDCNEGJZ-XVKPBYJWSA-N Val-Gly-Gln Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O BEGDZYNDCNEGJZ-XVKPBYJWSA-N 0.000 description 2
- ZEBRMWPTJNHXAJ-JYJNAYRXSA-N Val-Phe-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(=O)O)N ZEBRMWPTJNHXAJ-JYJNAYRXSA-N 0.000 description 2
- KSFXWENSJABBFI-ZKWXMUAHSA-N Val-Ser-Asn Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O KSFXWENSJABBFI-ZKWXMUAHSA-N 0.000 description 2
- HWNYVQMOLCYHEA-IHRRRGAJSA-N Val-Ser-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N HWNYVQMOLCYHEA-IHRRRGAJSA-N 0.000 description 2
- WUFHZIRMAZZWRS-OSUNSFLBSA-N Val-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C(C)C)N WUFHZIRMAZZWRS-OSUNSFLBSA-N 0.000 description 2
- DVLWZWNAQUBZBC-ZNSHCXBVSA-N Val-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N)O DVLWZWNAQUBZBC-ZNSHCXBVSA-N 0.000 description 2
- 101100264077 Xenopus laevis wrn gene Proteins 0.000 description 2
- 102100023140 Zinc transporter ZIP4 Human genes 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000000556 agonist Substances 0.000 description 2
- 108010086434 alanyl-seryl-glycine Proteins 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 description 2
- 108010014502 beta-3 Adrenergic Receptors Proteins 0.000 description 2
- 238000013357 binding ELISA Methods 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000007876 drug discovery Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 102100021145 fMet-Leu-Phe receptor Human genes 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 108010079413 glycyl-prolyl-glutamic acid Proteins 0.000 description 2
- 108010089804 glycyl-threonine Proteins 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 2
- OHMBHFSEKCCCBW-UHFFFAOYSA-N hexane-2,5-diol Chemical compound CC(O)CCC(C)O OHMBHFSEKCCCBW-UHFFFAOYSA-N 0.000 description 2
- 108010036413 histidylglycine Proteins 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000003119 immunoblot Methods 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 230000016784 immunoglobulin production Effects 0.000 description 2
- 108010078274 isoleucylvaline Proteins 0.000 description 2
- 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- IIPYXGDZVMZOAP-UHFFFAOYSA-N lithium nitrate Chemical compound [Li+].[O-][N+]([O-])=O IIPYXGDZVMZOAP-UHFFFAOYSA-N 0.000 description 2
- 108010057952 lysyl-phenylalanyl-lysine Proteins 0.000 description 2
- MFUVDXOKPBAHMC-UHFFFAOYSA-N magnesium;dinitrate;hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O MFUVDXOKPBAHMC-UHFFFAOYSA-N 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 108010005942 methionylglycine Proteins 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000011580 nude mouse model Methods 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 108010064486 phenylalanyl-leucyl-valine Proteins 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 238000011197 physicochemical method Methods 0.000 description 2
- 229920002523 polyethylene Glycol 1000 Polymers 0.000 description 2
- 229940113116 polyethylene glycol 1000 Drugs 0.000 description 2
- 229940068886 polyethylene glycol 300 Drugs 0.000 description 2
- 230000004481 post-translational protein modification Effects 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 150000003148 prolines Chemical class 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 108010071207 serylmethionine Proteins 0.000 description 2
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 2
- CSRCBLMBBOJYEX-UHFFFAOYSA-M sodium;2-morpholin-4-ylethanesulfonic acid;hydroxide Chemical compound [OH-].[Na+].OS(=O)(=O)CCN1CCOCC1 CSRCBLMBBOJYEX-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000004989 spleen cell Anatomy 0.000 description 2
- 239000013595 supernatant sample Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
- 108010084932 tryptophyl-proline Proteins 0.000 description 2
- PBYZMCDFOULPGH-UHFFFAOYSA-N tungstate Chemical compound [O-][W]([O-])(=O)=O PBYZMCDFOULPGH-UHFFFAOYSA-N 0.000 description 2
- 108010003137 tyrosyltyrosine Proteins 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- XVZCXCTYGHPNEM-IHRRRGAJSA-N (2s)-1-[(2s)-2-[[(2s)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O XVZCXCTYGHPNEM-IHRRRGAJSA-N 0.000 description 1
- HWFKCAFKXZFOQT-UHFFFAOYSA-N 1-(3,6-dibromocarbazol-9-yl)-3-piperazin-1-ylpropan-2-ol;dihydrochloride Chemical compound Cl.Cl.C12=CC=C(Br)C=C2C2=CC(Br)=CC=C2N1CC(O)CN1CCNCC1 HWFKCAFKXZFOQT-UHFFFAOYSA-N 0.000 description 1
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- 102100036933 12-(S)-hydroxy-5,8,10,14-eicosatetraenoic acid receptor Human genes 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- RNIPJYFZGXJSDD-UHFFFAOYSA-N 2,4,5-triphenyl-1h-imidazole Chemical compound C1=CC=CC=C1C1=NC(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)N1 RNIPJYFZGXJSDD-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 1
- YQNRVGJCPCNMKT-JLPGSUDCSA-N 2-(4-benzylpiperazin-1-yl)-n-[(2-hydroxy-3-prop-2-enyl-phenyl)methylideneamino]acetamide Chemical compound OC1=C(CC=C)C=CC=C1\C=N/NC(=O)CN1CCN(CC=2C=CC=CC=2)CC1 YQNRVGJCPCNMKT-JLPGSUDCSA-N 0.000 description 1
- ONEGZXHXCLCVRF-UHFFFAOYSA-N 2-[[2-[[1-(2-amino-3-methylbutanoyl)pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoic acid Chemical compound CC(C)CC(C(O)=O)NC(=O)C(C(C)C)NC(=O)C1CCCN1C(=O)C(N)C(C)C ONEGZXHXCLCVRF-UHFFFAOYSA-N 0.000 description 1
- 102100039463 2-oxoglutarate receptor 1 Human genes 0.000 description 1
- SIVJKYRAPQKLIM-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-n-(3-fluoro-5-morpholin-4-ylphenyl)propanamide Chemical compound C=1C(N2CCOCC2)=CC(F)=CC=1NC(=O)CCC1=CC=C(F)C(F)=C1 SIVJKYRAPQKLIM-UHFFFAOYSA-N 0.000 description 1
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
- TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
- 102100033400 4F2 cell-surface antigen heavy chain Human genes 0.000 description 1
- 229940116892 5 Hydroxytryptamine 2B receptor antagonist Drugs 0.000 description 1
- 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 description 1
- 101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 description 1
- 102100027499 5-hydroxytryptamine receptor 1B Human genes 0.000 description 1
- 101710138639 5-hydroxytryptamine receptor 1B Proteins 0.000 description 1
- 102100027493 5-hydroxytryptamine receptor 1D Human genes 0.000 description 1
- 101710138068 5-hydroxytryptamine receptor 1D Proteins 0.000 description 1
- 102100036311 5-hydroxytryptamine receptor 1F Human genes 0.000 description 1
- 101710138086 5-hydroxytryptamine receptor 1F Proteins 0.000 description 1
- 102100036321 5-hydroxytryptamine receptor 2A Human genes 0.000 description 1
- 101710138091 5-hydroxytryptamine receptor 2A Proteins 0.000 description 1
- 102100024956 5-hydroxytryptamine receptor 2B Human genes 0.000 description 1
- 101710138092 5-hydroxytryptamine receptor 2B Proteins 0.000 description 1
- 102100024959 5-hydroxytryptamine receptor 2C Human genes 0.000 description 1
- 101710138093 5-hydroxytryptamine receptor 2C Proteins 0.000 description 1
- 102100040385 5-hydroxytryptamine receptor 4 Human genes 0.000 description 1
- 101710150225 5-hydroxytryptamine receptor 4 Proteins 0.000 description 1
- 102100039126 5-hydroxytryptamine receptor 7 Human genes 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 229960005508 8-azaguanine Drugs 0.000 description 1
- LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 1
- 102100028281 ABC-type oligopeptide transporter ABCB9 Human genes 0.000 description 1
- 102100036614 ABC-type organic anion transporter ABCA8 Human genes 0.000 description 1
- 108091005560 ADGRG3 Proteins 0.000 description 1
- 102100032533 ADP/ATP translocase 1 Human genes 0.000 description 1
- 102100026396 ADP/ATP translocase 2 Human genes 0.000 description 1
- 102100026397 ADP/ATP translocase 3 Human genes 0.000 description 1
- 102100026400 ADP/ATP translocase 4 Human genes 0.000 description 1
- 102100039602 ARF GTPase-activating protein GIT2 Human genes 0.000 description 1
- 102100027520 ATP synthase mitochondrial F1 complex assembly factor 2 Human genes 0.000 description 1
- 102100036622 ATP-binding cassette sub-family A member 10 Human genes 0.000 description 1
- 102100036618 ATP-binding cassette sub-family A member 13 Human genes 0.000 description 1
- 102100033618 ATP-binding cassette sub-family A member 2 Human genes 0.000 description 1
- 102100036612 ATP-binding cassette sub-family A member 6 Human genes 0.000 description 1
- 102100036613 ATP-binding cassette sub-family A member 9 Human genes 0.000 description 1
- 102100028280 ATP-binding cassette sub-family B member 10, mitochondrial Human genes 0.000 description 1
- 102100021501 ATP-binding cassette sub-family B member 5 Human genes 0.000 description 1
- 102100021503 ATP-binding cassette sub-family B member 6 Human genes 0.000 description 1
- 102100037128 ATP-binding cassette sub-family C member 10 Human genes 0.000 description 1
- 102100037129 ATP-binding cassette sub-family C member 11 Human genes 0.000 description 1
- 102100037131 ATP-binding cassette sub-family C member 12 Human genes 0.000 description 1
- 102100028161 ATP-binding cassette sub-family C member 2 Human genes 0.000 description 1
- 102100028162 ATP-binding cassette sub-family C member 3 Human genes 0.000 description 1
- 102100028163 ATP-binding cassette sub-family C member 4 Human genes 0.000 description 1
- 102100028186 ATP-binding cassette sub-family C member 5 Human genes 0.000 description 1
- 102100028187 ATP-binding cassette sub-family C member 6 Human genes 0.000 description 1
- 102100024645 ATP-binding cassette sub-family C member 8 Human genes 0.000 description 1
- 102100024642 ATP-binding cassette sub-family C member 9 Human genes 0.000 description 1
- 102100024643 ATP-binding cassette sub-family D member 1 Human genes 0.000 description 1
- 102100020970 ATP-binding cassette sub-family D member 2 Human genes 0.000 description 1
- 102100020973 ATP-binding cassette sub-family D member 3 Human genes 0.000 description 1
- 102100022594 ATP-binding cassette sub-family G member 1 Human genes 0.000 description 1
- 102100033094 ATP-binding cassette sub-family G member 4 Human genes 0.000 description 1
- 102100033106 ATP-binding cassette sub-family G member 5 Human genes 0.000 description 1
- 102100033092 ATP-binding cassette sub-family G member 8 Human genes 0.000 description 1
- 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 description 1
- 101150065370 ATP10 gene Proteins 0.000 description 1
- 102000007471 Adenosine A2A receptor Human genes 0.000 description 1
- 108010085277 Adenosine A2A receptor Proteins 0.000 description 1
- 102100024437 Adhesion G protein-coupled receptor A1 Human genes 0.000 description 1
- 102100024439 Adhesion G protein-coupled receptor A2 Human genes 0.000 description 1
- 102100024438 Adhesion G protein-coupled receptor A3 Human genes 0.000 description 1
- 102100032605 Adhesion G protein-coupled receptor B1 Human genes 0.000 description 1
- 102100032601 Adhesion G protein-coupled receptor B2 Human genes 0.000 description 1
- 102100032599 Adhesion G protein-coupled receptor B3 Human genes 0.000 description 1
- 102100026402 Adhesion G protein-coupled receptor E2 Human genes 0.000 description 1
- 102100026425 Adhesion G protein-coupled receptor E3 Human genes 0.000 description 1
- 102100026423 Adhesion G protein-coupled receptor E5 Human genes 0.000 description 1
- 102100031932 Adhesion G protein-coupled receptor F4 Human genes 0.000 description 1
- 102100031933 Adhesion G protein-coupled receptor F5 Human genes 0.000 description 1
- 102100040037 Adhesion G protein-coupled receptor G3 Human genes 0.000 description 1
- 102100039736 Adhesion G protein-coupled receptor L1 Human genes 0.000 description 1
- 102100036791 Adhesion G protein-coupled receptor L2 Human genes 0.000 description 1
- 102100036793 Adhesion G protein-coupled receptor L3 Human genes 0.000 description 1
- 102100036792 Adhesion G protein-coupled receptor L4 Human genes 0.000 description 1
- 102100026441 Adhesion G-protein coupled receptor D1 Human genes 0.000 description 1
- 102100026438 Adhesion G-protein coupled receptor D2 Human genes 0.000 description 1
- 102100026443 Adhesion G-protein coupled receptor F1 Human genes 0.000 description 1
- 102100031931 Adhesion G-protein coupled receptor F2 Human genes 0.000 description 1
- 102100031927 Adhesion G-protein coupled receptor F3 Human genes 0.000 description 1
- 102100031934 Adhesion G-protein coupled receptor G1 Human genes 0.000 description 1
- 102100031836 Adhesion G-protein coupled receptor G2 Human genes 0.000 description 1
- 102100040036 Adhesion G-protein coupled receptor G4 Human genes 0.000 description 1
- 102100040024 Adhesion G-protein coupled receptor G5 Human genes 0.000 description 1
- 102100040023 Adhesion G-protein coupled receptor G6 Human genes 0.000 description 1
- 102100039732 Adhesion G-protein coupled receptor G7 Human genes 0.000 description 1
- 102100036799 Adhesion G-protein coupled receptor V1 Human genes 0.000 description 1
- 108060003345 Adrenergic Receptor Proteins 0.000 description 1
- 102000017910 Adrenergic receptor Human genes 0.000 description 1
- 102100036601 Aggrecan core protein Human genes 0.000 description 1
- HHGYNJRJIINWAK-FXQIFTODSA-N Ala-Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HHGYNJRJIINWAK-FXQIFTODSA-N 0.000 description 1
- DKJPOZOEBONHFS-ZLUOBGJFSA-N Ala-Ala-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O DKJPOZOEBONHFS-ZLUOBGJFSA-N 0.000 description 1
- BUANFPRKJKJSRR-ACZMJKKPSA-N Ala-Ala-Gln Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](C)C(=O)N[C@H](C([O-])=O)CCC(N)=O BUANFPRKJKJSRR-ACZMJKKPSA-N 0.000 description 1
- YLTKNGYYPIWKHZ-ACZMJKKPSA-N Ala-Ala-Glu Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O YLTKNGYYPIWKHZ-ACZMJKKPSA-N 0.000 description 1
- VBDMWOKJZDCFJM-FXQIFTODSA-N Ala-Ala-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N VBDMWOKJZDCFJM-FXQIFTODSA-N 0.000 description 1
- PXKLCFFSVLKOJM-ACZMJKKPSA-N Ala-Asn-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PXKLCFFSVLKOJM-ACZMJKKPSA-N 0.000 description 1
- FXKNPWNXPQZLES-ZLUOBGJFSA-N Ala-Asn-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O FXKNPWNXPQZLES-ZLUOBGJFSA-N 0.000 description 1
- GSCLWXDNIMNIJE-ZLUOBGJFSA-N Ala-Asp-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O GSCLWXDNIMNIJE-ZLUOBGJFSA-N 0.000 description 1
- NJIFPLAJSVUQOZ-JBDRJPRFSA-N Ala-Cys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)N NJIFPLAJSVUQOZ-JBDRJPRFSA-N 0.000 description 1
- LGFCAXJBAZESCF-ACZMJKKPSA-N Ala-Gln-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O LGFCAXJBAZESCF-ACZMJKKPSA-N 0.000 description 1
- AWAXZRDKUHOPBO-GUBZILKMSA-N Ala-Gln-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O AWAXZRDKUHOPBO-GUBZILKMSA-N 0.000 description 1
- BGNLUHXLSAQYRQ-FXQIFTODSA-N Ala-Glu-Gln Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O BGNLUHXLSAQYRQ-FXQIFTODSA-N 0.000 description 1
- QHASENCZLDHBGX-ONGXEEELSA-N Ala-Gly-Phe Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QHASENCZLDHBGX-ONGXEEELSA-N 0.000 description 1
- OBVSBEYOMDWLRJ-BFHQHQDPSA-N Ala-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N OBVSBEYOMDWLRJ-BFHQHQDPSA-N 0.000 description 1
- KMGOBAQSCKTBGD-DLOVCJGASA-N Ala-His-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CN=CN1 KMGOBAQSCKTBGD-DLOVCJGASA-N 0.000 description 1
- PNALXAODQKTNLV-JBDRJPRFSA-N Ala-Ile-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O PNALXAODQKTNLV-JBDRJPRFSA-N 0.000 description 1
- LBYMZCVBOKYZNS-CIUDSAMLSA-N Ala-Leu-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O LBYMZCVBOKYZNS-CIUDSAMLSA-N 0.000 description 1
- MNZHHDPWDWQJCQ-YUMQZZPRSA-N Ala-Leu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O MNZHHDPWDWQJCQ-YUMQZZPRSA-N 0.000 description 1
- AWZKCUCQJNTBAD-SRVKXCTJSA-N Ala-Leu-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN AWZKCUCQJNTBAD-SRVKXCTJSA-N 0.000 description 1
- SOBIAADAMRHGKH-CIUDSAMLSA-N Ala-Leu-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SOBIAADAMRHGKH-CIUDSAMLSA-N 0.000 description 1
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 1
- REAQAWSENITKJL-DDWPSWQVSA-N Ala-Met-Asp-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O REAQAWSENITKJL-DDWPSWQVSA-N 0.000 description 1
- OARAZORWIMYUPO-FXQIFTODSA-N Ala-Met-Cys Chemical compound CSCC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CS)C(O)=O OARAZORWIMYUPO-FXQIFTODSA-N 0.000 description 1
- DEWWPUNXRNGMQN-LPEHRKFASA-N Ala-Met-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@@H]1C(=O)O)N DEWWPUNXRNGMQN-LPEHRKFASA-N 0.000 description 1
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 1
- VJVQKGYHIZPSNS-FXQIFTODSA-N Ala-Ser-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N VJVQKGYHIZPSNS-FXQIFTODSA-N 0.000 description 1
- YYAVDNKUWLAFCV-ACZMJKKPSA-N Ala-Ser-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O YYAVDNKUWLAFCV-ACZMJKKPSA-N 0.000 description 1
- JJHBEVZAZXZREW-LFSVMHDDSA-N Ala-Thr-Phe Chemical compound C[C@@H](O)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O JJHBEVZAZXZREW-LFSVMHDDSA-N 0.000 description 1
- QOIGKCBMXUCDQU-KDXUFGMBSA-N Ala-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N)O QOIGKCBMXUCDQU-KDXUFGMBSA-N 0.000 description 1
- GCTANJIJJROSLH-GVARAGBVSA-N Ala-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C)N GCTANJIJJROSLH-GVARAGBVSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 108010032595 Antibody Binding Sites Proteins 0.000 description 1
- 102100030346 Antigen peptide transporter 1 Human genes 0.000 description 1
- 102100030343 Antigen peptide transporter 2 Human genes 0.000 description 1
- 108090001004 Aquaporin 1 Proteins 0.000 description 1
- 102000004888 Aquaporin 1 Human genes 0.000 description 1
- 108010036221 Aquaporin 2 Proteins 0.000 description 1
- 102000004363 Aquaporin 3 Human genes 0.000 description 1
- 108090000991 Aquaporin 3 Proteins 0.000 description 1
- 108010036280 Aquaporin 4 Proteins 0.000 description 1
- 108090000976 Aquaporin 5 Proteins 0.000 description 1
- 102000004392 Aquaporin 5 Human genes 0.000 description 1
- 102000004391 Aquaporin 6 Human genes 0.000 description 1
- 108090000977 Aquaporin 6 Proteins 0.000 description 1
- 102100023649 Aquaporin-10 Human genes 0.000 description 1
- 102100034414 Aquaporin-2 Human genes 0.000 description 1
- 102100037276 Aquaporin-4 Human genes 0.000 description 1
- 102100029463 Aquaporin-8 Human genes 0.000 description 1
- 101100505291 Arabidopsis thaliana GC2 gene Proteins 0.000 description 1
- 101100532536 Arabidopsis thaliana SAMC1 gene Proteins 0.000 description 1
- 101100489389 Arabidopsis thaliana ZIP11 gene Proteins 0.000 description 1
- 101100489390 Arabidopsis thaliana ZIP12 gene Proteins 0.000 description 1
- GIVATXIGCXFQQA-FXQIFTODSA-N Arg-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N GIVATXIGCXFQQA-FXQIFTODSA-N 0.000 description 1
- DCGLNNVKIZXQOJ-FXQIFTODSA-N Arg-Asn-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N DCGLNNVKIZXQOJ-FXQIFTODSA-N 0.000 description 1
- DPXDVGDLWJYZBH-GUBZILKMSA-N Arg-Asn-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O DPXDVGDLWJYZBH-GUBZILKMSA-N 0.000 description 1
- HJAICMSAKODKRF-GUBZILKMSA-N Arg-Cys-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O HJAICMSAKODKRF-GUBZILKMSA-N 0.000 description 1
- XTGGTAWGUFXJSV-NAKRPEOUSA-N Arg-Cys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCN=C(N)N)N XTGGTAWGUFXJSV-NAKRPEOUSA-N 0.000 description 1
- MSILNNHVVMMTHZ-UWVGGRQHSA-N Arg-His-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CN=CN1 MSILNNHVVMMTHZ-UWVGGRQHSA-N 0.000 description 1
- UGZUVYDKAYNCII-ULQDDVLXSA-N Arg-Phe-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O UGZUVYDKAYNCII-ULQDDVLXSA-N 0.000 description 1
- OQPAZKMGCWPERI-GUBZILKMSA-N Arg-Ser-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O OQPAZKMGCWPERI-GUBZILKMSA-N 0.000 description 1
- RYQSYXFGFOTJDJ-RHYQMDGZSA-N Arg-Thr-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O RYQSYXFGFOTJDJ-RHYQMDGZSA-N 0.000 description 1
- INOIAEUXVVNJKA-XGEHTFHBSA-N Arg-Thr-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O INOIAEUXVVNJKA-XGEHTFHBSA-N 0.000 description 1
- 101710142885 Arginine N-succinyltransferase Proteins 0.000 description 1
- 102100024630 Asc-type amino acid transporter 1 Human genes 0.000 description 1
- MFFOYNGMOYFPBD-DCAQKATOSA-N Asn-Arg-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O MFFOYNGMOYFPBD-DCAQKATOSA-N 0.000 description 1
- PIWWUBYJNONVTJ-ZLUOBGJFSA-N Asn-Asp-Asn Chemical compound C([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)C(=O)N PIWWUBYJNONVTJ-ZLUOBGJFSA-N 0.000 description 1
- OLGCWMNDJTWQAG-GUBZILKMSA-N Asn-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(N)=O OLGCWMNDJTWQAG-GUBZILKMSA-N 0.000 description 1
- MYCSPQIARXTUTP-SRVKXCTJSA-N Asn-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(=O)N)N MYCSPQIARXTUTP-SRVKXCTJSA-N 0.000 description 1
- YVXRYLVELQYAEQ-SRVKXCTJSA-N Asn-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N YVXRYLVELQYAEQ-SRVKXCTJSA-N 0.000 description 1
- PBFXCUOEGVJTMV-QXEWZRGKSA-N Asn-Met-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O PBFXCUOEGVJTMV-QXEWZRGKSA-N 0.000 description 1
- HZZIFFOVHLWGCS-KKUMJFAQSA-N Asn-Phe-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O HZZIFFOVHLWGCS-KKUMJFAQSA-N 0.000 description 1
- YXVAESUIQFDBHN-SRVKXCTJSA-N Asn-Phe-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O YXVAESUIQFDBHN-SRVKXCTJSA-N 0.000 description 1
- KYQJHBWHRASMKG-ZLUOBGJFSA-N Asn-Ser-Cys Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(O)=O KYQJHBWHRASMKG-ZLUOBGJFSA-N 0.000 description 1
- XHTUGJCAEYOZOR-UBHSHLNASA-N Asn-Ser-Trp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O XHTUGJCAEYOZOR-UBHSHLNASA-N 0.000 description 1
- PBVLJOIPOGUQQP-CIUDSAMLSA-N Asp-Ala-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O PBVLJOIPOGUQQP-CIUDSAMLSA-N 0.000 description 1
- XYBJLTKSGFBLCS-QXEWZRGKSA-N Asp-Arg-Val Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CC(O)=O XYBJLTKSGFBLCS-QXEWZRGKSA-N 0.000 description 1
- UGKZHCBLMLSANF-CIUDSAMLSA-N Asp-Asn-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O UGKZHCBLMLSANF-CIUDSAMLSA-N 0.000 description 1
- ICTXFVKYAGQURS-UBHSHLNASA-N Asp-Asn-Trp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O ICTXFVKYAGQURS-UBHSHLNASA-N 0.000 description 1
- HOBNTSHITVVNBN-ZPFDUUQYSA-N Asp-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N HOBNTSHITVVNBN-ZPFDUUQYSA-N 0.000 description 1
- KYQNAIMCTRZLNP-QSFUFRPTSA-N Asp-Ile-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O KYQNAIMCTRZLNP-QSFUFRPTSA-N 0.000 description 1
- UMHUHHJMEXNSIV-CIUDSAMLSA-N Asp-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UMHUHHJMEXNSIV-CIUDSAMLSA-N 0.000 description 1
- DPNWSMBUYCLEDG-CIUDSAMLSA-N Asp-Lys-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O DPNWSMBUYCLEDG-CIUDSAMLSA-N 0.000 description 1
- LIJXJYGRSRWLCJ-IHRRRGAJSA-N Asp-Phe-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O LIJXJYGRSRWLCJ-IHRRRGAJSA-N 0.000 description 1
- WOPJVEMFXYHZEE-SRVKXCTJSA-N Asp-Phe-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O WOPJVEMFXYHZEE-SRVKXCTJSA-N 0.000 description 1
- USNJAPJZSGTTPX-XVSYOHENSA-N Asp-Phe-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O USNJAPJZSGTTPX-XVSYOHENSA-N 0.000 description 1
- NONWUQAWAANERO-BZSNNMDCSA-N Asp-Phe-Tyr Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 NONWUQAWAANERO-BZSNNMDCSA-N 0.000 description 1
- DRCOAZZDQRCGGP-GHCJXIJMSA-N Asp-Ser-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DRCOAZZDQRCGGP-GHCJXIJMSA-N 0.000 description 1
- MNQMTYSEKZHIDF-GCJQMDKQSA-N Asp-Thr-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O MNQMTYSEKZHIDF-GCJQMDKQSA-N 0.000 description 1
- NJLLRXWFPQQPHV-SRVKXCTJSA-N Asp-Tyr-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O NJLLRXWFPQQPHV-SRVKXCTJSA-N 0.000 description 1
- ZQFZEBRNAMXXJV-KKUMJFAQSA-N Asp-Tyr-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O ZQFZEBRNAMXXJV-KKUMJFAQSA-N 0.000 description 1
- NWAHPBGBDIFUFD-KKUMJFAQSA-N Asp-Tyr-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O NWAHPBGBDIFUFD-KKUMJFAQSA-N 0.000 description 1
- 102100022716 Atypical chemokine receptor 3 Human genes 0.000 description 1
- 108010082845 Bacteriorhodopsins Proteins 0.000 description 1
- 108010015087 Basic Amino Acid Transport Systems Proteins 0.000 description 1
- 102000001733 Basic Amino Acid Transport Systems Human genes 0.000 description 1
- 102100040794 Beta-1 adrenergic receptor Human genes 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 102100028282 Bile salt export pump Human genes 0.000 description 1
- 101001086405 Bos taurus Rhodopsin Proteins 0.000 description 1
- 102100022595 Broad substrate specificity ATP-binding cassette transporter ABCG2 Human genes 0.000 description 1
- 101710098191 C-4 methylsterol oxidase ERG25 Proteins 0.000 description 1
- DTQKCBGIAORJOE-UHFFFAOYSA-N CC(C)CCCC(C)CCCC(C)CCCC(C)C.CC(C)CCCC(CCCC(CCCC(CC)C)C)C Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C.CC(C)CCCC(CCCC(CCCC(CC)C)C)C DTQKCBGIAORJOE-UHFFFAOYSA-N 0.000 description 1
- 239000008000 CHES buffer Substances 0.000 description 1
- 102100025659 Cadherin EGF LAG seven-pass G-type receptor 1 Human genes 0.000 description 1
- 102100035680 Cadherin EGF LAG seven-pass G-type receptor 2 Human genes 0.000 description 1
- 102100035671 Cadherin EGF LAG seven-pass G-type receptor 3 Human genes 0.000 description 1
- 101100113656 Caenorhabditis elegans clc-5 gene Proteins 0.000 description 1
- 101100274575 Caenorhabditis elegans clh-3 gene Proteins 0.000 description 1
- 101100494773 Caenorhabditis elegans ctl-2 gene Proteins 0.000 description 1
- 101100459438 Caenorhabditis elegans nac-1 gene Proteins 0.000 description 1
- 101100459439 Caenorhabditis elegans nac-2 gene Proteins 0.000 description 1
- 101100459440 Caenorhabditis elegans nac-3 gene Proteins 0.000 description 1
- 101100347993 Caenorhabditis elegans nas-1 gene Proteins 0.000 description 1
- 101100348008 Caenorhabditis elegans nas-2 gene Proteins 0.000 description 1
- 101100243399 Caenorhabditis elegans pept-2 gene Proteins 0.000 description 1
- 101100533757 Caenorhabditis elegans snf-3 gene Proteins 0.000 description 1
- 102100024654 Calcitonin gene-related peptide type 1 receptor Human genes 0.000 description 1
- 101710118454 Calcitonin gene-related peptide type 1 receptor Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 102100023073 Calcium-activated potassium channel subunit alpha-1 Human genes 0.000 description 1
- 101710189782 Calcium-activated potassium channel subunit alpha-1 Proteins 0.000 description 1
- 102100036290 Calcium-binding mitochondrial carrier protein SCaMC-1 Human genes 0.000 description 1
- 102100036293 Calcium-binding mitochondrial carrier protein SCaMC-3 Human genes 0.000 description 1
- 102100029801 Calcium-transporting ATPase type 2C member 1 Human genes 0.000 description 1
- 108050001979 Calcium-transporting ATPase type 2C member 1 Proteins 0.000 description 1
- 102100020671 Calcium-transporting ATPase type 2C member 2 Human genes 0.000 description 1
- 108050001980 Calcium-transporting ATPase type 2C member 2 Proteins 0.000 description 1
- 102100032581 Caprin-2 Human genes 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 102100028004 Cation channel sperm-associated protein 1 Human genes 0.000 description 1
- 101710132751 Cation channel sperm-associated protein 1 Proteins 0.000 description 1
- 102100021391 Cationic amino acid transporter 3 Human genes 0.000 description 1
- 101710195194 Cationic amino acid transporter 4 Proteins 0.000 description 1
- 102100021392 Cationic amino acid transporter 4 Human genes 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 102100033619 Cholesterol transporter ABCA5 Human genes 0.000 description 1
- 102100035954 Choline transporter-like protein 2 Human genes 0.000 description 1
- 102100039497 Choline transporter-like protein 3 Human genes 0.000 description 1
- 102100039496 Choline transporter-like protein 4 Human genes 0.000 description 1
- 102100039505 Choline transporter-like protein 5 Human genes 0.000 description 1
- 102100034330 Chromaffin granule amine transporter Human genes 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102100025892 Complement C1q tumor necrosis factor-related protein 1 Human genes 0.000 description 1
- 102100038018 Corticotropin-releasing factor receptor 1 Human genes 0.000 description 1
- 102100038019 Corticotropin-releasing factor receptor 2 Human genes 0.000 description 1
- 102000034534 Cotransporters Human genes 0.000 description 1
- 108020003264 Cotransporters Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102100029142 Cyclic nucleotide-gated cation channel alpha-3 Human genes 0.000 description 1
- 102100029157 Cyclic nucleotide-gated cation channel alpha-4 Human genes 0.000 description 1
- 102100029141 Cyclic nucleotide-gated cation channel beta-1 Human genes 0.000 description 1
- 102100029140 Cyclic nucleotide-gated cation channel beta-3 Human genes 0.000 description 1
- 102100036219 Cyclic nucleotide-gated olfactory channel Human genes 0.000 description 1
- SZQCDCKIGWQAQN-FXQIFTODSA-N Cys-Arg-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O SZQCDCKIGWQAQN-FXQIFTODSA-N 0.000 description 1
- BYALSSDCQYHKMY-XGEHTFHBSA-N Cys-Arg-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CS)N)O BYALSSDCQYHKMY-XGEHTFHBSA-N 0.000 description 1
- PQHYZJPCYRDYNE-QWRGUYRKSA-N Cys-Gly-Phe Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PQHYZJPCYRDYNE-QWRGUYRKSA-N 0.000 description 1
- VFGADOJXRLWTBU-JBDRJPRFSA-N Cys-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CS)N VFGADOJXRLWTBU-JBDRJPRFSA-N 0.000 description 1
- YXPNKXFOBHRUBL-BJDJZHNGSA-N Cys-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)N YXPNKXFOBHRUBL-BJDJZHNGSA-N 0.000 description 1
- RWVBNRYBHAGYSG-GUBZILKMSA-N Cys-Met-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)N RWVBNRYBHAGYSG-GUBZILKMSA-N 0.000 description 1
- WTEACWBAULENKE-SRVKXCTJSA-N Cys-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CS)N WTEACWBAULENKE-SRVKXCTJSA-N 0.000 description 1
- SMEYEQDCCBHTEF-FXQIFTODSA-N Cys-Pro-Ala Chemical compound [H]N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O SMEYEQDCCBHTEF-FXQIFTODSA-N 0.000 description 1
- QNNYDGBKNFDYOD-UBHSHLNASA-N Cys-Trp-Cys Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CS)N QNNYDGBKNFDYOD-UBHSHLNASA-N 0.000 description 1
- 108010079245 Cystic Fibrosis Transmembrane Conductance Regulator Proteins 0.000 description 1
- 102100023419 Cystic fibrosis transmembrane conductance regulator Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- 101150074155 DHFR gene Proteins 0.000 description 1
- 101100008101 Danio rerio cx23 gene Proteins 0.000 description 1
- 101100468640 Danio rerio rhcgl2 gene Proteins 0.000 description 1
- 101100316741 Danio rerio slc18a3b gene Proteins 0.000 description 1
- 239000005696 Diammonium phosphate Substances 0.000 description 1
- 101000785279 Dictyostelium discoideum Calcium-transporting ATPase PAT1 Proteins 0.000 description 1
- 101001129314 Dictyostelium discoideum Probable plasma membrane ATPase Proteins 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 241000275449 Diplectrum formosum Species 0.000 description 1
- 101710150311 Dolichyl-phosphooligosaccharide-protein glycotransferase Proteins 0.000 description 1
- 101710202156 Dolichyl-phosphooligosaccharide-protein glycotransferase 1 Proteins 0.000 description 1
- 101710202150 Dolichyl-phosphooligosaccharide-protein glycotransferase 2 Proteins 0.000 description 1
- 102100030068 Doublesex- and mab-3-related transcription factor 1 Human genes 0.000 description 1
- 101000965024 Drosophila melanogaster Acetylcholine receptor subunit alpha-like 1 Proteins 0.000 description 1
- 101000782835 Drosophila melanogaster Acetylcholine receptor subunit alpha-like 2 Proteins 0.000 description 1
- 101000782854 Drosophila melanogaster Acetylcholine receptor subunit beta-like 1 Proteins 0.000 description 1
- 101000782852 Drosophila melanogaster Acetylcholine receptor subunit beta-like 2 Proteins 0.000 description 1
- 102100021473 Electrogenic sodium bicarbonate cotransporter 4 Human genes 0.000 description 1
- 101100241243 Encephalitozoon cuniculi (strain GB-M1) NTT4 gene Proteins 0.000 description 1
- 101000925646 Enterobacteria phage T4 Endolysin Proteins 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 101000768061 Escherichia phage P1 Antirepressor protein 1 Proteins 0.000 description 1
- 102100031563 Excitatory amino acid transporter 1 Human genes 0.000 description 1
- 102100031560 Excitatory amino acid transporter 3 Human genes 0.000 description 1
- 102100031559 Excitatory amino acid transporter 4 Human genes 0.000 description 1
- 102100031766 Excitatory amino acid transporter 5 Human genes 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 101100112369 Fasciola hepatica Cat-1 gene Proteins 0.000 description 1
- 102100035049 Feline leukemia virus subgroup C receptor-related protein 2 Human genes 0.000 description 1
- 102100040134 Free fatty acid receptor 4 Human genes 0.000 description 1
- 108010045438 Frizzled receptors Proteins 0.000 description 1
- 102000005698 Frizzled receptors Human genes 0.000 description 1
- 102100021259 Frizzled-1 Human genes 0.000 description 1
- 102100021261 Frizzled-10 Human genes 0.000 description 1
- 102100021265 Frizzled-2 Human genes 0.000 description 1
- 102100039820 Frizzled-4 Human genes 0.000 description 1
- 102100039818 Frizzled-5 Human genes 0.000 description 1
- 102100039799 Frizzled-6 Human genes 0.000 description 1
- 102100039676 Frizzled-7 Human genes 0.000 description 1
- 102100028466 Frizzled-8 Human genes 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 102100033012 G-protein coupled receptor 12 Human genes 0.000 description 1
- 102100033837 G-protein coupled receptor 135 Human genes 0.000 description 1
- 102100039860 G-protein coupled receptor 143 Human genes 0.000 description 1
- 102100023416 G-protein coupled receptor 15 Human genes 0.000 description 1
- 102100041035 G-protein coupled receptor 151 Human genes 0.000 description 1
- 102100041016 G-protein coupled receptor 157 Human genes 0.000 description 1
- 102100025361 G-protein coupled receptor 161 Human genes 0.000 description 1
- 102100021200 G-protein coupled receptor 176 Human genes 0.000 description 1
- 102100021243 G-protein coupled receptor 182 Human genes 0.000 description 1
- 102100021245 G-protein coupled receptor 183 Human genes 0.000 description 1
- 102100036939 G-protein coupled receptor 20 Human genes 0.000 description 1
- 102100036940 G-protein coupled receptor 22 Human genes 0.000 description 1
- 102100036931 G-protein coupled receptor 26 Human genes 0.000 description 1
- 102100030279 G-protein coupled receptor 35 Human genes 0.000 description 1
- 102100031183 G-protein coupled receptor 37-like 1 Human genes 0.000 description 1
- 102100030280 G-protein coupled receptor 39 Human genes 0.000 description 1
- 102100033045 G-protein coupled receptor 4 Human genes 0.000 description 1
- 102100033046 G-protein coupled receptor 52 Human genes 0.000 description 1
- 102100033061 G-protein coupled receptor 55 Human genes 0.000 description 1
- 102100033861 G-protein coupled receptor 6 Human genes 0.000 description 1
- 102100033043 G-protein coupled receptor 62 Human genes 0.000 description 1
- 102100033859 G-protein coupled receptor 78 Human genes 0.000 description 1
- 102100033864 G-protein coupled receptor 84 Human genes 0.000 description 1
- 102100038407 G-protein coupled receptor 87 Human genes 0.000 description 1
- 102100032523 G-protein coupled receptor family C group 5 member B Human genes 0.000 description 1
- 102100032524 G-protein coupled receptor family C group 5 member C Human genes 0.000 description 1
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 description 1
- 102000001824 GPR146 Human genes 0.000 description 1
- 108050009062 GPR146 Proteins 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- 101150047684 Gabbr2 gene Proteins 0.000 description 1
- 102100034013 Gamma-glutamyl phosphate reductase Human genes 0.000 description 1
- 101710198928 Gamma-glutamyl phosphate reductase Proteins 0.000 description 1
- 108010004460 Gastric Inhibitory Polypeptide Proteins 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- LZRMPXRYLLTAJX-GUBZILKMSA-N Gln-Arg-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O LZRMPXRYLLTAJX-GUBZILKMSA-N 0.000 description 1
- LLVXTGUTDYMJLY-GUBZILKMSA-N Gln-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)N LLVXTGUTDYMJLY-GUBZILKMSA-N 0.000 description 1
- NXPXQIZKDOXIHH-JSGCOSHPSA-N Gln-Gly-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)N NXPXQIZKDOXIHH-JSGCOSHPSA-N 0.000 description 1
- JXBZEDIQFFCHPZ-PEFMBERDSA-N Gln-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N JXBZEDIQFFCHPZ-PEFMBERDSA-N 0.000 description 1
- IULKWYSYZSURJK-AVGNSLFASA-N Gln-Leu-Lys Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O IULKWYSYZSURJK-AVGNSLFASA-N 0.000 description 1
- ZEEPYMXTJWIMSN-GUBZILKMSA-N Gln-Lys-Ser Chemical compound NCCCC[C@@H](C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@@H](N)CCC(N)=O ZEEPYMXTJWIMSN-GUBZILKMSA-N 0.000 description 1
- DQLVHRFFBQOWFL-JYJNAYRXSA-N Gln-Lys-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N)N)O DQLVHRFFBQOWFL-JYJNAYRXSA-N 0.000 description 1
- XBWGJWXGUNSZAT-CIUDSAMLSA-N Gln-Met-Asp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N XBWGJWXGUNSZAT-CIUDSAMLSA-N 0.000 description 1
- OKARHJKJTKFQBM-ACZMJKKPSA-N Gln-Ser-Asn Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)O)N OKARHJKJTKFQBM-ACZMJKKPSA-N 0.000 description 1
- SYZZMPFLOLSMHL-XHNCKOQMSA-N Gln-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)N)C(=O)O SYZZMPFLOLSMHL-XHNCKOQMSA-N 0.000 description 1
- OTQSTOXRUBVWAP-NRPADANISA-N Gln-Ser-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O OTQSTOXRUBVWAP-NRPADANISA-N 0.000 description 1
- WOSRKEJQESVHGA-CIUDSAMLSA-N Glu-Arg-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O WOSRKEJQESVHGA-CIUDSAMLSA-N 0.000 description 1
- XXCDTYBVGMPIOA-FXQIFTODSA-N Glu-Asp-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XXCDTYBVGMPIOA-FXQIFTODSA-N 0.000 description 1
- PAQUJCSYVIBPLC-AVGNSLFASA-N Glu-Asp-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PAQUJCSYVIBPLC-AVGNSLFASA-N 0.000 description 1
- SBCYJMOOHUDWDA-NUMRIWBASA-N Glu-Asp-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SBCYJMOOHUDWDA-NUMRIWBASA-N 0.000 description 1
- PVBBEKPHARMPHX-DCAQKATOSA-N Glu-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(O)=O PVBBEKPHARMPHX-DCAQKATOSA-N 0.000 description 1
- VSRCAOIHMGCIJK-SRVKXCTJSA-N Glu-Leu-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O VSRCAOIHMGCIJK-SRVKXCTJSA-N 0.000 description 1
- OQXDUSZKISQQSS-GUBZILKMSA-N Glu-Lys-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O OQXDUSZKISQQSS-GUBZILKMSA-N 0.000 description 1
- HMJULNMJWOZNFI-XHNCKOQMSA-N Glu-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N)C(=O)O HMJULNMJWOZNFI-XHNCKOQMSA-N 0.000 description 1
- GPSHCSTUYOQPAI-JHEQGTHGSA-N Glu-Thr-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O GPSHCSTUYOQPAI-JHEQGTHGSA-N 0.000 description 1
- YQAQQKPWFOBSMU-WDCWCFNPSA-N Glu-Thr-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O YQAQQKPWFOBSMU-WDCWCFNPSA-N 0.000 description 1
- JVZLZVJTIXVIHK-SXNHZJKMSA-N Glu-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCC(=O)O)N JVZLZVJTIXVIHK-SXNHZJKMSA-N 0.000 description 1
- KXRORHJIRAOQPG-SOUVJXGZSA-N Glu-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCC(=O)O)N)C(=O)O KXRORHJIRAOQPG-SOUVJXGZSA-N 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 1
- 102400000326 Glucagon-like peptide 2 Human genes 0.000 description 1
- 101800000221 Glucagon-like peptide 2 Proteins 0.000 description 1
- 102100033839 Glucose-dependent insulinotropic receptor Human genes 0.000 description 1
- 102100036621 Glucosylceramide transporter ABCA12 Human genes 0.000 description 1
- UGVQELHRNUDMAA-BYPYZUCNSA-N Gly-Ala-Gly Chemical compound [NH3+]CC(=O)N[C@@H](C)C(=O)NCC([O-])=O UGVQELHRNUDMAA-BYPYZUCNSA-N 0.000 description 1
- FMNHBTKMRFVGRO-FOHZUACHSA-N Gly-Asn-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CN FMNHBTKMRFVGRO-FOHZUACHSA-N 0.000 description 1
- IWAXHBCACVWNHT-BQBZGAKWSA-N Gly-Asp-Arg Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IWAXHBCACVWNHT-BQBZGAKWSA-N 0.000 description 1
- XBWMTPAIUQIWKA-BYULHYEWSA-N Gly-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CN XBWMTPAIUQIWKA-BYULHYEWSA-N 0.000 description 1
- DTRUBYPMMVPQPD-YUMQZZPRSA-N Gly-Gln-Arg Chemical compound [H]NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O DTRUBYPMMVPQPD-YUMQZZPRSA-N 0.000 description 1
- JMQFHZWESBGPFC-WDSKDSINSA-N Gly-Gln-Asp Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O JMQFHZWESBGPFC-WDSKDSINSA-N 0.000 description 1
- LPCKHUXOGVNZRS-YUMQZZPRSA-N Gly-His-Ser Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O LPCKHUXOGVNZRS-YUMQZZPRSA-N 0.000 description 1
- PTIIBFKSLCYQBO-NHCYSSNCSA-N Gly-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CN PTIIBFKSLCYQBO-NHCYSSNCSA-N 0.000 description 1
- OQQKUTVULYLCDG-ONGXEEELSA-N Gly-Lys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(O)=O OQQKUTVULYLCDG-ONGXEEELSA-N 0.000 description 1
- MDKCBHZLQJZOCJ-STQMWFEESA-N Gly-Met-Tyr Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)CN MDKCBHZLQJZOCJ-STQMWFEESA-N 0.000 description 1
- JPVGHHQGKPQYIL-KBPBESRZSA-N Gly-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 JPVGHHQGKPQYIL-KBPBESRZSA-N 0.000 description 1
- JYPCXBJRLBHWME-IUCAKERBSA-N Gly-Pro-Arg Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JYPCXBJRLBHWME-IUCAKERBSA-N 0.000 description 1
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 1
- WCORRBXVISTKQL-WHFBIAKZSA-N Gly-Ser-Ser Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WCORRBXVISTKQL-WHFBIAKZSA-N 0.000 description 1
- ZLCLYFGMKFCDCN-XPUUQOCRSA-N Gly-Ser-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)CN)C(O)=O ZLCLYFGMKFCDCN-XPUUQOCRSA-N 0.000 description 1
- NVTPVQLIZCOJFK-FOHZUACHSA-N Gly-Thr-Asp Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O NVTPVQLIZCOJFK-FOHZUACHSA-N 0.000 description 1
- 108010076533 Glycine Receptors Proteins 0.000 description 1
- 102000011714 Glycine Receptors Human genes 0.000 description 1
- 101710159101 Green-light absorbing proteorhodopsin Proteins 0.000 description 1
- 102100021383 Guanine nucleotide exchange factor DBS Human genes 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- 102100027618 Heme transporter HRG1 Human genes 0.000 description 1
- 102100027045 High affinity choline transporter 1 Human genes 0.000 description 1
- 101710123424 High-affinity choline transporter 1 Proteins 0.000 description 1
- ZPVJJPAIUZLSNE-DCAQKATOSA-N His-Arg-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O ZPVJJPAIUZLSNE-DCAQKATOSA-N 0.000 description 1
- KNNSUUOHFVVJOP-GUBZILKMSA-N His-Glu-Ser Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N KNNSUUOHFVVJOP-GUBZILKMSA-N 0.000 description 1
- RAVLQPXCMRCLKT-KBPBESRZSA-N His-Gly-Phe Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O RAVLQPXCMRCLKT-KBPBESRZSA-N 0.000 description 1
- WYSJPCTWSBJFCO-AVGNSLFASA-N His-Met-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC1=CN=CN1)N WYSJPCTWSBJFCO-AVGNSLFASA-N 0.000 description 1
- ZNTSGDNUITWTRA-WDSOQIARSA-N His-Trp-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C(C)C)C(O)=O ZNTSGDNUITWTRA-WDSOQIARSA-N 0.000 description 1
- SWBUZLFWGJETAO-KKUMJFAQSA-N His-Tyr-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N)O SWBUZLFWGJETAO-KKUMJFAQSA-N 0.000 description 1
- 101001071349 Homo sapiens 12-(S)-hydroxy-5,8,10,14-eicosatetraenoic acid receptor Proteins 0.000 description 1
- 101000609562 Homo sapiens 2-oxoglutarate receptor 1 Proteins 0.000 description 1
- 101000724357 Homo sapiens ABC-type oligopeptide transporter ABCB9 Proteins 0.000 description 1
- 101000929669 Homo sapiens ABC-type organic anion transporter ABCA8 Proteins 0.000 description 1
- 101000796932 Homo sapiens ADP/ATP translocase 1 Proteins 0.000 description 1
- 101000718417 Homo sapiens ADP/ATP translocase 2 Proteins 0.000 description 1
- 101000718437 Homo sapiens ADP/ATP translocase 3 Proteins 0.000 description 1
- 101000718447 Homo sapiens ADP/ATP translocase 4 Proteins 0.000 description 1
- 101000936108 Homo sapiens ATP synthase mitochondrial F1 complex assembly factor 2 Proteins 0.000 description 1
- 101000929654 Homo sapiens ATP-binding cassette sub-family A member 10 Proteins 0.000 description 1
- 101000929660 Homo sapiens ATP-binding cassette sub-family A member 13 Proteins 0.000 description 1
- 101000801645 Homo sapiens ATP-binding cassette sub-family A member 2 Proteins 0.000 description 1
- 101000929676 Homo sapiens ATP-binding cassette sub-family A member 6 Proteins 0.000 description 1
- 101000929667 Homo sapiens ATP-binding cassette sub-family A member 9 Proteins 0.000 description 1
- 101000724360 Homo sapiens ATP-binding cassette sub-family B member 10, mitochondrial Proteins 0.000 description 1
- 101000677872 Homo sapiens ATP-binding cassette sub-family B member 5 Proteins 0.000 description 1
- 101000677883 Homo sapiens ATP-binding cassette sub-family B member 6 Proteins 0.000 description 1
- 101001029059 Homo sapiens ATP-binding cassette sub-family C member 10 Proteins 0.000 description 1
- 101001029057 Homo sapiens ATP-binding cassette sub-family C member 11 Proteins 0.000 description 1
- 101001029062 Homo sapiens ATP-binding cassette sub-family C member 12 Proteins 0.000 description 1
- 101000986633 Homo sapiens ATP-binding cassette sub-family C member 3 Proteins 0.000 description 1
- 101000986629 Homo sapiens ATP-binding cassette sub-family C member 4 Proteins 0.000 description 1
- 101000986622 Homo sapiens ATP-binding cassette sub-family C member 5 Proteins 0.000 description 1
- 101000986621 Homo sapiens ATP-binding cassette sub-family C member 6 Proteins 0.000 description 1
- 101000760570 Homo sapiens ATP-binding cassette sub-family C member 8 Proteins 0.000 description 1
- 101000760581 Homo sapiens ATP-binding cassette sub-family C member 9 Proteins 0.000 description 1
- 101000783774 Homo sapiens ATP-binding cassette sub-family D member 2 Proteins 0.000 description 1
- 101000783770 Homo sapiens ATP-binding cassette sub-family D member 3 Proteins 0.000 description 1
- 101000800393 Homo sapiens ATP-binding cassette sub-family G member 4 Proteins 0.000 description 1
- 101000833343 Homo sapiens Adhesion G protein-coupled receptor A1 Proteins 0.000 description 1
- 101000833358 Homo sapiens Adhesion G protein-coupled receptor A2 Proteins 0.000 description 1
- 101000833357 Homo sapiens Adhesion G protein-coupled receptor A3 Proteins 0.000 description 1
- 101000796780 Homo sapiens Adhesion G protein-coupled receptor B1 Proteins 0.000 description 1
- 101000796784 Homo sapiens Adhesion G protein-coupled receptor B2 Proteins 0.000 description 1
- 101000796801 Homo sapiens Adhesion G protein-coupled receptor B3 Proteins 0.000 description 1
- 101000718211 Homo sapiens Adhesion G protein-coupled receptor E2 Proteins 0.000 description 1
- 101000718235 Homo sapiens Adhesion G protein-coupled receptor E3 Proteins 0.000 description 1
- 101000718243 Homo sapiens Adhesion G protein-coupled receptor E5 Proteins 0.000 description 1
- 101000775046 Homo sapiens Adhesion G protein-coupled receptor F4 Proteins 0.000 description 1
- 101000775045 Homo sapiens Adhesion G protein-coupled receptor F5 Proteins 0.000 description 1
- 101000959588 Homo sapiens Adhesion G protein-coupled receptor L1 Proteins 0.000 description 1
- 101000928189 Homo sapiens Adhesion G protein-coupled receptor L2 Proteins 0.000 description 1
- 101000928176 Homo sapiens Adhesion G protein-coupled receptor L3 Proteins 0.000 description 1
- 101000928172 Homo sapiens Adhesion G protein-coupled receptor L4 Proteins 0.000 description 1
- 101000718219 Homo sapiens Adhesion G-protein coupled receptor D1 Proteins 0.000 description 1
- 101000718223 Homo sapiens Adhesion G-protein coupled receptor D2 Proteins 0.000 description 1
- 101000718228 Homo sapiens Adhesion G-protein coupled receptor F1 Proteins 0.000 description 1
- 101000775031 Homo sapiens Adhesion G-protein coupled receptor F2 Proteins 0.000 description 1
- 101000775048 Homo sapiens Adhesion G-protein coupled receptor F3 Proteins 0.000 description 1
- 101000775042 Homo sapiens Adhesion G-protein coupled receptor G1 Proteins 0.000 description 1
- 101000775058 Homo sapiens Adhesion G-protein coupled receptor G2 Proteins 0.000 description 1
- 101000959604 Homo sapiens Adhesion G-protein coupled receptor G4 Proteins 0.000 description 1
- 101000959600 Homo sapiens Adhesion G-protein coupled receptor G5 Proteins 0.000 description 1
- 101000959602 Homo sapiens Adhesion G-protein coupled receptor G6 Proteins 0.000 description 1
- 101000959592 Homo sapiens Adhesion G-protein coupled receptor G7 Proteins 0.000 description 1
- 101000928167 Homo sapiens Adhesion G-protein coupled receptor V1 Proteins 0.000 description 1
- 101000779309 Homo sapiens Amyloid protein-binding protein 2 Proteins 0.000 description 1
- 101000684465 Homo sapiens Aquaporin-10 Proteins 0.000 description 1
- 101000771417 Homo sapiens Aquaporin-8 Proteins 0.000 description 1
- 101000771413 Homo sapiens Aquaporin-9 Proteins 0.000 description 1
- 101000678890 Homo sapiens Atypical chemokine receptor 3 Proteins 0.000 description 1
- 101000746022 Homo sapiens CX3C chemokine receptor 1 Proteins 0.000 description 1
- 101000914155 Homo sapiens Cadherin EGF LAG seven-pass G-type receptor 1 Proteins 0.000 description 1
- 101000715674 Homo sapiens Cadherin EGF LAG seven-pass G-type receptor 2 Proteins 0.000 description 1
- 101000715671 Homo sapiens Cadherin EGF LAG seven-pass G-type receptor 3 Proteins 0.000 description 1
- 101000867742 Homo sapiens Caprin-2 Proteins 0.000 description 1
- 101000801660 Homo sapiens Cholesterol transporter ABCA5 Proteins 0.000 description 1
- 101000948115 Homo sapiens Choline transporter-like protein 2 Proteins 0.000 description 1
- 101000889279 Homo sapiens Choline transporter-like protein 3 Proteins 0.000 description 1
- 101000889282 Homo sapiens Choline transporter-like protein 4 Proteins 0.000 description 1
- 101000889267 Homo sapiens Choline transporter-like protein 5 Proteins 0.000 description 1
- 101000878678 Homo sapiens Corticotropin-releasing factor receptor 1 Proteins 0.000 description 1
- 101000878664 Homo sapiens Corticotropin-releasing factor receptor 2 Proteins 0.000 description 1
- 101000771071 Homo sapiens Cyclic nucleotide-gated cation channel alpha-3 Proteins 0.000 description 1
- 101000771069 Homo sapiens Cyclic nucleotide-gated cation channel alpha-4 Proteins 0.000 description 1
- 101000771075 Homo sapiens Cyclic nucleotide-gated cation channel beta-1 Proteins 0.000 description 1
- 101000771083 Homo sapiens Cyclic nucleotide-gated cation channel beta-3 Proteins 0.000 description 1
- 101000875054 Homo sapiens Cyclic nucleotide-gated olfactory channel Proteins 0.000 description 1
- 101000907783 Homo sapiens Cystic fibrosis transmembrane conductance regulator Proteins 0.000 description 1
- 101000864807 Homo sapiens Doublesex- and mab-3-related transcription factor 1 Proteins 0.000 description 1
- 101000740107 Homo sapiens Equilibrative nucleobase transporter 1 Proteins 0.000 description 1
- 101000866286 Homo sapiens Excitatory amino acid transporter 1 Proteins 0.000 description 1
- 101000866302 Homo sapiens Excitatory amino acid transporter 3 Proteins 0.000 description 1
- 101000866308 Homo sapiens Excitatory amino acid transporter 4 Proteins 0.000 description 1
- 101000866606 Homo sapiens Excitatory amino acid transporter 5 Proteins 0.000 description 1
- 101001022717 Homo sapiens Feline leukemia virus subgroup C receptor-related protein 2 Proteins 0.000 description 1
- 101000890672 Homo sapiens Free fatty acid receptor 4 Proteins 0.000 description 1
- 101000819438 Homo sapiens Frizzled-1 Proteins 0.000 description 1
- 101000819451 Homo sapiens Frizzled-10 Proteins 0.000 description 1
- 101000819477 Homo sapiens Frizzled-2 Proteins 0.000 description 1
- 101000819458 Homo sapiens Frizzled-3 Proteins 0.000 description 1
- 101000885581 Homo sapiens Frizzled-4 Proteins 0.000 description 1
- 101000885585 Homo sapiens Frizzled-5 Proteins 0.000 description 1
- 101000885673 Homo sapiens Frizzled-6 Proteins 0.000 description 1
- 101000885797 Homo sapiens Frizzled-7 Proteins 0.000 description 1
- 101001061408 Homo sapiens Frizzled-8 Proteins 0.000 description 1
- 101001015106 Homo sapiens G-protein coupled receptor 12 Proteins 0.000 description 1
- 101000996783 Homo sapiens G-protein coupled receptor 135 Proteins 0.000 description 1
- 101000887425 Homo sapiens G-protein coupled receptor 143 Proteins 0.000 description 1
- 101000829794 Homo sapiens G-protein coupled receptor 15 Proteins 0.000 description 1
- 101001039308 Homo sapiens G-protein coupled receptor 151 Proteins 0.000 description 1
- 101001039303 Homo sapiens G-protein coupled receptor 157 Proteins 0.000 description 1
- 101000857756 Homo sapiens G-protein coupled receptor 161 Proteins 0.000 description 1
- 101001040723 Homo sapiens G-protein coupled receptor 176 Proteins 0.000 description 1
- 101001040797 Homo sapiens G-protein coupled receptor 182 Proteins 0.000 description 1
- 101001040801 Homo sapiens G-protein coupled receptor 183 Proteins 0.000 description 1
- 101001071355 Homo sapiens G-protein coupled receptor 20 Proteins 0.000 description 1
- 101001071360 Homo sapiens G-protein coupled receptor 22 Proteins 0.000 description 1
- 101001071346 Homo sapiens G-protein coupled receptor 26 Proteins 0.000 description 1
- 101001009545 Homo sapiens G-protein coupled receptor 35 Proteins 0.000 description 1
- 101001066101 Homo sapiens G-protein coupled receptor 37-like 1 Proteins 0.000 description 1
- 101001009541 Homo sapiens G-protein coupled receptor 39 Proteins 0.000 description 1
- 101000871138 Homo sapiens G-protein coupled receptor 4 Proteins 0.000 description 1
- 101000871149 Homo sapiens G-protein coupled receptor 52 Proteins 0.000 description 1
- 101000871151 Homo sapiens G-protein coupled receptor 55 Proteins 0.000 description 1
- 101001069613 Homo sapiens G-protein coupled receptor 6 Proteins 0.000 description 1
- 101000871128 Homo sapiens G-protein coupled receptor 62 Proteins 0.000 description 1
- 101001069603 Homo sapiens G-protein coupled receptor 78 Proteins 0.000 description 1
- 101001069589 Homo sapiens G-protein coupled receptor 84 Proteins 0.000 description 1
- 101001033052 Homo sapiens G-protein coupled receptor 87 Proteins 0.000 description 1
- 101001014684 Homo sapiens G-protein coupled receptor family C group 5 member B Proteins 0.000 description 1
- 101001014685 Homo sapiens G-protein coupled receptor family C group 5 member C Proteins 0.000 description 1
- 101000996752 Homo sapiens Glucose-dependent insulinotropic receptor Proteins 0.000 description 1
- 101000929652 Homo sapiens Glucosylceramide transporter ABCA12 Proteins 0.000 description 1
- 101000990566 Homo sapiens HEAT repeat-containing protein 6 Proteins 0.000 description 1
- 101001081412 Homo sapiens Heme transporter HRG1 Proteins 0.000 description 1
- 101001002508 Homo sapiens Immunoglobulin-binding protein 1 Proteins 0.000 description 1
- 101000975421 Homo sapiens Inositol 1,4,5-trisphosphate receptor type 2 Proteins 0.000 description 1
- 101000975401 Homo sapiens Inositol 1,4,5-trisphosphate receptor type 3 Proteins 0.000 description 1
- 101000677891 Homo sapiens Iron-sulfur clusters transporter ABCB7, mitochondrial Proteins 0.000 description 1
- 101001139126 Homo sapiens Krueppel-like factor 6 Proteins 0.000 description 1
- 101001063463 Homo sapiens Leucine-rich repeat-containing G-protein coupled receptor 4 Proteins 0.000 description 1
- 101001063456 Homo sapiens Leucine-rich repeat-containing G-protein coupled receptor 5 Proteins 0.000 description 1
- 101000981765 Homo sapiens Leucine-rich repeat-containing G-protein coupled receptor 6 Proteins 0.000 description 1
- 101001038034 Homo sapiens Lysophosphatidic acid receptor 6 Proteins 0.000 description 1
- 101000937642 Homo sapiens Malonyl-CoA-acyl carrier protein transacylase, mitochondrial Proteins 0.000 description 1
- 101001055977 Homo sapiens Mas-related G-protein coupled receptor MRG Proteins 0.000 description 1
- 101001014548 Homo sapiens Mas-related G-protein coupled receptor member D Proteins 0.000 description 1
- 101001029024 Homo sapiens Mas-related G-protein coupled receptor member E Proteins 0.000 description 1
- 101001029028 Homo sapiens Mas-related G-protein coupled receptor member F Proteins 0.000 description 1
- 101001029029 Homo sapiens Mas-related G-protein coupled receptor member G Proteins 0.000 description 1
- 101001029067 Homo sapiens Mas-related G-protein coupled receptor member X1 Proteins 0.000 description 1
- 101001029072 Homo sapiens Mas-related G-protein coupled receptor member X2 Proteins 0.000 description 1
- 101000986598 Homo sapiens Mas-related G-protein coupled receptor member X3 Proteins 0.000 description 1
- 101000986597 Homo sapiens Mas-related G-protein coupled receptor member X4 Proteins 0.000 description 1
- 101001116388 Homo sapiens Melatonin-related receptor Proteins 0.000 description 1
- 101000740112 Homo sapiens Membrane-associated transporter protein Proteins 0.000 description 1
- 101001071437 Homo sapiens Metabotropic glutamate receptor 1 Proteins 0.000 description 1
- 101001071429 Homo sapiens Metabotropic glutamate receptor 2 Proteins 0.000 description 1
- 101001032848 Homo sapiens Metabotropic glutamate receptor 3 Proteins 0.000 description 1
- 101001032851 Homo sapiens Metabotropic glutamate receptor 4 Proteins 0.000 description 1
- 101001032845 Homo sapiens Metabotropic glutamate receptor 5 Proteins 0.000 description 1
- 101001032837 Homo sapiens Metabotropic glutamate receptor 6 Proteins 0.000 description 1
- 101001032841 Homo sapiens Metabotropic glutamate receptor 7 Proteins 0.000 description 1
- 101001027295 Homo sapiens Metabotropic glutamate receptor 8 Proteins 0.000 description 1
- 101000869426 Homo sapiens Metal cation symporter ZIP14 Proteins 0.000 description 1
- 101000623667 Homo sapiens Mitochondrial carrier homolog 1 Proteins 0.000 description 1
- 101001013994 Homo sapiens Mitochondrial carrier homolog 2 Proteins 0.000 description 1
- 101001038443 Homo sapiens Mitochondrial glutamate carrier 1 Proteins 0.000 description 1
- 101000590830 Homo sapiens Monocarboxylate transporter 1 Proteins 0.000 description 1
- 101000969630 Homo sapiens Monocarboxylate transporter 10 Proteins 0.000 description 1
- 101000969625 Homo sapiens Monocarboxylate transporter 11 Proteins 0.000 description 1
- 101000969621 Homo sapiens Monocarboxylate transporter 12 Proteins 0.000 description 1
- 101000590811 Homo sapiens Monocarboxylate transporter 13 Proteins 0.000 description 1
- 101000590819 Homo sapiens Monocarboxylate transporter 14 Proteins 0.000 description 1
- 101000577121 Homo sapiens Monocarboxylate transporter 3 Proteins 0.000 description 1
- 101000987113 Homo sapiens Monocarboxylate transporter 9 Proteins 0.000 description 1
- 101000655467 Homo sapiens Multidrug and toxin extrusion protein 1 Proteins 0.000 description 1
- 101000655429 Homo sapiens Multidrug and toxin extrusion protein 2 Proteins 0.000 description 1
- 101000969812 Homo sapiens Multidrug resistance-associated protein 1 Proteins 0.000 description 1
- 101000829761 Homo sapiens N-arachidonyl glycine receptor Proteins 0.000 description 1
- 101001108330 Homo sapiens Natural resistance-associated macrophage protein 2 Proteins 0.000 description 1
- 101000655246 Homo sapiens Neutral amino acid transporter A Proteins 0.000 description 1
- 101000724418 Homo sapiens Neutral amino acid transporter B(0) Proteins 0.000 description 1
- 101001120760 Homo sapiens Olfactomedin-4 Proteins 0.000 description 1
- 101000720966 Homo sapiens Opsin-3 Proteins 0.000 description 1
- 101001086282 Homo sapiens Opsin-5 Proteins 0.000 description 1
- 101000740126 Homo sapiens Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5 Proteins 0.000 description 1
- 101001120710 Homo sapiens Ovarian cancer G-protein coupled receptor 1 Proteins 0.000 description 1
- 101000986810 Homo sapiens P2Y purinoceptor 8 Proteins 0.000 description 1
- 101001094700 Homo sapiens POU domain, class 5, transcription factor 1 Proteins 0.000 description 1
- 101001135770 Homo sapiens Parathyroid hormone Proteins 0.000 description 1
- 101001084254 Homo sapiens Peptidyl-tRNA hydrolase 2, mitochondrial Proteins 0.000 description 1
- 101001028756 Homo sapiens Phosphate carrier protein, mitochondrial Proteins 0.000 description 1
- 101000955481 Homo sapiens Phosphatidylcholine translocator ABCB4 Proteins 0.000 description 1
- 101000801684 Homo sapiens Phospholipid-transporting ATPase ABCA1 Proteins 0.000 description 1
- 101000801640 Homo sapiens Phospholipid-transporting ATPase ABCA3 Proteins 0.000 description 1
- 101000929663 Homo sapiens Phospholipid-transporting ATPase ABCA7 Proteins 0.000 description 1
- 101000701366 Homo sapiens Phospholipid-transporting ATPase IB Proteins 0.000 description 1
- 101000701363 Homo sapiens Phospholipid-transporting ATPase IC Proteins 0.000 description 1
- 101000701522 Homo sapiens Phospholipid-transporting ATPase ID Proteins 0.000 description 1
- 101000923320 Homo sapiens Phospholipid-transporting ATPase IF Proteins 0.000 description 1
- 101000923322 Homo sapiens Phospholipid-transporting ATPase IH Proteins 0.000 description 1
- 101000701520 Homo sapiens Phospholipid-transporting ATPase IK Proteins 0.000 description 1
- 101000923326 Homo sapiens Phospholipid-transporting ATPase VD Proteins 0.000 description 1
- 101001133600 Homo sapiens Pituitary adenylate cyclase-activating polypeptide type I receptor Proteins 0.000 description 1
- 101000944004 Homo sapiens Potassium channel subfamily U member 1 Proteins 0.000 description 1
- 101000753506 Homo sapiens Potassium-transporting ATPase alpha chain 1 Proteins 0.000 description 1
- 101001009074 Homo sapiens Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 Proteins 0.000 description 1
- 101001009079 Homo sapiens Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 Proteins 0.000 description 1
- 101001009082 Homo sapiens Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 Proteins 0.000 description 1
- 101001032038 Homo sapiens Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 Proteins 0.000 description 1
- 101001070479 Homo sapiens Probable G-protein coupled receptor 101 Proteins 0.000 description 1
- 101000996785 Homo sapiens Probable G-protein coupled receptor 132 Proteins 0.000 description 1
- 101000996780 Homo sapiens Probable G-protein coupled receptor 139 Proteins 0.000 description 1
- 101000887420 Homo sapiens Probable G-protein coupled receptor 141 Proteins 0.000 description 1
- 101000887427 Homo sapiens Probable G-protein coupled receptor 142 Proteins 0.000 description 1
- 101000887485 Homo sapiens Probable G-protein coupled receptor 148 Proteins 0.000 description 1
- 101000887481 Homo sapiens Probable G-protein coupled receptor 149 Proteins 0.000 description 1
- 101000887486 Homo sapiens Probable G-protein coupled receptor 150 Proteins 0.000 description 1
- 101001039294 Homo sapiens Probable G-protein coupled receptor 152 Proteins 0.000 description 1
- 101001039297 Homo sapiens Probable G-protein coupled receptor 153 Proteins 0.000 description 1
- 101001039301 Homo sapiens Probable G-protein coupled receptor 156 Proteins 0.000 description 1
- 101001039359 Homo sapiens Probable G-protein coupled receptor 158 Proteins 0.000 description 1
- 101000857740 Homo sapiens Probable G-protein coupled receptor 160 Proteins 0.000 description 1
- 101000857759 Homo sapiens Probable G-protein coupled receptor 162 Proteins 0.000 description 1
- 101001014654 Homo sapiens Probable G-protein coupled receptor 171 Proteins 0.000 description 1
- 101001014640 Homo sapiens Probable G-protein coupled receptor 173 Proteins 0.000 description 1
- 101001040717 Homo sapiens Probable G-protein coupled receptor 174 Proteins 0.000 description 1
- 101000829779 Homo sapiens Probable G-protein coupled receptor 19 Proteins 0.000 description 1
- 101001071363 Homo sapiens Probable G-protein coupled receptor 21 Proteins 0.000 description 1
- 101001071348 Homo sapiens Probable G-protein coupled receptor 25 Proteins 0.000 description 1
- 101001071353 Homo sapiens Probable G-protein coupled receptor 27 Proteins 0.000 description 1
- 101001009517 Homo sapiens Probable G-protein coupled receptor 32 Proteins 0.000 description 1
- 101001009518 Homo sapiens Probable G-protein coupled receptor 33 Proteins 0.000 description 1
- 101001009552 Homo sapiens Probable G-protein coupled receptor 34 Proteins 0.000 description 1
- 101000871096 Homo sapiens Probable G-protein coupled receptor 45 Proteins 0.000 description 1
- 101001069617 Homo sapiens Probable G-protein coupled receptor 63 Proteins 0.000 description 1
- 101001069607 Homo sapiens Probable G-protein coupled receptor 75 Proteins 0.000 description 1
- 101001069601 Homo sapiens Probable G-protein coupled receptor 82 Proteins 0.000 description 1
- 101001069595 Homo sapiens Probable G-protein coupled receptor 83 Proteins 0.000 description 1
- 101001069583 Homo sapiens Probable G-protein coupled receptor 85 Proteins 0.000 description 1
- 101001033058 Homo sapiens Probable G-protein coupled receptor 88 Proteins 0.000 description 1
- 101000655476 Homo sapiens Probable mitochondrial glutathione transporter SLC25A39 Proteins 0.000 description 1
- 101000869717 Homo sapiens Probable mitochondrial glutathione transporter SLC25A40 Proteins 0.000 description 1
- 101001135995 Homo sapiens Probable peptidyl-tRNA hydrolase Proteins 0.000 description 1
- 101000729626 Homo sapiens Probable phospholipid-transporting ATPase IIA Proteins 0.000 description 1
- 101000701518 Homo sapiens Probable phospholipid-transporting ATPase IM Proteins 0.000 description 1
- 101001080401 Homo sapiens Proteasome assembly chaperone 1 Proteins 0.000 description 1
- 101000836826 Homo sapiens Protein shortage in chiasmata 1 ortholog Proteins 0.000 description 1
- 101000713296 Homo sapiens Proton-coupled amino acid transporter 1 Proteins 0.000 description 1
- 101000713293 Homo sapiens Proton-coupled amino acid transporter 2 Proteins 0.000 description 1
- 101000713290 Homo sapiens Proton-coupled amino acid transporter 3 Proteins 0.000 description 1
- 101000713298 Homo sapiens Proton-coupled amino acid transporter 4 Proteins 0.000 description 1
- 101001116987 Homo sapiens Proton-coupled folate transporter Proteins 0.000 description 1
- 101000738506 Homo sapiens Psychosine receptor Proteins 0.000 description 1
- 101001120091 Homo sapiens Putative P2Y purinoceptor 10 Proteins 0.000 description 1
- 101000718237 Homo sapiens Putative adhesion G protein-coupled receptor E4P Proteins 0.000 description 1
- 101000693429 Homo sapiens Putative sodium-coupled neutral amino acid transporter 11 Proteins 0.000 description 1
- 101000685684 Homo sapiens Putative solute carrier family 22 member 31 Proteins 0.000 description 1
- 101000637794 Homo sapiens Putative solute carrier family 35 member G4 Proteins 0.000 description 1
- 101000788242 Homo sapiens Putative trace amine-associated receptor 3 Proteins 0.000 description 1
- 101000727836 Homo sapiens Reduced folate transporter Proteins 0.000 description 1
- 101000801643 Homo sapiens Retinal-specific phospholipid-transporting ATPase ABCA4 Proteins 0.000 description 1
- 101001100101 Homo sapiens Retinoic acid-induced protein 3 Proteins 0.000 description 1
- 101100504426 Homo sapiens SLC25A18 gene Proteins 0.000 description 1
- 101100094903 Homo sapiens SLC4A7 gene Proteins 0.000 description 1
- 101100256230 Homo sapiens SLC5A8 gene Proteins 0.000 description 1
- 101000688930 Homo sapiens Signaling threshold-regulating transmembrane adapter 1 Proteins 0.000 description 1
- 101001094079 Homo sapiens Sodium- and chloride-dependent GABA transporter 2 Proteins 0.000 description 1
- 101001094098 Homo sapiens Sodium- and chloride-dependent GABA transporter 3 Proteins 0.000 description 1
- 101000740162 Homo sapiens Sodium- and chloride-dependent transporter XTRP3 Proteins 0.000 description 1
- 101000740211 Homo sapiens Sodium-coupled monocarboxylate transporter 2 Proteins 0.000 description 1
- 101000693890 Homo sapiens Sodium-dependent multivitamin transporter Proteins 0.000 description 1
- 101000604051 Homo sapiens Sodium-dependent phosphate transport protein 3 Proteins 0.000 description 1
- 101000604049 Homo sapiens Sodium-dependent phosphate transport protein 4 Proteins 0.000 description 1
- 101000631948 Homo sapiens Sodium-dependent proline transporter Proteins 0.000 description 1
- 101001030470 Homo sapiens Sodium/calcium exchanger 2 Proteins 0.000 description 1
- 101000588943 Homo sapiens Sodium/calcium exchanger 3 Proteins 0.000 description 1
- 101000693895 Homo sapiens Sodium/glucose cotransporter 4 Proteins 0.000 description 1
- 101000693910 Homo sapiens Sodium/glucose cotransporter 5 Proteins 0.000 description 1
- 101000685689 Homo sapiens Solute carrier family 17 member 9 Proteins 0.000 description 1
- 101001094047 Homo sapiens Solute carrier family 22 member 10 Proteins 0.000 description 1
- 101000821903 Homo sapiens Solute carrier family 22 member 12 Proteins 0.000 description 1
- 101000821832 Homo sapiens Solute carrier family 22 member 16 Proteins 0.000 description 1
- 101000821829 Homo sapiens Solute carrier family 22 member 17 Proteins 0.000 description 1
- 101000685675 Homo sapiens Solute carrier family 22 member 20 Proteins 0.000 description 1
- 101000685682 Homo sapiens Solute carrier family 22 member 25 Proteins 0.000 description 1
- 101000713275 Homo sapiens Solute carrier family 22 member 3 Proteins 0.000 description 1
- 101000713272 Homo sapiens Solute carrier family 22 member 4 Proteins 0.000 description 1
- 101001094021 Homo sapiens Solute carrier family 22 member 7 Proteins 0.000 description 1
- 101001093997 Homo sapiens Solute carrier family 22 member 8 Proteins 0.000 description 1
- 101001094053 Homo sapiens Solute carrier family 22 member 9 Proteins 0.000 description 1
- 101000821972 Homo sapiens Solute carrier family 4 member 11 Proteins 0.000 description 1
- 101000637813 Homo sapiens Solute carrier family 40 member 1 Proteins 0.000 description 1
- 101000821959 Homo sapiens Solute carrier family 49 member A3 Proteins 0.000 description 1
- 101000716695 Homo sapiens Solute carrier family 5 member 4 Proteins 0.000 description 1
- 101000879116 Homo sapiens Succinate receptor 1 Proteins 0.000 description 1
- 101000795626 Homo sapiens Thymic stromal cotransporter homolog Proteins 0.000 description 1
- 101000788239 Homo sapiens Trace amine-associated receptor 2 Proteins 0.000 description 1
- 101000788257 Homo sapiens Trace amine-associated receptor 5 Proteins 0.000 description 1
- 101000788251 Homo sapiens Trace amine-associated receptor 6 Proteins 0.000 description 1
- 101000788171 Homo sapiens Trace amine-associated receptor 8 Proteins 0.000 description 1
- 101000674727 Homo sapiens Trace amine-associated receptor 9 Proteins 0.000 description 1
- 101000764872 Homo sapiens Transient receptor potential cation channel subfamily A member 1 Proteins 0.000 description 1
- 101000844521 Homo sapiens Transient receptor potential cation channel subfamily M member 5 Proteins 0.000 description 1
- 101000844519 Homo sapiens Transient receptor potential cation channel subfamily M member 6 Proteins 0.000 description 1
- 101000598103 Homo sapiens Tuberoinfundibular peptide of 39 residues Proteins 0.000 description 1
- 101000763003 Homo sapiens Two pore channel protein 1 Proteins 0.000 description 1
- 101000679525 Homo sapiens Two pore channel protein 2 Proteins 0.000 description 1
- 101000829770 Homo sapiens Uracil nucleotide/cysteinyl leukotriene receptor Proteins 0.000 description 1
- 101000666868 Homo sapiens Vasoactive intestinal polypeptide receptor 2 Proteins 0.000 description 1
- 101000708573 Homo sapiens Y+L amino acid transporter 2 Proteins 0.000 description 1
- 101000730643 Homo sapiens Zinc finger protein PLAGL1 Proteins 0.000 description 1
- 101000693447 Homo sapiens Zinc transporter ZIP1 Proteins 0.000 description 1
- 101000693444 Homo sapiens Zinc transporter ZIP2 Proteins 0.000 description 1
- 101000693468 Homo sapiens Zinc transporter ZIP3 Proteins 0.000 description 1
- 101000818510 Homo sapiens Zinc-activated ligand-gated ion channel Proteins 0.000 description 1
- 101000883219 Homo sapiens cGMP-gated cation channel alpha-1 Proteins 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- CYHYBSGMHMHKOA-CIQUZCHMSA-N Ile-Ala-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N CYHYBSGMHMHKOA-CIQUZCHMSA-N 0.000 description 1
- PFPUFNLHBXKPHY-HTFCKZLJSA-N Ile-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)O)N PFPUFNLHBXKPHY-HTFCKZLJSA-N 0.000 description 1
- FZWVCYCYWCLQDH-NHCYSSNCSA-N Ile-Leu-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N FZWVCYCYWCLQDH-NHCYSSNCSA-N 0.000 description 1
- XLXPYSDGMXTTNQ-UHFFFAOYSA-N Ile-Phe-Leu Natural products CCC(C)C(N)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=CC=C1 XLXPYSDGMXTTNQ-UHFFFAOYSA-N 0.000 description 1
- CAHCWMVNBZJVAW-NAKRPEOUSA-N Ile-Pro-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)N CAHCWMVNBZJVAW-NAKRPEOUSA-N 0.000 description 1
- CNMOKANDJMLAIF-CIQUZCHMSA-N Ile-Thr-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O CNMOKANDJMLAIF-CIQUZCHMSA-N 0.000 description 1
- DGTOKVBDZXJHNZ-WZLNRYEVSA-N Ile-Thr-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N DGTOKVBDZXJHNZ-WZLNRYEVSA-N 0.000 description 1
- MGUTVMBNOMJLKC-VKOGCVSHSA-N Ile-Trp-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](C(C)C)C(=O)O)N MGUTVMBNOMJLKC-VKOGCVSHSA-N 0.000 description 1
- NUEHSWNAFIEBCQ-NAKRPEOUSA-N Ile-Val-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)O)N NUEHSWNAFIEBCQ-NAKRPEOUSA-N 0.000 description 1
- SWNRZNLXMXRCJC-VKOGCVSHSA-N Ile-Val-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(O)=O)=CNC2=C1 SWNRZNLXMXRCJC-VKOGCVSHSA-N 0.000 description 1
- 102100021711 Ileal sodium/bile acid cotransporter Human genes 0.000 description 1
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 1
- 102100021042 Immunoglobulin-binding protein 1 Human genes 0.000 description 1
- 102100024037 Inositol 1,4,5-trisphosphate receptor type 2 Human genes 0.000 description 1
- 102100024035 Inositol 1,4,5-trisphosphate receptor type 3 Human genes 0.000 description 1
- 102100037441 Intermediate conductance calcium-activated potassium channel protein 4 Human genes 0.000 description 1
- 101710087467 Intermediate conductance calcium-activated potassium channel protein 4 Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 102100021504 Iron-sulfur clusters transporter ABCB7, mitochondrial Human genes 0.000 description 1
- 102100020679 Krueppel-like factor 6 Human genes 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 1
- LZDNBBYBDGBADK-UHFFFAOYSA-N L-valyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C(C)C)C(O)=O)=CNC2=C1 LZDNBBYBDGBADK-UHFFFAOYSA-N 0.000 description 1
- 102100038204 Large neutral amino acids transporter small subunit 1 Human genes 0.000 description 1
- 102100038235 Large neutral amino acids transporter small subunit 2 Human genes 0.000 description 1
- 102100038269 Large neutral amino acids transporter small subunit 3 Human genes 0.000 description 1
- 102100034693 Large neutral amino acids transporter small subunit 4 Human genes 0.000 description 1
- 102100023487 Lens fiber major intrinsic protein Human genes 0.000 description 1
- CZCSUZMIRKFFFA-CIUDSAMLSA-N Leu-Ala-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O CZCSUZMIRKFFFA-CIUDSAMLSA-N 0.000 description 1
- QPRQGENIBFLVEB-BJDJZHNGSA-N Leu-Ala-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O QPRQGENIBFLVEB-BJDJZHNGSA-N 0.000 description 1
- XIRYQRLFHWWWTC-QEJZJMRPSA-N Leu-Ala-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XIRYQRLFHWWWTC-QEJZJMRPSA-N 0.000 description 1
- VCSBGUACOYUIGD-CIUDSAMLSA-N Leu-Asn-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O VCSBGUACOYUIGD-CIUDSAMLSA-N 0.000 description 1
- VPKIQULSKFVCSM-SRVKXCTJSA-N Leu-Gln-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VPKIQULSKFVCSM-SRVKXCTJSA-N 0.000 description 1
- FEHQLKKBVJHSEC-SZMVWBNQSA-N Leu-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 FEHQLKKBVJHSEC-SZMVWBNQSA-N 0.000 description 1
- CFZZDVMBRYFFNU-QWRGUYRKSA-N Leu-His-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)NCC(O)=O CFZZDVMBRYFFNU-QWRGUYRKSA-N 0.000 description 1
- LKXANTUNFMVCNF-IHPCNDPISA-N Leu-His-Trp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O LKXANTUNFMVCNF-IHPCNDPISA-N 0.000 description 1
- HNDWYLYAYNBWMP-AJNGGQMLSA-N Leu-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)N HNDWYLYAYNBWMP-AJNGGQMLSA-N 0.000 description 1
- QLDHBYRUNQZIJQ-DKIMLUQUSA-N Leu-Ile-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QLDHBYRUNQZIJQ-DKIMLUQUSA-N 0.000 description 1
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 1
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 1
- RXGLHDWAZQECBI-SRVKXCTJSA-N Leu-Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O RXGLHDWAZQECBI-SRVKXCTJSA-N 0.000 description 1
- IEWBEPKLKUXQBU-VOAKCMCISA-N Leu-Leu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IEWBEPKLKUXQBU-VOAKCMCISA-N 0.000 description 1
- BGZCJDGBBUUBHA-KKUMJFAQSA-N Leu-Lys-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O BGZCJDGBBUUBHA-KKUMJFAQSA-N 0.000 description 1
- OVZLLFONXILPDZ-VOAKCMCISA-N Leu-Lys-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OVZLLFONXILPDZ-VOAKCMCISA-N 0.000 description 1
- LZHJZLHSRGWBBE-IHRRRGAJSA-N Leu-Lys-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O LZHJZLHSRGWBBE-IHRRRGAJSA-N 0.000 description 1
- DDVHDMSBLRAKNV-IHRRRGAJSA-N Leu-Met-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O DDVHDMSBLRAKNV-IHRRRGAJSA-N 0.000 description 1
- DRWMRVFCKKXHCH-BZSNNMDCSA-N Leu-Phe-Leu Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C([O-])=O)CC1=CC=CC=C1 DRWMRVFCKKXHCH-BZSNNMDCSA-N 0.000 description 1
- MVHXGBZUJLWZOH-BJDJZHNGSA-N Leu-Ser-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MVHXGBZUJLWZOH-BJDJZHNGSA-N 0.000 description 1
- PPGBXYKMUMHFBF-KATARQTJSA-N Leu-Ser-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PPGBXYKMUMHFBF-KATARQTJSA-N 0.000 description 1
- LCNASHSOFMRYFO-WDCWCFNPSA-N Leu-Thr-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(N)=O LCNASHSOFMRYFO-WDCWCFNPSA-N 0.000 description 1
- LJBVRCDPWOJOEK-PPCPHDFISA-N Leu-Thr-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LJBVRCDPWOJOEK-PPCPHDFISA-N 0.000 description 1
- DAYQSYGBCUKVKT-VOAKCMCISA-N Leu-Thr-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O DAYQSYGBCUKVKT-VOAKCMCISA-N 0.000 description 1
- ODRREERHVHMIPT-OEAJRASXSA-N Leu-Thr-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ODRREERHVHMIPT-OEAJRASXSA-N 0.000 description 1
- AAKRWBIIGKPOKQ-ONGXEEELSA-N Leu-Val-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AAKRWBIIGKPOKQ-ONGXEEELSA-N 0.000 description 1
- FDBTVENULFNTAL-XQQFMLRXSA-N Leu-Val-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N FDBTVENULFNTAL-XQQFMLRXSA-N 0.000 description 1
- 102100031035 Leucine-rich repeat-containing G-protein coupled receptor 4 Human genes 0.000 description 1
- 102100031036 Leucine-rich repeat-containing G-protein coupled receptor 5 Human genes 0.000 description 1
- 102100024140 Leucine-rich repeat-containing G-protein coupled receptor 6 Human genes 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- HKCCVDWHHTVVPN-CIUDSAMLSA-N Lys-Asp-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O HKCCVDWHHTVVPN-CIUDSAMLSA-N 0.000 description 1
- QIJVAFLRMVBHMU-KKUMJFAQSA-N Lys-Asp-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QIJVAFLRMVBHMU-KKUMJFAQSA-N 0.000 description 1
- JYXBNQOKPRQNQS-YTFOTSKYSA-N Lys-Ile-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JYXBNQOKPRQNQS-YTFOTSKYSA-N 0.000 description 1
- MYZMQWHPDAYKIE-SRVKXCTJSA-N Lys-Leu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O MYZMQWHPDAYKIE-SRVKXCTJSA-N 0.000 description 1
- ONPDTSFZAIWMDI-AVGNSLFASA-N Lys-Leu-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O ONPDTSFZAIWMDI-AVGNSLFASA-N 0.000 description 1
- YXPJCVNIDDKGOE-MELADBBJSA-N Lys-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)N)C(=O)O YXPJCVNIDDKGOE-MELADBBJSA-N 0.000 description 1
- PLDJDCJLRCYPJB-VOAKCMCISA-N Lys-Lys-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PLDJDCJLRCYPJB-VOAKCMCISA-N 0.000 description 1
- MTBLFIQZECOEBY-IHRRRGAJSA-N Lys-Met-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(O)=O MTBLFIQZECOEBY-IHRRRGAJSA-N 0.000 description 1
- PDIDTSZKKFEDMB-UWVGGRQHSA-N Lys-Pro-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O PDIDTSZKKFEDMB-UWVGGRQHSA-N 0.000 description 1
- LECIJRIRMVOFMH-ULQDDVLXSA-N Lys-Pro-Phe Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 LECIJRIRMVOFMH-ULQDDVLXSA-N 0.000 description 1
- LKDXINHHSWFFJC-SRVKXCTJSA-N Lys-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)N LKDXINHHSWFFJC-SRVKXCTJSA-N 0.000 description 1
- CAVRAQIDHUPECU-UVOCVTCTSA-N Lys-Thr-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAVRAQIDHUPECU-UVOCVTCTSA-N 0.000 description 1
- VHTOGMKQXXJOHG-RHYQMDGZSA-N Lys-Thr-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O VHTOGMKQXXJOHG-RHYQMDGZSA-N 0.000 description 1
- SUZVLFWOCKHWET-CQDKDKBSSA-N Lys-Tyr-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O SUZVLFWOCKHWET-CQDKDKBSSA-N 0.000 description 1
- RPWQJSBMXJSCPD-XUXIUFHCSA-N Lys-Val-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(O)=O RPWQJSBMXJSCPD-XUXIUFHCSA-N 0.000 description 1
- 102100040406 Lysophosphatidic acid receptor 6 Human genes 0.000 description 1
- 102100029755 MFS-type transporter SLC18B1 Human genes 0.000 description 1
- 101710195255 MFS-type transporter SLC18B1 Proteins 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102100026065 Mas-related G-protein coupled receptor MRG Human genes 0.000 description 1
- 102100032520 Mas-related G-protein coupled receptor member D Human genes 0.000 description 1
- 102100037117 Mas-related G-protein coupled receptor member E Human genes 0.000 description 1
- 102100037120 Mas-related G-protein coupled receptor member F Human genes 0.000 description 1
- 102100037119 Mas-related G-protein coupled receptor member G Human genes 0.000 description 1
- 102100037130 Mas-related G-protein coupled receptor member X1 Human genes 0.000 description 1
- 102100037125 Mas-related G-protein coupled receptor member X2 Human genes 0.000 description 1
- 102100028178 Mas-related G-protein coupled receptor member X3 Human genes 0.000 description 1
- 102100028179 Mas-related G-protein coupled receptor member X4 Human genes 0.000 description 1
- 102100024972 Melatonin-related receptor Human genes 0.000 description 1
- 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
- 108010049137 Member 1 Subfamily D ATP Binding Cassette Transporter Proteins 0.000 description 1
- 108010090314 Member 1 Subfamily G ATP Binding Cassette Transporter Proteins 0.000 description 1
- 108010093662 Member 11 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
- 108010023335 Member 2 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
- 108010090306 Member 2 Subfamily G ATP Binding Cassette Transporter Proteins 0.000 description 1
- 108010023338 Member 3 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
- 108010090837 Member 5 Subfamily G ATP Binding Cassette Transporter Proteins 0.000 description 1
- 108010090822 Member 8 Subfamily G ATP Binding Cassette Transporter Proteins 0.000 description 1
- 102100037258 Membrane-associated transporter protein Human genes 0.000 description 1
- 241000699673 Mesocricetus auratus Species 0.000 description 1
- QRHWTCJBCLGYRB-FXQIFTODSA-N Met-Ala-Cys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(O)=O QRHWTCJBCLGYRB-FXQIFTODSA-N 0.000 description 1
- DLAFCQWUMFMZSN-GUBZILKMSA-N Met-Arg-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CCCN=C(N)N DLAFCQWUMFMZSN-GUBZILKMSA-N 0.000 description 1
- RJEFZSIVBHGRQJ-SRVKXCTJSA-N Met-Arg-Met Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(O)=O RJEFZSIVBHGRQJ-SRVKXCTJSA-N 0.000 description 1
- DNDVVILEHVMWIS-LPEHRKFASA-N Met-Asp-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N DNDVVILEHVMWIS-LPEHRKFASA-N 0.000 description 1
- MHQXIBRPDKXDGZ-ZFWWWQNUSA-N Met-Gly-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)CNC(=O)[C@@H](N)CCSC)C(O)=O)=CNC2=C1 MHQXIBRPDKXDGZ-ZFWWWQNUSA-N 0.000 description 1
- YYEIFXZOBZVDPH-DCAQKATOSA-N Met-Lys-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O YYEIFXZOBZVDPH-DCAQKATOSA-N 0.000 description 1
- VSJAPSMRFYUOKS-IUCAKERBSA-N Met-Pro-Gly Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O VSJAPSMRFYUOKS-IUCAKERBSA-N 0.000 description 1
- MIXPUVSPPOWTCR-FXQIFTODSA-N Met-Ser-Ser Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MIXPUVSPPOWTCR-FXQIFTODSA-N 0.000 description 1
- JACMWNXOOUYXCD-JYJNAYRXSA-N Met-Val-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JACMWNXOOUYXCD-JYJNAYRXSA-N 0.000 description 1
- IQJMEDDVOGMTKT-SRVKXCTJSA-N Met-Val-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IQJMEDDVOGMTKT-SRVKXCTJSA-N 0.000 description 1
- 102100036834 Metabotropic glutamate receptor 1 Human genes 0.000 description 1
- 102100036837 Metabotropic glutamate receptor 2 Human genes 0.000 description 1
- 102100038352 Metabotropic glutamate receptor 3 Human genes 0.000 description 1
- 102100038354 Metabotropic glutamate receptor 4 Human genes 0.000 description 1
- 102100038357 Metabotropic glutamate receptor 5 Human genes 0.000 description 1
- 102100038300 Metabotropic glutamate receptor 6 Human genes 0.000 description 1
- 102100038294 Metabotropic glutamate receptor 7 Human genes 0.000 description 1
- 102100037636 Metabotropic glutamate receptor 8 Human genes 0.000 description 1
- 102100032280 Metal cation symporter ZIP14 Human genes 0.000 description 1
- 102100023137 Metal cation symporter ZIP8 Human genes 0.000 description 1
- 102100038735 Mitochondrial basic amino acids transporter Human genes 0.000 description 1
- 102100023198 Mitochondrial carrier homolog 1 Human genes 0.000 description 1
- 102100031332 Mitochondrial carrier homolog 2 Human genes 0.000 description 1
- 102100032429 Mitochondrial coenzyme A transporter SLC25A42 Human genes 0.000 description 1
- 102100040270 Mitochondrial glutamate carrier 2 Human genes 0.000 description 1
- 102100032111 Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51 Human genes 0.000 description 1
- 101710134098 Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51 Proteins 0.000 description 1
- 102100032108 Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A52 Human genes 0.000 description 1
- 101710134097 Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A52 Proteins 0.000 description 1
- 102100030108 Mitochondrial ornithine transporter 1 Human genes 0.000 description 1
- 102100028134 Mitochondrial potassium channel ATP-binding subunit Human genes 0.000 description 1
- 101710106113 Mitochondrial potassium channel ATP-binding subunit Proteins 0.000 description 1
- 102100034068 Monocarboxylate transporter 1 Human genes 0.000 description 1
- 102100021425 Monocarboxylate transporter 10 Human genes 0.000 description 1
- 102100021445 Monocarboxylate transporter 11 Human genes 0.000 description 1
- 102100021444 Monocarboxylate transporter 12 Human genes 0.000 description 1
- 102100034084 Monocarboxylate transporter 13 Human genes 0.000 description 1
- 102100034085 Monocarboxylate transporter 14 Human genes 0.000 description 1
- 102100025276 Monocarboxylate transporter 4 Human genes 0.000 description 1
- 102100025274 Monocarboxylate transporter 6 Human genes 0.000 description 1
- 102100025311 Monocarboxylate transporter 7 Human genes 0.000 description 1
- 102100027871 Monocarboxylate transporter 8 Human genes 0.000 description 1
- 102100027861 Monocarboxylate transporter 9 Human genes 0.000 description 1
- 108010066419 Multidrug Resistance-Associated Protein 2 Proteins 0.000 description 1
- 102100032877 Multidrug and toxin extrusion protein 1 Human genes 0.000 description 1
- 102100032858 Multidrug and toxin extrusion protein 2 Human genes 0.000 description 1
- 102100021339 Multidrug resistance-associated protein 1 Human genes 0.000 description 1
- 101100041804 Mus musculus Slc6a6 gene Proteins 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- WYBVBIHNJWOLCJ-UHFFFAOYSA-N N-L-arginyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCCN=C(N)N WYBVBIHNJWOLCJ-UHFFFAOYSA-N 0.000 description 1
- PESQCPHRXOFIPX-UHFFFAOYSA-N N-L-methionyl-L-tyrosine Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 PESQCPHRXOFIPX-UHFFFAOYSA-N 0.000 description 1
- 102100023414 N-arachidonyl glycine receptor Human genes 0.000 description 1
- MKWKNSIESPFAQN-UHFFFAOYSA-N N-cyclohexyl-2-aminoethanesulfonic acid Chemical compound OS(=O)(=O)CCNC1CCCCC1 MKWKNSIESPFAQN-UHFFFAOYSA-N 0.000 description 1
- 108010066427 N-valyltryptophan Proteins 0.000 description 1
- 102100034559 Natural resistance-associated macrophage protein 1 Human genes 0.000 description 1
- 101100005271 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cat-1 gene Proteins 0.000 description 1
- 101100426589 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) trp-3 gene Proteins 0.000 description 1
- 102100032884 Neutral amino acid transporter A Human genes 0.000 description 1
- 102100028267 Neutral amino acid transporter B(0) Human genes 0.000 description 1
- 102100026071 Olfactomedin-4 Human genes 0.000 description 1
- 102100025909 Opsin-3 Human genes 0.000 description 1
- 102100032646 Opsin-5 Human genes 0.000 description 1
- 102000016304 Origin Recognition Complex Human genes 0.000 description 1
- 102100037193 Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5 Human genes 0.000 description 1
- 102100026070 Ovarian cancer G-protein coupled receptor 1 Human genes 0.000 description 1
- 102100040444 P2X purinoceptor 1 Human genes 0.000 description 1
- 101710189973 P2X purinoceptor 1 Proteins 0.000 description 1
- 102100040479 P2X purinoceptor 2 Human genes 0.000 description 1
- 101710189968 P2X purinoceptor 2 Proteins 0.000 description 1
- 102100040460 P2X purinoceptor 3 Human genes 0.000 description 1
- 101710189970 P2X purinoceptor 3 Proteins 0.000 description 1
- 102100037601 P2X purinoceptor 4 Human genes 0.000 description 1
- 101710189967 P2X purinoceptor 4 Proteins 0.000 description 1
- 102100037603 P2X purinoceptor 5 Human genes 0.000 description 1
- 101710189969 P2X purinoceptor 5 Proteins 0.000 description 1
- 102100037606 P2X purinoceptor 6 Human genes 0.000 description 1
- 101710190089 P2X purinoceptor 6 Proteins 0.000 description 1
- 101710189965 P2X purinoceptor 7 Proteins 0.000 description 1
- 102100037602 P2X purinoceptor 7 Human genes 0.000 description 1
- 102100028069 P2Y purinoceptor 8 Human genes 0.000 description 1
- 229960005552 PAC-1 Drugs 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102100035593 POU domain, class 2, transcription factor 1 Human genes 0.000 description 1
- 101710084414 POU domain, class 2, transcription factor 1 Proteins 0.000 description 1
- 101150054854 POU1F1 gene Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 102100020954 Peroxisomal membrane protein PMP34 Human genes 0.000 description 1
- BBDSZDHUCPSYAC-QEJZJMRPSA-N Phe-Ala-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O BBDSZDHUCPSYAC-QEJZJMRPSA-N 0.000 description 1
- VHWOBXIWBDWZHK-IHRRRGAJSA-N Phe-Arg-Asp Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 VHWOBXIWBDWZHK-IHRRRGAJSA-N 0.000 description 1
- MQWISMJKHOUEMW-ULQDDVLXSA-N Phe-Arg-His Chemical compound C([C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CC=CC=C1 MQWISMJKHOUEMW-ULQDDVLXSA-N 0.000 description 1
- FSPGBMWPNMRWDB-AVGNSLFASA-N Phe-Cys-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N FSPGBMWPNMRWDB-AVGNSLFASA-N 0.000 description 1
- VJLLEKDQJSMHRU-STQMWFEESA-N Phe-Gly-Met Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O VJLLEKDQJSMHRU-STQMWFEESA-N 0.000 description 1
- QPVFUAUFEBPIPT-CDMKHQONSA-N Phe-Gly-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O QPVFUAUFEBPIPT-CDMKHQONSA-N 0.000 description 1
- TXKWKTWYTIAZSV-KKUMJFAQSA-N Phe-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N TXKWKTWYTIAZSV-KKUMJFAQSA-N 0.000 description 1
- YTILBRIUASDGBL-BZSNNMDCSA-N Phe-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 YTILBRIUASDGBL-BZSNNMDCSA-N 0.000 description 1
- MSHZERMPZKCODG-ACRUOGEOSA-N Phe-Leu-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 MSHZERMPZKCODG-ACRUOGEOSA-N 0.000 description 1
- YCCUXNNKXDGMAM-KKUMJFAQSA-N Phe-Leu-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YCCUXNNKXDGMAM-KKUMJFAQSA-N 0.000 description 1
- ZUQACJLOHYRVPJ-DKIMLUQUSA-N Phe-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 ZUQACJLOHYRVPJ-DKIMLUQUSA-N 0.000 description 1
- PEFJUUYFEGBXFA-BZSNNMDCSA-N Phe-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 PEFJUUYFEGBXFA-BZSNNMDCSA-N 0.000 description 1
- PHJUFDQVVKVOPU-ULQDDVLXSA-N Phe-Lys-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC1=CC=CC=C1)N PHJUFDQVVKVOPU-ULQDDVLXSA-N 0.000 description 1
- UNBFGVQVQGXXCK-KKUMJFAQSA-N Phe-Ser-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O UNBFGVQVQGXXCK-KKUMJFAQSA-N 0.000 description 1
- RAGOJJCBGXARPO-XVSYOHENSA-N Phe-Thr-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 RAGOJJCBGXARPO-XVSYOHENSA-N 0.000 description 1
- KLYYKKGCPOGDPE-OEAJRASXSA-N Phe-Thr-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O KLYYKKGCPOGDPE-OEAJRASXSA-N 0.000 description 1
- PTDAGKJHZBGDKD-OEAJRASXSA-N Phe-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N)O PTDAGKJHZBGDKD-OEAJRASXSA-N 0.000 description 1
- YCEWAVIRWNGGSS-NQCBNZPSSA-N Phe-Trp-Ile Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O)C1=CC=CC=C1 YCEWAVIRWNGGSS-NQCBNZPSSA-N 0.000 description 1
- 102100037170 Phosphate carrier protein, mitochondrial Human genes 0.000 description 1
- 102100039032 Phosphatidylcholine translocator ABCB4 Human genes 0.000 description 1
- 102100033616 Phospholipid-transporting ATPase ABCA1 Human genes 0.000 description 1
- 102100033623 Phospholipid-transporting ATPase ABCA3 Human genes 0.000 description 1
- 102100036620 Phospholipid-transporting ATPase ABCA7 Human genes 0.000 description 1
- 102100030447 Phospholipid-transporting ATPase IB Human genes 0.000 description 1
- 102100030448 Phospholipid-transporting ATPase IC Human genes 0.000 description 1
- 102100030474 Phospholipid-transporting ATPase ID Human genes 0.000 description 1
- 102100032687 Phospholipid-transporting ATPase IF Human genes 0.000 description 1
- 102100032688 Phospholipid-transporting ATPase IH Human genes 0.000 description 1
- 102100030472 Phospholipid-transporting ATPase IK Human genes 0.000 description 1
- 102100032689 Phospholipid-transporting ATPase VD Human genes 0.000 description 1
- 102100029751 Plasma membrane calcium-transporting ATPase 1 Human genes 0.000 description 1
- 108050001987 Plasma membrane calcium-transporting ATPase 1 Proteins 0.000 description 1
- 102100029742 Plasma membrane calcium-transporting ATPase 2 Human genes 0.000 description 1
- 108050002011 Plasma membrane calcium-transporting ATPase 2 Proteins 0.000 description 1
- 102100029744 Plasma membrane calcium-transporting ATPase 3 Human genes 0.000 description 1
- 101710205582 Plasma membrane calcium-transporting ATPase 3 Proteins 0.000 description 1
- 102100029743 Plasma membrane calcium-transporting ATPase 4 Human genes 0.000 description 1
- 108050003586 Plasma membrane calcium-transporting ATPase 4 Proteins 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 239000004353 Polyethylene glycol 8000 Substances 0.000 description 1
- 102100033525 Potassium channel subfamily U member 1 Human genes 0.000 description 1
- 102100022810 Potassium voltage-gated channel subfamily H member 1 Human genes 0.000 description 1
- 102100021904 Potassium-transporting ATPase alpha chain 1 Human genes 0.000 description 1
- 102100027376 Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 Human genes 0.000 description 1
- 102100027391 Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 Human genes 0.000 description 1
- 102100027390 Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 Human genes 0.000 description 1
- 102100038718 Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 Human genes 0.000 description 1
- NMELOOXSGDRBRU-YUMQZZPRSA-N Pro-Glu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1 NMELOOXSGDRBRU-YUMQZZPRSA-N 0.000 description 1
- CLNJSLSHKJECME-BQBZGAKWSA-N Pro-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1 CLNJSLSHKJECME-BQBZGAKWSA-N 0.000 description 1
- DMKWYMWNEKIPFC-IUCAKERBSA-N Pro-Gly-Arg Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O DMKWYMWNEKIPFC-IUCAKERBSA-N 0.000 description 1
- FXGIMYRVJJEIIM-UWVGGRQHSA-N Pro-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 FXGIMYRVJJEIIM-UWVGGRQHSA-N 0.000 description 1
- VTFXTWDFPTWNJY-RHYQMDGZSA-N Pro-Leu-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VTFXTWDFPTWNJY-RHYQMDGZSA-N 0.000 description 1
- RMODQFBNDDENCP-IHRRRGAJSA-N Pro-Lys-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O RMODQFBNDDENCP-IHRRRGAJSA-N 0.000 description 1
- KWMZPPWYBVZIER-XGEHTFHBSA-N Pro-Ser-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KWMZPPWYBVZIER-XGEHTFHBSA-N 0.000 description 1
- GBUNEGKQPSAMNK-QTKMDUPCSA-N Pro-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@@H]2CCCN2)O GBUNEGKQPSAMNK-QTKMDUPCSA-N 0.000 description 1
- SHTKRJHDMNSKRM-ULQDDVLXSA-N Pro-Tyr-His Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC3=CN=CN3)C(=O)O SHTKRJHDMNSKRM-ULQDDVLXSA-N 0.000 description 1
- FUOGXAQMNJMBFG-WPRPVWTQSA-N Pro-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 FUOGXAQMNJMBFG-WPRPVWTQSA-N 0.000 description 1
- FIODMZKLZFLYQP-GUBZILKMSA-N Pro-Val-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O FIODMZKLZFLYQP-GUBZILKMSA-N 0.000 description 1
- MTMJNKFZDQEVSY-BZSNNMDCSA-N Pro-Val-Trp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O MTMJNKFZDQEVSY-BZSNNMDCSA-N 0.000 description 1
- 102100040918 Pro-glucagon Human genes 0.000 description 1
- 102100034137 Probable G-protein coupled receptor 101 Human genes 0.000 description 1
- 102100033838 Probable G-protein coupled receptor 132 Human genes 0.000 description 1
- 102100033836 Probable G-protein coupled receptor 139 Human genes 0.000 description 1
- 102100039863 Probable G-protein coupled receptor 141 Human genes 0.000 description 1
- 102100039861 Probable G-protein coupled receptor 142 Human genes 0.000 description 1
- 102100039878 Probable G-protein coupled receptor 148 Human genes 0.000 description 1
- 102100039859 Probable G-protein coupled receptor 149 Human genes 0.000 description 1
- 102100039876 Probable G-protein coupled receptor 150 Human genes 0.000 description 1
- 102100041020 Probable G-protein coupled receptor 152 Human genes 0.000 description 1
- 102100041018 Probable G-protein coupled receptor 153 Human genes 0.000 description 1
- 102100041015 Probable G-protein coupled receptor 156 Human genes 0.000 description 1
- 102100041031 Probable G-protein coupled receptor 158 Human genes 0.000 description 1
- 102100025346 Probable G-protein coupled receptor 160 Human genes 0.000 description 1
- 102100025358 Probable G-protein coupled receptor 162 Human genes 0.000 description 1
- 102100032555 Probable G-protein coupled receptor 171 Human genes 0.000 description 1
- 102100032561 Probable G-protein coupled receptor 173 Human genes 0.000 description 1
- 102100021199 Probable G-protein coupled receptor 174 Human genes 0.000 description 1
- 102100021191 Probable G-protein coupled receptor 179 Human genes 0.000 description 1
- 108091011158 Probable G-protein coupled receptor 179 Proteins 0.000 description 1
- 102100023417 Probable G-protein coupled receptor 19 Human genes 0.000 description 1
- 102100036934 Probable G-protein coupled receptor 21 Human genes 0.000 description 1
- 102100036932 Probable G-protein coupled receptor 25 Human genes 0.000 description 1
- 102100036938 Probable G-protein coupled receptor 27 Human genes 0.000 description 1
- 102100030321 Probable G-protein coupled receptor 32 Human genes 0.000 description 1
- 102100030282 Probable G-protein coupled receptor 33 Human genes 0.000 description 1
- 102100030263 Probable G-protein coupled receptor 34 Human genes 0.000 description 1
- 102100033048 Probable G-protein coupled receptor 45 Human genes 0.000 description 1
- 102100033862 Probable G-protein coupled receptor 63 Human genes 0.000 description 1
- 102100033860 Probable G-protein coupled receptor 75 Human genes 0.000 description 1
- 102100033866 Probable G-protein coupled receptor 82 Human genes 0.000 description 1
- 102100033865 Probable G-protein coupled receptor 83 Human genes 0.000 description 1
- 102100033863 Probable G-protein coupled receptor 85 Human genes 0.000 description 1
- 102100038404 Probable G-protein coupled receptor 88 Human genes 0.000 description 1
- 102100032871 Probable mitochondrial glutathione transporter SLC25A39 Human genes 0.000 description 1
- 102100032418 Probable mitochondrial glutathione transporter SLC25A40 Human genes 0.000 description 1
- 102100036829 Probable peptidyl-tRNA hydrolase Human genes 0.000 description 1
- 102100031600 Probable phospholipid-transporting ATPase IIA Human genes 0.000 description 1
- 102100030468 Probable phospholipid-transporting ATPase IM Human genes 0.000 description 1
- 102100033874 Probable sodium-coupled neutral amino acid transporter 6 Human genes 0.000 description 1
- 102100030624 Proton myo-inositol cotransporter Human genes 0.000 description 1
- 102100037257 Proton-associated sugar transporter A Human genes 0.000 description 1
- 101710192272 Proton-associated sugar transporter A Proteins 0.000 description 1
- 102100036920 Proton-coupled amino acid transporter 1 Human genes 0.000 description 1
- 102100036919 Proton-coupled amino acid transporter 2 Human genes 0.000 description 1
- 102100036918 Proton-coupled amino acid transporter 3 Human genes 0.000 description 1
- 102100036914 Proton-coupled amino acid transporter 4 Human genes 0.000 description 1
- 102100024267 Proton-coupled folate transporter Human genes 0.000 description 1
- 102100037860 Psychosine receptor Human genes 0.000 description 1
- 102100026173 Putative P2Y purinoceptor 10 Human genes 0.000 description 1
- 102100026426 Putative adhesion G protein-coupled receptor E4P Human genes 0.000 description 1
- 102100025793 Putative sodium-coupled neutral amino acid transporter 11 Human genes 0.000 description 1
- 102100021471 Putative sodium-coupled neutral amino acid transporter 7 Human genes 0.000 description 1
- 102100021480 Putative sodium-coupled neutral amino acid transporter 8 Human genes 0.000 description 1
- 101710114266 Putative sodium-coupled neutral amino acid transporter 8 Proteins 0.000 description 1
- 102100023104 Putative solute carrier family 22 member 31 Human genes 0.000 description 1
- 102100030096 Putative thiamine transporter SLC35F3 Human genes 0.000 description 1
- 101710118851 Putative thiamine transporter SLC35F3 Proteins 0.000 description 1
- 102100025206 Putative trace amine-associated receptor 3 Human genes 0.000 description 1
- 101001081402 Rattus norvegicus Histidine-rich glycoprotein Proteins 0.000 description 1
- 101000739162 Rattus norvegicus Secretoglobin family 2A member 2 Proteins 0.000 description 1
- 101100454355 Rattus norvegicus Slc7a8 gene Proteins 0.000 description 1
- 102100029753 Reduced folate transporter Human genes 0.000 description 1
- 102100033617 Retinal-specific phospholipid-transporting ATPase ABCA4 Human genes 0.000 description 1
- 102100038453 Retinoic acid-induced protein 3 Human genes 0.000 description 1
- 101150107345 Rhag gene Proteins 0.000 description 1
- 102000037054 SLC-Transporter Human genes 0.000 description 1
- 108091006207 SLC-Transporter Proteins 0.000 description 1
- 108091006611 SLC10A1 Proteins 0.000 description 1
- 108091006614 SLC10A2 Proteins 0.000 description 1
- 108091006625 SLC10A6 Proteins 0.000 description 1
- 108091006619 SLC11A1 Proteins 0.000 description 1
- 108091006621 SLC12A1 Proteins 0.000 description 1
- 108091006620 SLC12A2 Proteins 0.000 description 1
- 108091006623 SLC12A3 Proteins 0.000 description 1
- 108091006622 SLC12A4 Proteins 0.000 description 1
- 108091006634 SLC12A5 Proteins 0.000 description 1
- 108091006633 SLC12A6 Proteins 0.000 description 1
- 108091006626 SLC12A7 Proteins 0.000 description 1
- 108091006628 SLC12A8 Proteins 0.000 description 1
- 108091006627 SLC12A9 Proteins 0.000 description 1
- 108091006583 SLC14A2 Proteins 0.000 description 1
- 108091006595 SLC15A3 Proteins 0.000 description 1
- 108091006597 SLC15A4 Proteins 0.000 description 1
- 108091006162 SLC17A6 Proteins 0.000 description 1
- 108091006283 SLC17A7 Proteins 0.000 description 1
- 108091006772 SLC18A1 Proteins 0.000 description 1
- 108091006735 SLC22A2 Proteins 0.000 description 1
- 108091006739 SLC22A6 Proteins 0.000 description 1
- 108091006693 SLC23A1 Proteins 0.000 description 1
- 108091006692 SLC23A2 Proteins 0.000 description 1
- 108091006694 SLC23A3 Proteins 0.000 description 1
- 108091006698 SLC23A4 Proteins 0.000 description 1
- 108091006419 SLC25A12 Proteins 0.000 description 1
- 108091006418 SLC25A13 Proteins 0.000 description 1
- 108091006431 SLC25A17 Proteins 0.000 description 1
- 108091006423 SLC25A19 Proteins 0.000 description 1
- 108091006464 SLC25A23 Proteins 0.000 description 1
- 108091006463 SLC25A24 Proteins 0.000 description 1
- 108091006468 SLC25A35 Proteins 0.000 description 1
- 108060004934 SLC25A38 Proteins 0.000 description 1
- 102000016696 SLC25A38 Human genes 0.000 description 1
- 108091006479 SLC25A42 Proteins 0.000 description 1
- 108091006480 SLC25A44 Proteins 0.000 description 1
- 108091006482 SLC25A45 Proteins 0.000 description 1
- 108091006296 SLC2A1 Proteins 0.000 description 1
- 108091006307 SLC2A10 Proteins 0.000 description 1
- 108091006306 SLC2A11 Proteins 0.000 description 1
- 108091006310 SLC2A12 Proteins 0.000 description 1
- 108091006309 SLC2A13 Proteins 0.000 description 1
- 108091006299 SLC2A2 Proteins 0.000 description 1
- 108091006298 SLC2A3 Proteins 0.000 description 1
- 108091006300 SLC2A4 Proteins 0.000 description 1
- 108091006301 SLC2A5 Proteins 0.000 description 1
- 108091006305 SLC2A6 Proteins 0.000 description 1
- 108091006304 SLC2A7 Proteins 0.000 description 1
- 108091006308 SLC2A8 Proteins 0.000 description 1
- 108091006303 SLC2A9 Proteins 0.000 description 1
- 108091006920 SLC38A2 Proteins 0.000 description 1
- 108091006923 SLC38A3 Proteins 0.000 description 1
- 108091006922 SLC38A4 Proteins 0.000 description 1
- 108091006936 SLC38A5 Proteins 0.000 description 1
- 108091006935 SLC38A6 Proteins 0.000 description 1
- 108091006937 SLC38A7 Proteins 0.000 description 1
- 101150047991 SLC39A11 gene Proteins 0.000 description 1
- 101150108342 SLC39A12 gene Proteins 0.000 description 1
- 108091006313 SLC3A2 Proteins 0.000 description 1
- 108091007628 SLC49A4 Proteins 0.000 description 1
- 108091007629 SLC50A1 Proteins 0.000 description 1
- 108091007632 SLC52A1 Proteins 0.000 description 1
- 108091007634 SLC52A2 Proteins 0.000 description 1
- 108091007642 SLC52A3 Proteins 0.000 description 1
- 101150103405 SLC6A19 gene Proteins 0.000 description 1
- 108091006242 SLC7A10 Proteins 0.000 description 1
- 108091006243 SLC7A13 Proteins 0.000 description 1
- 108091006231 SLC7A2 Proteins 0.000 description 1
- 108091006230 SLC7A3 Proteins 0.000 description 1
- 108091006232 SLC7A5 Proteins 0.000 description 1
- 108091006237 SLC7A6 Proteins 0.000 description 1
- 108091006236 SLC7A7 Proteins 0.000 description 1
- 108091006238 SLC7A8 Proteins 0.000 description 1
- 108091006647 SLC9A1 Proteins 0.000 description 1
- 108091006650 SLC9A2 Proteins 0.000 description 1
- 108091006649 SLC9A3 Proteins 0.000 description 1
- 108091006655 SLC9A4 Proteins 0.000 description 1
- 108091006654 SLC9A5 Proteins 0.000 description 1
- 108091006657 SLC9A6 Proteins 0.000 description 1
- 108091006656 SLC9A7 Proteins 0.000 description 1
- 108091006658 SLC9A8 Proteins 0.000 description 1
- 108091006660 SLC9A9 Proteins 0.000 description 1
- 108091006662 SLC9B1 Proteins 0.000 description 1
- 108091006666 SLC9B2 Proteins 0.000 description 1
- 108091006669 SLC9C1 Proteins 0.000 description 1
- 108091006668 SLC9C2 Proteins 0.000 description 1
- 108091006687 SLCO1A2 Proteins 0.000 description 1
- 108091006731 SLCO1B1 Proteins 0.000 description 1
- 108091006730 SLCO1B3 Proteins 0.000 description 1
- 108091006725 SLCO1C1 Proteins 0.000 description 1
- 108091006732 SLCO4C1 Proteins 0.000 description 1
- 108091006682 SLCO5A1 Proteins 0.000 description 1
- 108091006684 SLCO6A1 Proteins 0.000 description 1
- 101150016222 SNAT1 gene Proteins 0.000 description 1
- 101150036141 SPX3 gene Proteins 0.000 description 1
- 101150100424 SPX4 gene Proteins 0.000 description 1
- 101000948733 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Probable phospholipid translocase non-catalytic subunit CRF1 Proteins 0.000 description 1
- 102100027697 Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 Human genes 0.000 description 1
- 101710109122 Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 Proteins 0.000 description 1
- 102100027732 Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 Human genes 0.000 description 1
- 101710109123 Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 Proteins 0.000 description 1
- 102100027733 Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 Human genes 0.000 description 1
- 101710109118 Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 Proteins 0.000 description 1
- 102100037505 Secretin Human genes 0.000 description 1
- 108010086019 Secretin Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- JPIDMRXXNMIVKY-VZFHVOOUSA-N Ser-Ala-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JPIDMRXXNMIVKY-VZFHVOOUSA-N 0.000 description 1
- VQBLHWSPVYYZTB-DCAQKATOSA-N Ser-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)N VQBLHWSPVYYZTB-DCAQKATOSA-N 0.000 description 1
- KAAPNMOKUUPKOE-SRVKXCTJSA-N Ser-Asn-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KAAPNMOKUUPKOE-SRVKXCTJSA-N 0.000 description 1
- ICHZYBVODUVUKN-SRVKXCTJSA-N Ser-Asn-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ICHZYBVODUVUKN-SRVKXCTJSA-N 0.000 description 1
- CNIIKZQXBBQHCX-FXQIFTODSA-N Ser-Asp-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O CNIIKZQXBBQHCX-FXQIFTODSA-N 0.000 description 1
- BLPYXIXXCFVIIF-FXQIFTODSA-N Ser-Cys-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CO)N)CN=C(N)N BLPYXIXXCFVIIF-FXQIFTODSA-N 0.000 description 1
- XSYJDGIDKRNWFX-SRVKXCTJSA-N Ser-Cys-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O XSYJDGIDKRNWFX-SRVKXCTJSA-N 0.000 description 1
- CDVFZMOFNJPUDD-ACZMJKKPSA-N Ser-Gln-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CDVFZMOFNJPUDD-ACZMJKKPSA-N 0.000 description 1
- IOVHBRCQOGWAQH-ZKWXMUAHSA-N Ser-Gly-Ile Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O IOVHBRCQOGWAQH-ZKWXMUAHSA-N 0.000 description 1
- UIGMAMGZOJVTDN-WHFBIAKZSA-N Ser-Gly-Ser Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O UIGMAMGZOJVTDN-WHFBIAKZSA-N 0.000 description 1
- SFTZWNJFZYOLBD-ZDLURKLDSA-N Ser-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO SFTZWNJFZYOLBD-ZDLURKLDSA-N 0.000 description 1
- QBUWQRKEHJXTOP-DCAQKATOSA-N Ser-His-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QBUWQRKEHJXTOP-DCAQKATOSA-N 0.000 description 1
- LQESNKGTTNHZPZ-GHCJXIJMSA-N Ser-Ile-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O LQESNKGTTNHZPZ-GHCJXIJMSA-N 0.000 description 1
- YUJLIIRMIAGMCQ-CIUDSAMLSA-N Ser-Leu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YUJLIIRMIAGMCQ-CIUDSAMLSA-N 0.000 description 1
- NNFMANHDYSVNIO-DCAQKATOSA-N Ser-Lys-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NNFMANHDYSVNIO-DCAQKATOSA-N 0.000 description 1
- WOJYIMBIKTWKJO-KKUMJFAQSA-N Ser-Phe-His Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CO)N WOJYIMBIKTWKJO-KKUMJFAQSA-N 0.000 description 1
- ADJDNJCSPNFFPI-FXQIFTODSA-N Ser-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO ADJDNJCSPNFFPI-FXQIFTODSA-N 0.000 description 1
- PJIQEIFXZPCWOJ-FXQIFTODSA-N Ser-Pro-Asp Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O PJIQEIFXZPCWOJ-FXQIFTODSA-N 0.000 description 1
- BSXKBOUZDAZXHE-CIUDSAMLSA-N Ser-Pro-Glu Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O BSXKBOUZDAZXHE-CIUDSAMLSA-N 0.000 description 1
- AZWNCEBQZXELEZ-FXQIFTODSA-N Ser-Pro-Ser Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O AZWNCEBQZXELEZ-FXQIFTODSA-N 0.000 description 1
- PPCZVWHJWJFTFN-ZLUOBGJFSA-N Ser-Ser-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPCZVWHJWJFTFN-ZLUOBGJFSA-N 0.000 description 1
- DKGRNFUXVTYRAS-UBHSHLNASA-N Ser-Ser-Trp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O DKGRNFUXVTYRAS-UBHSHLNASA-N 0.000 description 1
- XJDMUQCLVSCRSJ-VZFHVOOUSA-N Ser-Thr-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O XJDMUQCLVSCRSJ-VZFHVOOUSA-N 0.000 description 1
- ZSDXEKUKQAKZFE-XAVMHZPKSA-N Ser-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N)O ZSDXEKUKQAKZFE-XAVMHZPKSA-N 0.000 description 1
- ATEQEHCGZKBEMU-GQGQLFGLSA-N Ser-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CO)N ATEQEHCGZKBEMU-GQGQLFGLSA-N 0.000 description 1
- FHXGMDRKJHKLKW-QWRGUYRKSA-N Ser-Tyr-Gly Chemical compound OC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 FHXGMDRKJHKLKW-QWRGUYRKSA-N 0.000 description 1
- KIEIJCFVGZCUAS-MELADBBJSA-N Ser-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)N)C(=O)O KIEIJCFVGZCUAS-MELADBBJSA-N 0.000 description 1
- YEDSOSIKVUMIJE-DCAQKATOSA-N Ser-Val-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O YEDSOSIKVUMIJE-DCAQKATOSA-N 0.000 description 1
- HNDMFDBQXYZSRM-IHRRRGAJSA-N Ser-Val-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HNDMFDBQXYZSRM-IHRRRGAJSA-N 0.000 description 1
- 102100026842 Serine-pyruvate aminotransferase Human genes 0.000 description 1
- 102100023105 Sialin Human genes 0.000 description 1
- 101710105284 Sialin Proteins 0.000 description 1
- 101150086693 Slc17a8 gene Proteins 0.000 description 1
- 101150088805 Slc18a3 gene Proteins 0.000 description 1
- 101150040442 Slc25a29 gene Proteins 0.000 description 1
- 101150081544 Slc37a3 gene Proteins 0.000 description 1
- 101150029345 Slc38a1 gene Proteins 0.000 description 1
- 101150038440 Slc39a13 gene Proteins 0.000 description 1
- 101150090825 Slc39a5 gene Proteins 0.000 description 1
- 101150031731 Slc39a6 gene Proteins 0.000 description 1
- 101150052504 Slc39a8 gene Proteins 0.000 description 1
- 101150013310 Slc43a2 gene Proteins 0.000 description 1
- 101150092957 Slc6a15 gene Proteins 0.000 description 1
- 101150094989 Slc6a17 gene Proteins 0.000 description 1
- 102100022747 Small conductance calcium-activated potassium channel protein 1 Human genes 0.000 description 1
- 101710201180 Small conductance calcium-activated potassium channel protein 1 Proteins 0.000 description 1
- 102100037446 Small conductance calcium-activated potassium channel protein 2 Human genes 0.000 description 1
- 101710201182 Small conductance calcium-activated potassium channel protein 2 Proteins 0.000 description 1
- 102100037442 Small conductance calcium-activated potassium channel protein 3 Human genes 0.000 description 1
- 101710201179 Small conductance calcium-activated potassium channel protein 3 Proteins 0.000 description 1
- 102000013380 Smoothened Receptor Human genes 0.000 description 1
- 101710090597 Smoothened homolog Proteins 0.000 description 1
- 102100036911 Sodium bicarbonate cotransporter 3 Human genes 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- 102100035242 Sodium- and chloride-dependent GABA transporter 2 Human genes 0.000 description 1
- 102100035254 Sodium- and chloride-dependent GABA transporter 3 Human genes 0.000 description 1
- 101710162246 Sodium- and chloride-dependent creatine transporter 1 Proteins 0.000 description 1
- 102100037189 Sodium- and chloride-dependent transporter XTRP3 Human genes 0.000 description 1
- 102000006633 Sodium-Bicarbonate Symporters Human genes 0.000 description 1
- 102100027215 Sodium-coupled monocarboxylate transporter 1 Human genes 0.000 description 1
- 102100037203 Sodium-coupled monocarboxylate transporter 2 Human genes 0.000 description 1
- 102100036916 Sodium-coupled neutral amino acid transporter 1 Human genes 0.000 description 1
- 102100033774 Sodium-coupled neutral amino acid transporter 2 Human genes 0.000 description 1
- 102100033769 Sodium-coupled neutral amino acid transporter 3 Human genes 0.000 description 1
- 102100033869 Sodium-coupled neutral amino acid transporter 4 Human genes 0.000 description 1
- 102100033872 Sodium-coupled neutral amino acid transporter 5 Human genes 0.000 description 1
- 102100021479 Sodium-coupled neutral amino acid transporter 9 Human genes 0.000 description 1
- 101710188283 Sodium-coupled neutral amino acid transporter 9 Proteins 0.000 description 1
- 102100027046 Sodium-dependent multivitamin transporter Human genes 0.000 description 1
- 102100037190 Sodium-dependent neutral amino acid transporter B(0)AT1 Human genes 0.000 description 1
- 102100037252 Sodium-dependent neutral amino acid transporter B(0)AT2 Human genes 0.000 description 1
- 102100037194 Sodium-dependent neutral amino acid transporter SLC6A17 Human genes 0.000 description 1
- 102100038435 Sodium-dependent phosphate transport protein 3 Human genes 0.000 description 1
- 102100038439 Sodium-dependent phosphate transport protein 4 Human genes 0.000 description 1
- 102100028114 Sodium-dependent proline transporter Human genes 0.000 description 1
- 102100021988 Sodium/bile acid cotransporter Human genes 0.000 description 1
- 102100038538 Sodium/calcium exchanger 2 Human genes 0.000 description 1
- 102100032576 Sodium/calcium exchanger 3 Human genes 0.000 description 1
- 102100027214 Sodium/glucose cotransporter 4 Human genes 0.000 description 1
- 102100027204 Sodium/glucose cotransporter 5 Human genes 0.000 description 1
- 102100030980 Sodium/hydrogen exchanger 1 Human genes 0.000 description 1
- 102100022897 Sodium/hydrogen exchanger 10 Human genes 0.000 description 1
- 102100030382 Sodium/hydrogen exchanger 2 Human genes 0.000 description 1
- 102100030375 Sodium/hydrogen exchanger 3 Human genes 0.000 description 1
- 102100030707 Sodium/hydrogen exchanger 4 Human genes 0.000 description 1
- 102100029973 Sodium/hydrogen exchanger 5 Human genes 0.000 description 1
- 102100029972 Sodium/hydrogen exchanger 6 Human genes 0.000 description 1
- 102100029971 Sodium/hydrogen exchanger 7 Human genes 0.000 description 1
- 102100029970 Sodium/hydrogen exchanger 8 Human genes 0.000 description 1
- 102100029967 Sodium/hydrogen exchanger 9 Human genes 0.000 description 1
- 102100022894 Sodium/hydrogen exchanger 9B1 Human genes 0.000 description 1
- 102100022896 Sodium/hydrogen exchanger 9B2 Human genes 0.000 description 1
- 108010038615 Solute Carrier Family 22 Member 5 Proteins 0.000 description 1
- 102100036667 Solute carrier family 10 member 6 Human genes 0.000 description 1
- 102100025671 Solute carrier family 12 member 1 Human genes 0.000 description 1
- 102100034243 Solute carrier family 12 member 2 Human genes 0.000 description 1
- 102100034261 Solute carrier family 12 member 3 Human genes 0.000 description 1
- 102100034244 Solute carrier family 12 member 4 Human genes 0.000 description 1
- 102100034250 Solute carrier family 12 member 5 Human genes 0.000 description 1
- 102100034245 Solute carrier family 12 member 6 Human genes 0.000 description 1
- 102100034252 Solute carrier family 12 member 7 Human genes 0.000 description 1
- 102100036751 Solute carrier family 12 member 8 Human genes 0.000 description 1
- 102100036742 Solute carrier family 12 member 9 Human genes 0.000 description 1
- 102100021485 Solute carrier family 15 member 3 Human genes 0.000 description 1
- 102100021484 Solute carrier family 15 member 4 Human genes 0.000 description 1
- 102100023106 Solute carrier family 17 member 9 Human genes 0.000 description 1
- 102100023536 Solute carrier family 2, facilitated glucose transporter member 1 Human genes 0.000 description 1
- 102100023537 Solute carrier family 2, facilitated glucose transporter member 2 Human genes 0.000 description 1
- 102100022722 Solute carrier family 2, facilitated glucose transporter member 3 Human genes 0.000 description 1
- 102100033939 Solute carrier family 2, facilitated glucose transporter member 4 Human genes 0.000 description 1
- 102100022719 Solute carrier family 2, facilitated glucose transporter member 5 Human genes 0.000 description 1
- 102100030937 Solute carrier family 2, facilitated glucose transporter member 7 Human genes 0.000 description 1
- 102100035282 Solute carrier family 22 member 10 Human genes 0.000 description 1
- 102100021495 Solute carrier family 22 member 12 Human genes 0.000 description 1
- 101710102937 Solute carrier family 22 member 16 Proteins 0.000 description 1
- 102100021542 Solute carrier family 22 member 17 Human genes 0.000 description 1
- 102100032417 Solute carrier family 22 member 2 Human genes 0.000 description 1
- 102100023101 Solute carrier family 22 member 25 Human genes 0.000 description 1
- 102100036929 Solute carrier family 22 member 3 Human genes 0.000 description 1
- 102100036928 Solute carrier family 22 member 4 Human genes 0.000 description 1
- 102100036924 Solute carrier family 22 member 5 Human genes 0.000 description 1
- 102100036930 Solute carrier family 22 member 6 Human genes 0.000 description 1
- 102100035270 Solute carrier family 22 member 7 Human genes 0.000 description 1
- 102100035227 Solute carrier family 22 member 8 Human genes 0.000 description 1
- 102100034251 Solute carrier family 23 member 1 Human genes 0.000 description 1
- 102100034246 Solute carrier family 23 member 2 Human genes 0.000 description 1
- 102100034248 Solute carrier family 23 member 3 Human genes 0.000 description 1
- 102100030118 Solute carrier family 25 member 35 Human genes 0.000 description 1
- 102100032414 Solute carrier family 25 member 44 Human genes 0.000 description 1
- 102100032117 Solute carrier family 25 member 45 Human genes 0.000 description 1
- 102100032112 Solute carrier family 25 member 47 Human genes 0.000 description 1
- 101710177564 Solute carrier family 25 member 47 Proteins 0.000 description 1
- 102100032110 Solute carrier family 25 member 48 Human genes 0.000 description 1
- 101710177574 Solute carrier family 25 member 48 Proteins 0.000 description 1
- 102100030107 Solute carrier family 25 member 53 Human genes 0.000 description 1
- 101710177582 Solute carrier family 25 member 53 Proteins 0.000 description 1
- 102100029731 Solute carrier family 35 member F4 Human genes 0.000 description 1
- 101710088611 Solute carrier family 35 member F4 Proteins 0.000 description 1
- 102100030112 Solute carrier family 35 member F5 Human genes 0.000 description 1
- 101710088610 Solute carrier family 35 member F5 Proteins 0.000 description 1
- 102100032109 Solute carrier family 35 member F6 Human genes 0.000 description 1
- 101710088609 Solute carrier family 35 member F6 Proteins 0.000 description 1
- 102100032211 Solute carrier family 35 member G1 Human genes 0.000 description 1
- 101710088590 Solute carrier family 35 member G1 Proteins 0.000 description 1
- 101710088594 Solute carrier family 35 member G2 Proteins 0.000 description 1
- 102100032208 Solute carrier family 35 member G3 Human genes 0.000 description 1
- 101710088584 Solute carrier family 35 member G3 Proteins 0.000 description 1
- 102100032019 Solute carrier family 35 member G5 Human genes 0.000 description 1
- 101710088598 Solute carrier family 35 member G5 Proteins 0.000 description 1
- 102100036892 Solute carrier family 35 member G6 Human genes 0.000 description 1
- 101710088597 Solute carrier family 35 member G6 Proteins 0.000 description 1
- 102100021475 Solute carrier family 4 member 11 Human genes 0.000 description 1
- 102100032008 Solute carrier family 40 member 1 Human genes 0.000 description 1
- 101710127899 Solute carrier family 41 member 2 Proteins 0.000 description 1
- 102100037196 Solute carrier family 41 member 2 Human genes 0.000 description 1
- 101710127883 Solute carrier family 41 member 3 Proteins 0.000 description 1
- 102100037254 Solute carrier family 41 member 3 Human genes 0.000 description 1
- 102100037253 Solute carrier family 45 member 3 Human genes 0.000 description 1
- 101710139061 Solute carrier family 45 member 3 Proteins 0.000 description 1
- 102100032875 Solute carrier family 45 member 4 Human genes 0.000 description 1
- 101710139060 Solute carrier family 45 member 4 Proteins 0.000 description 1
- 102100037945 Solute carrier family 49 member 4 Human genes 0.000 description 1
- 102100021482 Solute carrier family 49 member A3 Human genes 0.000 description 1
- 102100020883 Solute carrier family 5 member 4 Human genes 0.000 description 1
- 102100036863 Solute carrier family 52, riboflavin transporter, member 1 Human genes 0.000 description 1
- 102100036862 Solute carrier family 52, riboflavin transporter, member 2 Human genes 0.000 description 1
- 102100036865 Solute carrier family 52, riboflavin transporter, member 3 Human genes 0.000 description 1
- 102100032846 Solute carrier organic anion transporter family member 1A2 Human genes 0.000 description 1
- 102100027233 Solute carrier organic anion transporter family member 1B1 Human genes 0.000 description 1
- 102100027239 Solute carrier organic anion transporter family member 1B3 Human genes 0.000 description 1
- 102100027229 Solute carrier organic anion transporter family member 1C1 Human genes 0.000 description 1
- 102100022001 Solute carrier organic anion transporter family member 4C1 Human genes 0.000 description 1
- 102100021990 Solute carrier organic anion transporter family member 5A1 Human genes 0.000 description 1
- 102100021991 Solute carrier organic anion transporter family member 6A1 Human genes 0.000 description 1
- 102100022831 Somatoliberin Human genes 0.000 description 1
- 101710142969 Somatoliberin Proteins 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 102100037464 Succinate receptor 1 Human genes 0.000 description 1
- 102100038952 Sugar phosphate exchanger 3 Human genes 0.000 description 1
- 102100036280 Sugar transporter SWEET1 Human genes 0.000 description 1
- 239000012505 Superdex™ Substances 0.000 description 1
- 102000003629 TRPC3 Human genes 0.000 description 1
- 102000003621 TRPC5 Human genes 0.000 description 1
- 101150042815 TRPC5 gene Proteins 0.000 description 1
- 102000003623 TRPC6 Human genes 0.000 description 1
- 102000003609 TRPM5 Human genes 0.000 description 1
- 102000003608 TRPM6 Human genes 0.000 description 1
- 101150060175 Taar4 gene Proteins 0.000 description 1
- DFTCYYILCSQGIZ-GCJQMDKQSA-N Thr-Ala-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O DFTCYYILCSQGIZ-GCJQMDKQSA-N 0.000 description 1
- KEGBFULVYKYJRD-LFSVMHDDSA-N Thr-Ala-Phe Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KEGBFULVYKYJRD-LFSVMHDDSA-N 0.000 description 1
- KRPKYGOFYUNIGM-XVSYOHENSA-N Thr-Asp-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N)O KRPKYGOFYUNIGM-XVSYOHENSA-N 0.000 description 1
- KGKWKSSSQGGYAU-SUSMZKCASA-N Thr-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O KGKWKSSSQGGYAU-SUSMZKCASA-N 0.000 description 1
- LGNBRHZANHMZHK-NUMRIWBASA-N Thr-Glu-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O LGNBRHZANHMZHK-NUMRIWBASA-N 0.000 description 1
- KRGDDWVBBDLPSJ-CUJWVEQBSA-N Thr-His-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O KRGDDWVBBDLPSJ-CUJWVEQBSA-N 0.000 description 1
- GMXIJHCBTZDAPD-QPHKQPEJSA-N Thr-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N GMXIJHCBTZDAPD-QPHKQPEJSA-N 0.000 description 1
- YOOAQCZYZHGUAZ-KATARQTJSA-N Thr-Leu-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YOOAQCZYZHGUAZ-KATARQTJSA-N 0.000 description 1
- SPVHQURZJCUDQC-VOAKCMCISA-N Thr-Lys-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O SPVHQURZJCUDQC-VOAKCMCISA-N 0.000 description 1
- BIBYEFRASCNLAA-CDMKHQONSA-N Thr-Phe-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 BIBYEFRASCNLAA-CDMKHQONSA-N 0.000 description 1
- LKJCABTUFGTPPY-HJGDQZAQSA-N Thr-Pro-Gln Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O LKJCABTUFGTPPY-HJGDQZAQSA-N 0.000 description 1
- MROIJTGJGIDEEJ-RCWTZXSCSA-N Thr-Pro-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 MROIJTGJGIDEEJ-RCWTZXSCSA-N 0.000 description 1
- NQQMWWVVGIXUOX-SVSWQMSJSA-N Thr-Ser-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NQQMWWVVGIXUOX-SVSWQMSJSA-N 0.000 description 1
- LXXCHJKHJYRMIY-FQPOAREZSA-N Thr-Tyr-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O LXXCHJKHJYRMIY-FQPOAREZSA-N 0.000 description 1
- KZTLZZQTJMCGIP-ZJDVBMNYSA-N Thr-Val-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KZTLZZQTJMCGIP-ZJDVBMNYSA-N 0.000 description 1
- 108010022394 Threonine synthase Proteins 0.000 description 1
- 102100031558 Thymic stromal cotransporter homolog Human genes 0.000 description 1
- 241000723792 Tobacco etch virus Species 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- 102100025205 Trace amine-associated receptor 2 Human genes 0.000 description 1
- 102100025204 Trace amine-associated receptor 5 Human genes 0.000 description 1
- 102100025203 Trace amine-associated receptor 6 Human genes 0.000 description 1
- 102100025173 Trace amine-associated receptor 8 Human genes 0.000 description 1
- 102100021226 Trace amine-associated receptor 9 Human genes 0.000 description 1
- 102000001999 Transcription Factor Pit-1 Human genes 0.000 description 1
- 108010040742 Transcription Factor Pit-1 Proteins 0.000 description 1
- 102100026186 Transient receptor potential cation channel subfamily A member 1 Human genes 0.000 description 1
- 102100031234 Transient receptor potential cation channel subfamily M member 2 Human genes 0.000 description 1
- 108050001421 Transient receptor potential channel, canonical 6 Proteins 0.000 description 1
- XKKBFNPJFZLTMY-CWRNSKLLSA-N Trp-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N)C(=O)O XKKBFNPJFZLTMY-CWRNSKLLSA-N 0.000 description 1
- SVGAWGVHFIYAEE-JSGCOSHPSA-N Trp-Gly-Gln Chemical compound C1=CC=C2C(C[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)=CNC2=C1 SVGAWGVHFIYAEE-JSGCOSHPSA-N 0.000 description 1
- BYSKNUASOAGJSS-NQCBNZPSSA-N Trp-Ile-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N BYSKNUASOAGJSS-NQCBNZPSSA-N 0.000 description 1
- PWPJLBWYRTVYQS-PMVMPFDFSA-N Trp-Phe-Leu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O PWPJLBWYRTVYQS-PMVMPFDFSA-N 0.000 description 1
- PKZIWSHDJYIPRH-JBACZVJFSA-N Trp-Tyr-Gln Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O PKZIWSHDJYIPRH-JBACZVJFSA-N 0.000 description 1
- IEESWNWYUOETOT-BVSLBCMMSA-N Trp-Val-Phe Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(O)=O IEESWNWYUOETOT-BVSLBCMMSA-N 0.000 description 1
- 101150037542 Trpc3 gene Proteins 0.000 description 1
- 101150033973 Trpc7 gene Proteins 0.000 description 1
- 102100036964 Tuberoinfundibular peptide of 39 residues Human genes 0.000 description 1
- 102100026736 Two pore channel protein 1 Human genes 0.000 description 1
- 102100022609 Two pore channel protein 2 Human genes 0.000 description 1
- QUILOGWWLXMSAT-IHRRRGAJSA-N Tyr-Gln-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O QUILOGWWLXMSAT-IHRRRGAJSA-N 0.000 description 1
- CVXURBLRELTJKO-BWAGICSOSA-N Tyr-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)O CVXURBLRELTJKO-BWAGICSOSA-N 0.000 description 1
- YKCXQOBTISTQJD-BZSNNMDCSA-N Tyr-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N YKCXQOBTISTQJD-BZSNNMDCSA-N 0.000 description 1
- DMWNPLOERDAHSY-MEYUZBJRSA-N Tyr-Leu-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DMWNPLOERDAHSY-MEYUZBJRSA-N 0.000 description 1
- VYQQQIRHIFALGE-UWJYBYFXSA-N Tyr-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 VYQQQIRHIFALGE-UWJYBYFXSA-N 0.000 description 1
- RWOKVQUCENPXGE-IHRRRGAJSA-N Tyr-Ser-Arg Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RWOKVQUCENPXGE-IHRRRGAJSA-N 0.000 description 1
- RMRFSFXLFWWAJZ-HJOGWXRNSA-N Tyr-Tyr-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 RMRFSFXLFWWAJZ-HJOGWXRNSA-N 0.000 description 1
- 108091006585 UT-B Proteins 0.000 description 1
- 102100023407 Uracil nucleotide/cysteinyl leukotriene receptor Human genes 0.000 description 1
- IZFVRRYRMQFVGX-NRPADANISA-N Val-Ala-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N IZFVRRYRMQFVGX-NRPADANISA-N 0.000 description 1
- NWDOPHYLSORNEX-QXEWZRGKSA-N Val-Asn-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCSC)C(=O)O)N NWDOPHYLSORNEX-QXEWZRGKSA-N 0.000 description 1
- XIFAHCUNWWKUDE-DCAQKATOSA-N Val-Cys-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)N XIFAHCUNWWKUDE-DCAQKATOSA-N 0.000 description 1
- BVWPHWLFGRCECJ-JSGCOSHPSA-N Val-Gly-Tyr Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N BVWPHWLFGRCECJ-JSGCOSHPSA-N 0.000 description 1
- MANXHLOVEUHVFD-DCAQKATOSA-N Val-His-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CS)C(=O)O)N MANXHLOVEUHVFD-DCAQKATOSA-N 0.000 description 1
- LYERIXUFCYVFFX-GVXVVHGQSA-N Val-Leu-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N LYERIXUFCYVFFX-GVXVVHGQSA-N 0.000 description 1
- DAVNYIUELQBTAP-XUXIUFHCSA-N Val-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N DAVNYIUELQBTAP-XUXIUFHCSA-N 0.000 description 1
- SYSWVVCYSXBVJG-RHYQMDGZSA-N Val-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N)O SYSWVVCYSXBVJG-RHYQMDGZSA-N 0.000 description 1
- KTEZUXISLQTDDQ-NHCYSSNCSA-N Val-Lys-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N KTEZUXISLQTDDQ-NHCYSSNCSA-N 0.000 description 1
- IJGPOONOTBNTFS-GVXVVHGQSA-N Val-Lys-Glu Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O IJGPOONOTBNTFS-GVXVVHGQSA-N 0.000 description 1
- DIOSYUIWOQCXNR-ONGXEEELSA-N Val-Lys-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O DIOSYUIWOQCXNR-ONGXEEELSA-N 0.000 description 1
- MJFSRZZJQWZHFQ-SRVKXCTJSA-N Val-Met-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)O)N MJFSRZZJQWZHFQ-SRVKXCTJSA-N 0.000 description 1
- VNGKMNPAENRGDC-JYJNAYRXSA-N Val-Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=CC=C1 VNGKMNPAENRGDC-JYJNAYRXSA-N 0.000 description 1
- VHIZXDZMTDVFGX-DCAQKATOSA-N Val-Ser-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N VHIZXDZMTDVFGX-DCAQKATOSA-N 0.000 description 1
- NZYNRRGJJVSSTJ-GUBZILKMSA-N Val-Ser-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O NZYNRRGJJVSSTJ-GUBZILKMSA-N 0.000 description 1
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 1
- LZRWTJSPTJSWDN-FKBYEOEOSA-N Val-Trp-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)N LZRWTJSPTJSWDN-FKBYEOEOSA-N 0.000 description 1
- SVLAAUGFIHSJPK-JYJNAYRXSA-N Val-Trp-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CO)C(=O)O)N SVLAAUGFIHSJPK-JYJNAYRXSA-N 0.000 description 1
- PGBMPFKFKXYROZ-UFYCRDLUSA-N Val-Tyr-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)N PGBMPFKFKXYROZ-UFYCRDLUSA-N 0.000 description 1
- 102100038286 Vasoactive intestinal polypeptide receptor 2 Human genes 0.000 description 1
- 102100039452 Vesicular acetylcholine transporter Human genes 0.000 description 1
- 102100038039 Vesicular glutamate transporter 1 Human genes 0.000 description 1
- 102100038036 Vesicular glutamate transporter 2 Human genes 0.000 description 1
- 102100038033 Vesicular glutamate transporter 3 Human genes 0.000 description 1
- 101150023714 ZIP10 gene Proteins 0.000 description 1
- 101150100064 ZIP5 gene Proteins 0.000 description 1
- 101150035873 ZIP6 gene Proteins 0.000 description 1
- 101150029176 ZIP9 gene Proteins 0.000 description 1
- 102100023141 Zinc transporter SLC39A7 Human genes 0.000 description 1
- 101710191105 Zinc transporter SLC39A7 Proteins 0.000 description 1
- 102100025452 Zinc transporter ZIP1 Human genes 0.000 description 1
- 102100035243 Zinc transporter ZIP10 Human genes 0.000 description 1
- 102100035247 Zinc transporter ZIP11 Human genes 0.000 description 1
- 102100035257 Zinc transporter ZIP12 Human genes 0.000 description 1
- 102100032279 Zinc transporter ZIP13 Human genes 0.000 description 1
- 102100025451 Zinc transporter ZIP2 Human genes 0.000 description 1
- 102100025446 Zinc transporter ZIP3 Human genes 0.000 description 1
- 102100023142 Zinc transporter ZIP5 Human genes 0.000 description 1
- 102100023144 Zinc transporter ZIP6 Human genes 0.000 description 1
- 102100035239 Zinc transporter ZIP9 Human genes 0.000 description 1
- 102100021143 Zinc-activated ligand-gated ion channel Human genes 0.000 description 1
- 238000003916 acid precipitation Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 108010044940 alanylglutamine Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010070783 alanyltyrosine Proteins 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 108010056942 alpha4-subunit glycine receptor Proteins 0.000 description 1
- 108700006085 alpha7 Nicotinic Acetylcholine Receptor Proteins 0.000 description 1
- 102000047725 alpha7 Nicotinic Acetylcholine Receptor Human genes 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 229940024546 aluminum hydroxide gel Drugs 0.000 description 1
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 1
- 229960003896 aminopterin Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 description 1
- 229910000387 ammonium dihydrogen phosphate Inorganic materials 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 238000011091 antibody purification Methods 0.000 description 1
- 108010018755 aquaporin 0 Proteins 0.000 description 1
- 108010001271 arginyl-glutamyl-arginine Proteins 0.000 description 1
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 108010068265 aspartyltyrosine Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- ZMFVLYPTTFPBNG-ZVGUSBNCSA-N azanium;(2r,3r)-2,3,4-trihydroxy-4-oxobutanoate Chemical compound N.OC(=O)[C@H](O)[C@@H](O)C(O)=O ZMFVLYPTTFPBNG-ZVGUSBNCSA-N 0.000 description 1
- 108010014494 beta-1 Adrenergic Receptors Proteins 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 102100038623 cGMP-gated cation channel alpha-1 Human genes 0.000 description 1
- XQKKWWCELHKGKB-UHFFFAOYSA-L calcium acetate monohydrate Chemical compound O.[Ca+2].CC([O-])=O.CC([O-])=O XQKKWWCELHKGKB-UHFFFAOYSA-L 0.000 description 1
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 1
- 229940052299 calcium chloride dihydrate Drugs 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 238000002288 cocrystallisation Methods 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 238000002447 crystallographic data Methods 0.000 description 1
- 108010016616 cysteinylglycine Proteins 0.000 description 1
- 108010060199 cysteinylproline Proteins 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001687 destabilization Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- YXVFQADLFFNVDS-UHFFFAOYSA-N diammonium citrate Chemical compound [NH4+].[NH4+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O YXVFQADLFFNVDS-UHFFFAOYSA-N 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 229910000388 diammonium phosphate Inorganic materials 0.000 description 1
- 235000019838 diammonium phosphate Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- RKGLUDFWIKNKMX-UHFFFAOYSA-L dilithium;sulfate;hydrate Chemical compound [Li+].[Li+].O.[O-]S([O-])(=O)=O RKGLUDFWIKNKMX-UHFFFAOYSA-L 0.000 description 1
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 235000019524 disodium tartrate Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- TWSALRJGPBVBQU-PKQQPRCHSA-N glucagon-like peptide 2 Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O)[C@@H](C)CC)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)CC)C1=CC=CC=C1 TWSALRJGPBVBQU-PKQQPRCHSA-N 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 1
- 108010049041 glutamylalanine Proteins 0.000 description 1
- 108010079547 glutamylmethionine Proteins 0.000 description 1
- 108010043438 glycine receptor alpha3 subunit Proteins 0.000 description 1
- 239000007973 glycine-HCl buffer Substances 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- 108010010147 glycylglutamine Proteins 0.000 description 1
- 108010087823 glycyltyrosine Proteins 0.000 description 1
- XYXCXCJKZRDVPU-UHFFFAOYSA-N hexane-1,2,3-triol Chemical compound CCCC(O)C(O)CO XYXCXCJKZRDVPU-UHFFFAOYSA-N 0.000 description 1
- 239000012145 high-salt buffer Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 108010018006 histidylserine Proteins 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 102000008371 intracellularly ATP-gated chloride channel activity proteins Human genes 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 108010076756 leucyl-alanyl-phenylalanine Proteins 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- WNCZOFYWLAPNSS-UHFFFAOYSA-M lithium;3-carboxy-3,5-dihydroxy-5-oxopentanoate Chemical compound [Li+].OC(=O)CC(O)(C(O)=O)CC([O-])=O WNCZOFYWLAPNSS-UHFFFAOYSA-M 0.000 description 1
- IAQLJCYTGRMXMA-UHFFFAOYSA-M lithium;acetate;dihydrate Chemical compound [Li+].O.O.CC([O-])=O IAQLJCYTGRMXMA-UHFFFAOYSA-M 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 108010054155 lysyllysine Proteins 0.000 description 1
- 108010038320 lysylphenylalanine Proteins 0.000 description 1
- 229940097364 magnesium acetate tetrahydrate Drugs 0.000 description 1
- 229940050906 magnesium chloride hexahydrate Drugs 0.000 description 1
- DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 description 1
- XKPKPGCRSHFTKM-UHFFFAOYSA-L magnesium;diacetate;tetrahydrate Chemical compound O.O.O.O.[Mg+2].CC([O-])=O.CC([O-])=O XKPKPGCRSHFTKM-UHFFFAOYSA-L 0.000 description 1
- GMDNUWQNDQDBNQ-UHFFFAOYSA-L magnesium;diformate Chemical compound [Mg+2].[O-]C=O.[O-]C=O GMDNUWQNDQDBNQ-UHFFFAOYSA-L 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012577 media supplement Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 108010056582 methionylglutamic acid Proteins 0.000 description 1
- 101150117668 mgtE gene Proteins 0.000 description 1
- 239000007758 minimum essential medium Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 235000019837 monoammonium phosphate Nutrition 0.000 description 1
- 239000006012 monoammonium phosphate Substances 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- LAIZPRYFQUWUBN-UHFFFAOYSA-L nickel chloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].[Cl-].[Ni+2] LAIZPRYFQUWUBN-UHFFFAOYSA-L 0.000 description 1
- 108010017860 nicotinic acetylcholine receptor alpha4 subunit Proteins 0.000 description 1
- 108010019513 nicotinic receptor alpha6 Proteins 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 229940066827 pertussis vaccine Drugs 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- RXNXLAHQOVLMIE-UHFFFAOYSA-N phenyl 10-methylacridin-10-ium-9-carboxylate Chemical compound C12=CC=CC=C2[N+](C)=C2C=CC=CC2=C1C(=O)OC1=CC=CC=C1 RXNXLAHQOVLMIE-UHFFFAOYSA-N 0.000 description 1
- 108010073101 phenylalanylleucine Proteins 0.000 description 1
- 108010051242 phenylalanylserine Proteins 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229940085678 polyethylene glycol 8000 Drugs 0.000 description 1
- 235000019446 polyethylene glycol 8000 Nutrition 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 229960004109 potassium acetate Drugs 0.000 description 1
- 229960002816 potassium chloride Drugs 0.000 description 1
- PJAHUDTUZRZBKM-UHFFFAOYSA-K potassium citrate monohydrate Chemical compound O.[K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PJAHUDTUZRZBKM-UHFFFAOYSA-K 0.000 description 1
- 229940050931 potassium citrate monohydrate Drugs 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- WFIZEGIEIOHZCP-UHFFFAOYSA-M potassium formate Chemical compound [K+].[O-]C=O WFIZEGIEIOHZCP-UHFFFAOYSA-M 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 229940093914 potassium sulfate Drugs 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
- 229940116357 potassium thiocyanate Drugs 0.000 description 1
- VZOPRCCTKLAGPN-ZFJVMAEJSA-L potassium;sodium;(2r,3r)-2,3-dihydroxybutanedioate;tetrahydrate Chemical compound O.O.O.O.[Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O VZOPRCCTKLAGPN-ZFJVMAEJSA-L 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108010077112 prolyl-proline Proteins 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- 108010053725 prolylvaline Proteins 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 230000029983 protein stabilization Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 101150019512 rhbg gene Proteins 0.000 description 1
- 101150053759 rhcg gene Proteins 0.000 description 1
- YVSWPCCVTYEEHG-UHFFFAOYSA-N rhodamine B 5-isothiocyanate Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(N=C=S)C=C1C(O)=O YVSWPCCVTYEEHG-UHFFFAOYSA-N 0.000 description 1
- 229960002101 secretin Drugs 0.000 description 1
- OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 1
- 108010048818 seryl-histidine Proteins 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 101150117250 slc39a10 gene Proteins 0.000 description 1
- 101150109138 slc39a9 gene Proteins 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229940087562 sodium acetate trihydrate Drugs 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 101150056821 spx1 gene Proteins 0.000 description 1
- 101150091285 spx2 gene Proteins 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 108010001055 thymocartin Proteins 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 108010044292 tryptophyltyrosine Proteins 0.000 description 1
- 108010035534 tyrosyl-leucyl-alanine Proteins 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- DJWUNCQRNNEAKC-UHFFFAOYSA-L zinc acetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O DJWUNCQRNNEAKC-UHFFFAOYSA-L 0.000 description 1
- ULXBMFUIOGDDAH-UHFFFAOYSA-L zinc sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Zn++].[O-]S([O-])(=O)=O ULXBMFUIOGDDAH-UHFFFAOYSA-L 0.000 description 1
- 101150030145 zip-8 gene Proteins 0.000 description 1
- 108010082737 zymolyase Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
Abstract
本发明的目的在于提供通过使目标蛋白质稳定化,使得目前为止无法进行结构解析或难以进行结构解析的目标蛋白质能够有效地结构解析的方法。本发明提供与BRIL或BRIL融合蛋白质特异性结合的抗BRIL抗体及其抗原结合片段、编码该抗体及其抗原结合片段的核酸、包含该核酸的载体、包含该载体的抗体生产细胞、该抗体的制造方法和该抗体在蛋白质结构解析中的使用方法。
Description
技术领域
本发明涉及使用抗BRIL抗体使BRIL融合蛋白质稳定化的方法、使用抗BRIL抗体的BRIL融合蛋白质的结晶化方法、结晶制造方法和制作方法、使用抗BRIL抗体解析BRIL融合蛋白质的晶体结构的方法、抗BRIL抗体、编码该抗体的核酸、包含该核酸的载体、导入了该载体的转化细胞以及抗BRIL抗体的制造方法。
背景技术
发挥生命所必须的作用的蛋白质与多种疾病相关,特别是GPCR(G Protein-Coupled Receptor,G蛋白偶联受体)发挥着信号传递的重要功能,成为超过30%的医药品的靶标蛋白质。在现在的药物发现中,以靶标蛋白质的立体结构为基础,通过计算机模拟进行候补化合物的筛选、新化合物的设计,因此靶标蛋白质的结构解析的重要性高。
作为GPCR的结构解析进行X射线晶体结构解析,在20世纪90年代得知了细菌视紫红质的X射线晶体结构(非专利文献1),在2000年作为哺乳类的GPCR首次对牛的视紫红质进行了结构解析(非专利文献2)。之后,在2007年作为人的GPCR首次对β2-肾上腺素受体进行了结构解析(非专利文献3)。
目前为止,在结构确定了的GPCR中,以野生型的状态成功进行结构解析的GPCR能够大量制备,其他的GPCR无法以能够纯化的水平在组织中表达,即使在培养细胞使其强制表达的情况下,从稳定性和表达量的观点出发,也存在难以大量制备到以野生型状态能够结晶化的水平的问题。
GPCR共通由7条跨膜螺旋和第8位的两亲性螺旋构成。螺旋被6个环(loop)连接,N末端与3个环存在于细胞外,C末端和3个环存在于细胞内。GPCR的跨膜部分为将细胞外的激动剂结合传递到细胞内的部分,因此,本质上柔韧性高,在纯化时成为使GPCR不稳定的原因。另外,GPCR以细胞外环区域为中心的配体结合部位的结构具有很大的多样性,因此在不同的受体家族中,在家族中,并不容易预测立体结构的预测。
关于GPCR的结构解析,为了改善稳定性、表达量和结晶性等,目前为止进行了各种研究,进行了约40种人GPCR的结构解析。例如,存在使用将参与GPCR与G蛋白质的相互作用的GPCR的细胞内第3环替换称为T4 Lysozyme(以下,称为T4L)的方法(非专利文献3、专利文献1)或替换成Cytochrome b562RIL的方法(非专利文献4、专利文献1)成功进行结构解析的报告例。
另外,报告有通过在GPCR的氨基酸序列中导入变异,使GPCR的结构稳定化为任意的三维结构的方法(非专利文献5)。该方法在能够利用变异的导入部位使结构固定为激动剂结合型或拮抗剂结合型的方面有效。
形成特异性识别GPCR的抗体与GPCR的复合体的方法(非专利文献6)为对特定的GPCR特异性的抗体片段将特定的GPCR稳定化的方法。另外,在结晶化时,通过抗体片段与GPCR结合,参与晶格中的分子间接触的膜外亲水性表面被扩张,由此具有促进结晶生成的效果。
现有技术文献
专利文献
专利文献1:美国专利申请公开第2012/0288913号说明书
非专利文献
非专利文献1:Pebay-Peyroula E et al.Science,1997;277:1676-81
非专利文献2:Palczewski K et al.Science,2000;289(5480):739-45
非专利文献3:Rosenbaum et al.Science 2007;318:1266-73
非专利文献4:Chun et al.Structure 2012;20:967-976
非专利文献5:Serrano et al.Proc.Natl.Acad.Sci.USA,2008;105:877-882
非专利文献6:Hino et al.Nature,2012;482:237-240
发明内容
发明要解决的问题
如上所述,药物发现中靶标蛋白质的结构解析的重要性高,关于稳定性等上存在问题的GPCR的结构解析,目前为止进行了各种研究。然而,非专利文献5中记载的方法由于以腺苷A2a受体时有效的变异导入部位为基础,规定其他的GPCR的变异导入部位,因此难以说通用性高。进而变异导入部位的组合的探索和结构解析需要大量的劳力和时间。另外,非专利文献6中记载的方法需要对各个GPCR分别制备特异性的抗体片段。
本发明鉴于上述实际情况,其目的在于提供通过将目标蛋白质稳定化,使得目前为止不可能进行结构解析或难以进行结构解析的目标蛋白质能够进行有效的结构解析的方法。另外,其目的在于提供在目标蛋白质的结构解析中有效且有效使蛋白质稳定化的通用的抗体或其抗原结合片段。
解决问题的方法
本发明人发明在使目标膜蛋白质稳定化时,以BRIL为标签蛋白质,制备与该膜蛋白质融合得到的BRIL融合蛋白质,使用与BRIL结合的抗体或其抗原结合片段,能够使该BRIL融合蛋白质稳定化,从而完成了本发明。
即,本发明涉及以下的<1>~<27>。
<1>一种使BRIL融合蛋白质稳定化方法,其中使用与BRIL结合的抗体或其抗原结合片段,使目标蛋白质与BRIL融合使
<2>BRIL融合蛋白质稳定化。
<2>根据<1>所述的方法,其中,BRIL融合蛋白质为目标蛋白质的2个相邻的螺旋结构通过BRIL被融合得到的蛋白质。
<3>根据<1>或<2>所述的方法,其中,目标蛋白质为膜表达蛋白质。
<4>根据<3>所述的方法,其中,膜表达蛋白质为选自G蛋白偶联受体(GPCR)、离子通道和转运子中的任何一种。
<5>根据<1>~<4>中任一项所述的方法,其特征在于,通过使与BRIL结合的抗体或其抗原结合片段与BRIL融合蛋白质的BRIL结合,而使BRIL融合蛋白质稳定化。
<6>根据<1>~<5>中任一项所述的方法,其中,与BRIL结合的抗体或其抗原结合片段为选自以下的(1)~(3)中的任意一种的抗体或其抗原结合片段:
(1)与BRIL的第3螺旋结构和第4螺旋结构的至少任意一者结合的抗体或其抗原结合片段;
(2)与BRIL的第3螺旋结构到第4螺旋结构的至少一部分结合的抗体或其抗原结合片段;以及
(3)与BRIL的选自从N末端起第67位的Ile(I)、第71位的Gln(Q)、第74位的Asp(D)、第77位的Lys(K)、第78位的Leu(L)、第83位的Lys(K)、第85位的Lys(K)、第86位的Glu(E)、第88位的Gln(Q)、第89位的Ala(A)、第90位的Ala(A)、第92位的Glu(E)、第93位的Gln(Q)、第96位的Thr(T)、第97位的Thr(T)、第99位的Asn(N)和第100位的Ala(A)的氨基酸残基中的至少1个氨基酸残基结合的抗体或其抗原结合片段。
<7>根据<1>~<6>中任一项所述的方法,其中,与BRIL结合的抗体或其抗原结合片段为选自以下的(i)~(iii)中的任意一种。
(i)与抗体的H链可变区(VH)的互补决定区(CDR)1~3分别包含序列编号1~3所示的氨基酸序列,且抗体的L链可变区(VL)的CDR1~3分别包含序列编号4~6所示的氨基酸序列的抗体竞争性结合的抗体或其抗原结合片段;
(ii)与抗体的VH的CDR1~3分别包含序列编号1~3所示的氨基酸序列,且抗体的VL的CDR1~3分别包含序列编号4~6所示的氨基酸序列的抗体所结合的表位结合的抗体或其抗原结合片段;以及
(iii)与和抗体的VH的CDR1~3分别包含序列编号1~3所示的氨基酸序列,且抗体的VL的CDR1~3分别包含序列编号4~6所示的氨基酸序列的抗体所结合的表位相同的表位结合的抗体或其抗原结合片段。
<8>根据<1>~<7>中任一项所述的方法,其中,关于与BRIL结合的抗体或其抗原结合片段,抗体的VH的CDR1~3分别包含显示与序列编号1~3所示的氨基酸序列90%以上的相同性的氨基酸序列,且抗体的VL的CDR1~3分别包含显示与序列编号4~6所示的氨基酸序列90%以上的相同性的氨基酸序列。
<9>一种抗BRIL抗体或其抗原结合片段,其为选自以下的(1)~(3)中的任意一种:
(1)与BRIL的第3螺旋结构和第4螺旋结构的至少任意一者结合的抗体或其抗原结合片段;
(2)与BRIL的第3螺旋结构至第4螺旋结构的至少一部分结合的抗体或其抗原结合片段;以及
(3)与BRIL的选自从N末端起第67位的Ile(I)、第71位的Gln(Q)、第74位的Asp(D)、第77位的Lys(K)、第78位的Leu(L)、第83位的Lys(K)、第85位的Lys(K)、第86位的Glu(E)、第88位的Gln(Q)、第89位的Ala(A)、第90位的Ala(A)、第92位的Glu(E)、第93位的Gln(Q)、第96位的Thr(T)、第97位的Thr(T)、第99位的Asn(N)和第100位的Ala(A)的氨基酸残基中的至少1个氨基酸残基结合的抗体或其抗原结合片段。
<10>根据<9>所述的抗BRIL抗体或其抗原结合片段,其为选自以下的(i)~(iii)中的任意一种:
(i)与抗体的VH的CDR1~3分别包含序列编号1~3所示的氨基酸序列,且抗体的L链可变区(VL)的CDR1~3分别包含序列编号4~6所示的氨基酸序列的抗体竞争性结合的抗体或其抗原结合片段;
(ii)与抗体的VH的CDR1~3分别包含序列编号1~3所示的氨基酸序列,且抗体的VL的CDR1~3分别包含序列编号4~6所示的氨基酸序列的抗体所结合的表位结合的抗体或其抗原结合片段;以及
(iii)与和抗体的VH的CDR1~3分别包含序列编号1~3所示的氨基酸序列、且抗体的VL的CDR1~3分别包含序列编号4~6所示的氨基酸序列的抗体所结合的表位相同的表位结合的抗体或其抗原结合片段。
<11>根据<9>或<10>所述的抗BRIL抗体或其抗原结合片段,其中,关于与BRIL结合的抗体或其抗原结合片段,抗体的VH的CDR1~3分别包含显示与序列编号1~3所示的氨基酸序列90%以上的相同性的氨基酸序列,且抗体的VL的CDR1~3分别包含显示与序列编号4~6所示的氨基酸序列90%以上的相同性的氨基酸序列。
<12>一种BRIL融合蛋白质的结晶促进方法或结晶制造方法,该BRIL融合蛋白质是使目标蛋白质与BRIL融合得到的,其中,使用与BRIL结合的抗体或其抗原结合片段。
<13>根据<12>所述的结晶促进方法或结晶制造方法,其中,BRIL融合蛋白质为目标蛋白质的2个相邻的螺旋结构被BRIL融合后的BRIL融合蛋白质。
<14>根据<12>或<13>所述的结晶促进方法或结晶制造方法,其中,目标蛋白质为膜表达蛋白质。
<15>根据<14>所述的结晶促进方法或结晶制造方法,其中,膜表达蛋白质为选自GPCR、离子通道和转运子中的任意1种。
<16>根据<12>~<15>中任一种所述的结晶促进方法或结晶制造方法,其特征在于,通过使与BRIL结合的抗体或其抗原结合片段结合于BRIL融合蛋白质的BRIL,使BRIL融合蛋白质稳定化。
<17>根据<12>~<16>中任一种所述的结晶促进方法或结晶制造方法,其中,与BRIL结合的抗体或其抗原结合片段为选自以下的(1)~(3)中的任意一种:
(1)与BRIL的第3螺旋结构和第4螺旋结构中的至少任意一者结合的抗体或其抗原结合片段;
(2)与BRIL的第3螺旋结构至第4螺旋结构的至少一部分结合的抗体或其抗原结合片段;和
(3)与BRIL的选自从N末端起第67位的Ile(I)、第71位的Gln(Q)、第74位的Asp(D)、第77位的Lys(K)、第78位的Leu(L)、第83位的Lys(K)、第85位的Lys(K)、第86位的Glu(E)、第88位的Gln(Q)、第89位的Ala(A)、第90位的Ala(A)、第92位的Glu(E)、第93位的Gln(Q)、第96位的Thr(T)、第97位的Thr(T)、第99位的Asn(N)和第100位的Ala(A)的氨基酸残基中的至少1个氨基酸残基结合的抗体或其抗原结合片段。
<18>根据<12>~<17>中任一种所述的结晶促进方法或结晶制造方法,其中,与BRIL结合的抗体或其抗原结合片段为选自以下的(i)~(iii)中的任意一种:
(i)与抗体的VH的CDR1~3分别包含序列编号1~3所示的氨基酸序列,且抗体的L链可变区(VL)的CDR1~3分别包含序列编号4~6所示的氨基酸序列的抗体竞争性结合的抗体或其抗原结合片段;
(ii)与抗体的VH的CDR1~3分别包含序列编号1~3所示的氨基酸序列,且抗体的VL的CDR1~3分别包含序列编号4~6所示的氨基酸序列的抗体所结合的表位结合的抗体或其抗原结合片段;以及
(iii)与和抗体的VH的CDR1~3分别包含序列编号1~3所示的氨基酸序列,且抗体的VL的CDR1~3分别包含序列编号4~6所示的氨基酸序列的抗体所结合的表位相同的表位结合的抗体或其抗原结合片段。
<19>根据<12>~<18>中任一种所述的结晶促进方法或结晶制造方法,其中,关于与BRIL结合的抗体或其抗原结合片段,抗体的VH的CDR1~3分别包含显示与序列编号1~3所示的氨基酸序列90%以上的相同性的氨基酸序列,且抗体的VL的CDR1~3分别包含显示与序列编号4~6所示的氨基酸序列90%以上的相同性的氨基酸序列。
<20>一种BRIL融合蛋白质的立体结构解析方法,其中,该BRIL融合蛋白质是使目标蛋白质与BRIL融合得到的,其中,使用与BRIL结合的抗体或其抗原结合片段。
<21>根据<20>所述的立体结构解析方法,其中,BRIL融合蛋白质为目标蛋白质的2个相邻的螺旋结构被BRIL融合后的BRIL融合蛋白质。
<22>根据<20>或<21>所述的立体结构解析方法,其中,目标蛋白质为膜表达蛋白质。
<23>根据<22>所述的立体结构解析方法,其中,膜表达蛋白质为选自GPCR、离子通道和转运子中的任意一种。
<24>根据<20>~<23>中任一项所述的立体结构解析方法,其特征在于,通过使与BRIL结合的抗体或其抗原结合片段结合于BRIL融合蛋白质的BRIL,使BRIL融合蛋白质稳定化。
<25>根据<20>~<24>中任一项所述的立体结构解析方法,其中,与BRIL结合的抗体或其抗原结合片段为选自以下的(1)~(3)中的任意一种:
(1)与BRIL的第3螺旋结构和第4螺旋结构中的至少任意一者结合的抗体或其抗原结合片段;
(2)与BRIL的第3螺旋结构至第4螺旋结构的至少一部分结合的抗体或其抗原结合片段;和
(3)与BRIL的选自从N末端起第67位的Ile(I)、第71位的Gln(Q)、第74位的Asp(D)、第77位的Lys(K)、第78位的Leu(L)、第83位的Lys(K)、第85位的Lys(K)、第86位的Glu(E)、第88位的Gln(Q)、第89位的Ala(A)、第90位的Ala(A)、第92位的Glu(E)、第93位的Gln(Q)、第96位的Thr(T)、第97位的Thr(T)、第99位的Asn(N)和第100位的Ala(A)的氨基酸残基中的至少1个氨基酸残基结合的抗体或其抗原结合片段。
<26>根据<20>~<25>中任一项所述的立体结构解析方法,其中,与BRIL结合的抗体或其抗原结合片段为选自以下的(i)~(iii)中的任意一种:
(i)与抗体的H链可变区(VH)的互补决定区(CDR)1~3分别包含序列编号1~3,且抗体的L链可变区(VL)的CDR1~3分别包含序列编号4~6所示的氨基酸序列的抗体竞争性结合的抗体或其抗原结合片段;
(ii)与抗体的VH的CDR1~3分别包含序列编号1~3所示的氨基酸序列,且抗体的VL的CDR1~3分别包含序列编号4~6所示的氨基酸序列的抗体所结合的表位结合的抗体或其抗原结合片段;以及
(iii)与和抗体的VH的CDR1~3分别包含序列编号1~3所示的氨基酸序列,且抗体的VL的CDR1~3分别包含序列编号4~6所示的氨基酸序列的抗体所结合的表位相同的表位结合的抗体或其抗原结合片段。
<27>根据<20>~<26>中任一项所述的立体结构解析方法,其中,关于与BRIL结合的抗体或其抗原结合片段,抗体的VH的CDR1~3分别包含显示与序列编号1~3所示的氨基酸序列90%以上的相同性的氨基酸序列,且抗体的VL的CDR1~3分别包含显示与序列编号4~6所示的氨基酸序列90%以上的相同性的氨基酸序列。
发明的效果
根据本发明,能够提供能够将目前为止不能结构解析或难以结构解析的目标蛋白质有效地进行结构解析的方法。另外,还能够提供在目标蛋白质的结构解析中有效且有效地使蛋白质稳定化的方法。另外根据本发明,能够提供对该蛋白质稳定化有用的抗体、编码该抗体的核酸、包含该核酸的载体、包含该载体的抗体生产细胞、该抗体的制造方法以及该抗体在蛋白质结构解析中的使用方法。
附图说明
图1是表示hChemR23-BRIL融合蛋白质的利用Fluorescence Size ExclusionChromatography(FSEC,荧光尺寸排除色谱法)的柱形图的结果的图。图1的横轴表示蛋白质的洗脱时间(分钟),纵轴表示比荧光强度(RFU)。
图2是表示hChemR23-BRIL/apo/SRP2070Fab复合体结晶的X射线衍射像的图。
图3是表示hChemR23-BRIL/apo/SRP2070Fab复合体的结构解析的结果的图。
图4是表示5HT1B-BRIL/Ergotamine/SRP2070Fab复合体的结构解析的结果的图。
图5是用电子显微镜拍摄hChemR23-BRIL/apo/SRP2070Fab的复合体得到的图。箭头(实线)所示的部分为SRP2070Fab,箭头(虚线)所示的部分为GPCR部分。
图6是用电子显微镜拍摄5HT1B-BRIL/Ergotamine/SRP2070Fab复合体得到的图。箭头(实线)所示的部分为SRP2070Fab,箭头(虚线)所示的部分为GPCR部分。
发明的具体实施方式
本发明涉及使用与BRIL结合的抗体(以下,也简称为抗BRIL抗体。)或其抗原结合片段使BRIL融合蛋白质稳定化的方法(以下,也简称为本发明的稳定化方法。)。在本发明的稳定化方法中,在进行目标蛋白质的结构解析时,预先制作目标蛋白质与BRIL融合得到的BRIL融合蛋白质,使与BRIL融合蛋白质的BRIL部分结合的抗体或其抗原结合片段与BRIL融合蛋白质共存,使其结合,由此能够使BRIL融合蛋白质稳定化。
另外,本发明还包括通过使BRIL融合蛋白质稳定地存在的BRIL融合蛋白质的纯化方法、制造方法、结晶化方法、结晶化的促进方法、结晶制造方法和立体结构解析方法等。
作为本发明的稳定化方法中使用的抗BRIL抗体或其抗原结合片段,也可以使用后述的抗BRIL抗体或其抗原结合片段的任何一种。作为本发明的BRIL融合蛋白质的纯化方法,可以列举使抗BRIL抗体或其抗原结合片段在柱或珠子上固相化,使其与BRIL融合蛋白质结合,由此将BRIL融合蛋白质有效且特异性地纯化的方法。
根据本发明的稳定化方法,能够使BRIL融合蛋白质在溶液内稳定地存在,因此,本发明的稳定化方法也能够用于目标蛋白质的负染色电子显微镜解析或冷冻电子显微镜解析。此时,抗BRIL抗体或其抗原结合片段也能够作为以可溶性状态对目标BRIL融合蛋白质赋予方向性的标记物操作,因此能够用于目标蛋白质的电子显微镜解析像的解析。
即,如果在溶液中使本发明的抗BRIL抗体或其抗原结合片段与BRIL融合蛋白质结合,则能够将与目标BRIL融合蛋白质的BRIL部分结合的抗体或其抗原结合片段作为识别三维结构中的BRIL部分、目标蛋白质部分的标记物进行识别,因此对目标蛋白质的结构解析有用。
另外,根据本发明的稳定化方法,通过在结晶的生成过程中,使抗BRIL抗体或其抗原结合片段与BRIL融合蛋白质的BRIL部分结合,能够有规则地排列BRIL融合蛋白质,能够有效促进目标蛋白质的结晶化。本发明的稳定化方法作为有效地促进目前为止无法或难以结晶化的目标蛋白质的结晶化的方法也有用。
根据本发明的结晶制造方法,将BRIL融合蛋白质与抗BRIL抗体或其抗原结合片段以适当的摩尔比混合后,与聚乙二醇(PEG)、盐、有机溶剂和缓冲剂混合,能够制造目标BRIL融合蛋白质和抗BRIL抗体或其抗原结合片段的共结晶。
作为本发明的结晶制造方法,可以列举包括表达/纯化BRIL融合蛋白质的工序、使BRIL融合蛋白质与抗BRIL抗体或其抗原结合片段反应的工序、以及使BRIL融合蛋白质与抗BRIL抗体或其抗原结合片段共结晶化的工序的结晶的制造方法。
作为本发明的立体结构解析方法,可以列举包括表达/纯化BRIL融合蛋白质的工序、使BRIL融合蛋白质与抗BRIL抗体或其抗原结合片段反应的工序、使BRIL融合蛋白质与抗BRIL抗体或其抗原结合片段共结晶化的工序、以及包含得到X射线衍射数据的工序的晶体结构解析方法的立体结构解析方法、以及表达/纯化BRIL融合蛋白质的工序、使BRIL融合蛋白质与抗BRIL抗体或其抗原结合片段反应的工序、以及利用电子显微镜的结构解析的立体结构解析方法等。
另外,本发明涉及与BRIL融合蛋白质结合的抗BRIL抗体或其抗原结合片段。本发明的抗BRIL抗体或其抗原结合片段能够通过使与BRIL融合蛋白质的BRIL部分结合,而使BRIL融合蛋白质稳定化。
在本发明中,BRIL是指在apocytochrome(脱辅基细胞色素)b562的氨基酸序列中导入了M7W、H102I和R106L的氨基酸残基取代的热耐性apocytochrome b562突变蛋白质(也称为cytochrome b562RI)[Chu et al,J.Mol.Biol.(2002)323,253-262](Protein DataBank ID:PDB 1M6T)。
在本发明中,氨基酸残基取代以原始的氨基酸残基、氨基酸残基的位置、以及取代后的氨基酸残基的顺序表示。
另外,在本发明中BRIL包含由与序列编号9的氨基酸序列依次具有优选90%以上、91%以上、92%以上、93%以上、94%以上的相同性的蛋白质、更优选具有95%以上、96%以上、97%以上、98%以上、99%以上的相同性的氨基酸序列构成的且构成由cytochromeb562的氨基酸序列形成的立体结构的蛋白质。
在本发明中,BRIL融合蛋白质只要为在目标蛋白质上融合有BRIL的蛋白质,则可以包含任意的BRIL融合蛋白质。BRIL融合蛋白质优选以BRIL构成目标蛋白质的螺旋结构的至少一部分的方式与目标蛋白质融合,更优选以BRIL构成目标蛋白质的结构中的环结构的至少一部分的方式与目标蛋白质融合。
作为与目标蛋白质融合的BRIL,只要抗BRIL抗体或其抗原结合片段与BRIL融合蛋白质中的BRIL部分结合,则可以为其片段。作为BRIL片段,可以根据目标蛋白质的种类等适当调整。
作为BRIL融合蛋白质,具体可以列举例如以构成目标蛋白质的细胞外环结构、细胞内环结构、小胞膜外环结构或小胞内环结构的至少一部分的方式融合的BRIL融合蛋白质。
在本发明中作为BRIL融合蛋白质更具体地可以列举例如将在目标蛋白质的结构中存在的2个螺旋结构之间存在的环结构的全部或一部分用BRIL蛋白质或该片段取代或融合后的BRIL融合蛋白质。
在目标蛋白质的结构中存在的上述2个螺旋结构既可以在蛋白质的一级序列上相邻也可以不相邻,优选在三维立体结构上相邻,更优选构成目标蛋白质的2个螺旋结构在一级序列上相邻也在三维立体结构上相邻。
构成上述2个相邻的螺旋结构的第1螺旋结构和第2螺旋结构中,优选第1螺旋结构的C末端侧的氨基酸残基与第2螺旋结构的N末端侧或C末端侧的氨基酸残基的距离近,更优选该距离以以下顺序为
作为目标蛋白质的结构中的环结构,可以列举例如形成贯通各细胞膜、细胞小器官的小胞膜等的膜结构的螺旋结构的正下方的结构。能够使该环结构的一部分取代或融合BRIL蛋白质和该片段,来表达、纯化BRIL融合蛋白质。
具体而言,例如在GPCR的细胞内环融合BRIL的情况下,根据已经报道的GPCR晶体结构解析结果,在GPCR的从N末端起第5位的跨膜螺旋中保守的脯氨酸数第16~24位的氨基酸区域、和第6位的跨膜螺旋中保守的脯氨酸起第-24~-28位的氨基酸区域重叠的部分融合BRIL,由此能够制作稳定的GPCR-BRIL融合蛋白质(Eugene Chun et al.Structure,2012;20:967-976)。
另外,例如在转运子的细胞内环融合BRIL的情况下,在构成转运子蛋白质的跨膜结构域的螺旋结构中,测量相邻的2个螺旋结构的各自的C末端部分与N末端部分的距离,在距离左右的部分,融合BRIL或该片段,由此能够制作BRIL融合蛋白质。
作为本发明中使用的目标蛋白质,只要能够取代或融合BRIL或该片段,则可以为任何蛋白质,优选列举膜表达蛋白质(也称为膜蛋白质)等。作为膜蛋白质,可以列举受体、离子通道、转运子、酶和结构蛋白质等,更优选列举受体、离子通道和转运子。
作为受体,可以列举例如GPCR等。
作为离子通道,可以列举例如CatSper1、CatSper2、CatSper3、CatSper4、TPC1、TPC2、CNGA1、CNGA2、CNGA3、CNGA4、CNGB1、CNGB3、HCN1、HCN2、HCN3、HCN4、KCa1.1、KCa2.1、KCa2.2、KCa2.3、KCa3.1、KNa1.1、KNa1.2、KCa5.1、Kir1.1、Kir2.1、Kir2.2、Kir2.3、Kir2.4、Kir3.1、Kir3.2、Kir3.3、Kir3.4、Kir4.1、Kir4.2、Kir5.1、Kir6.1、Kir6.2、Kir7.1、K2P1.1、K2P2.1、K2P3.1、K2P4.1、K2P5.1、K2P6.1、K2P7.1、K2P9.1、K2P10.1、K2P12.1、K2P13.1、K2P15.1、K2P16.1、K2P17.1、K2P18.1、Kv1.1、Kv1.2、Kv1.3、Kv1.4、Kv1.5、Kv1.6、Kv1.7、Kv1.8、Kv2.1、Kv2.2、Kv3.1、Kv3.2、Kv3.4、Kv4.1、Kv4.2、Kv4.3、Kv5.1、Kv6.1、Kv6.2、Kv6.3、Kv6.4、Kv7.1、Kv7.2、Kv7.3、Kv7.4、Kv7.5、Kv8.1、Kv8.2、Kv9.1、Kv9.2、Kv9.3、Kv10.1、Kv10.2、Kv11.1、Kv11.2、Kv11.3、Kv12.1、Kv12.2、Kv12.3、RyR1、RyR2、RyR3、TRPA1、TRPC1、TRPC2、TRPC3、TRPC4、TRPC5、TRPC6、TRPC7、TRPM1、TRPM2、TRPM3、TRPM4、TRPM5、TRPM6、TRPM7、TRPM8、TRPML1、TRPML2、TRPML3、TRPP1、TRPP2、TRPP3、TRPV1、TRPV2、TRPV3、TRPV4、TRPV5、TRPV6、Cav1.1、Cav1.2、Cav1.3、Cav1.4、Cav2.1、Cav2.2、Cav2.3、Cav3.1、Cav3.2、Cav3.3、Hv1、Nav1.1、Nav1.2、Nav1.3、Nav1.4、Nav1.5、Nav1.56、Nav1.7、Nav1.8、Nav1.9、5-HT3AB、5-HT3A、5-HT3B、5-HT3C、5-HT3D、5-HT3E、ASIC1、ASIC2、ASIC3、ENaCαβγ、ENaCα、ENaCβ、ENaCδ、ENaCγ、GABAA受体α1亚基、GABAA受体α2亚基、GABAA受体α3亚基、GABAA受体α4亚基、GABAA受体α5亚基、GABAA受体α6亚基、GABAA受体β1亚基、GABAA受体β2亚基、GABAA受体β3亚基、GABAA受体γ1亚基、GABAA受体γ2亚基、GABAA受体γ3亚基、GABAA受体δ亚基、GABAA受体ε亚基、GABAA受体θ亚基、GABAA受体π亚基、GABAA受体ρ1亚基、GABAA受体ρ2亚基、GABAA受体ρ3亚基、甘氨酸受体α1亚基、甘氨酸受体α2亚基、甘氨酸受体α3亚基、甘氨酸受体α4亚基、甘氨酸受体β亚基、GluA1、GluA2、GluA3、GluA4、GluD1、GluD2、GluK1、GluK2、GluK3、GluK4、GluK5、GluN1、GluN2A、GluN2B、GluN2C、GluN2D、GluN3A、GluN3B、IP3R1、IP3R2、IP3R3、烟碱乙酰胆碱受体α1亚基、烟碱乙酰胆碱受体α2亚基、烟碱乙酰胆碱受体α3亚基、烟碱乙酰胆碱受体α4亚基、烟碱乙酰胆碱受体α5亚基、烟碱乙酰胆碱受体α6亚基、烟碱乙酰胆碱受体α7亚基、烟碱乙酰胆碱受体α8亚基、烟碱乙酰胆碱受体α9亚基、烟碱乙酰胆碱受体α10亚基、烟碱乙酰胆碱受体β1亚基、烟碱乙酰胆碱受体β2亚基、烟碱乙酰胆碱受体β3亚基、烟碱乙酰胆碱受体β4亚基、烟碱乙酰胆碱受体γ亚基、烟碱乙酰胆碱受体δ亚基、烟碱乙酰胆碱受体ε亚基、P2X1、P2X2、P2X3、P2X4、P2X5、P2X6、P2X7、ZAC、AQP0、AQP1、AQP2、AQP3、AQP4、AQP5、AQP6、AQP7、AQP8、AQP9、AQP10、ClC-1、ClC-2、ClC-3、ClC-4、ClC-5、ClC-6、ClC-7、ClC-Ka、ClC-Kb、CFTR、CaCC、Maxi Cl-、VRAC、Cx23、Cx25、Cx26、Cx30、Cx30.2、Cx30.3、Cx31、Cx31.1、Cx31.9、Cx32、Cx36、Cx37、Cx40、Cx40.1、Cx43、Cx45、Cx46、Cx47、Cx50、Cx59、Cx62、Px1、Px2、Px3、Navi2.1等。
作为GPCR,可以列举例如5-HT1A、5-HT1B、5-HT1D、5-ht1e、5-HT1F、5-HT2A、5-HT2B、5-HT2C、5-HT4、5-HT5a、5-HT6、5-HT7、M1、M2、M3、M4、M5、A1、A2A、A2B、A3、α1A-肾上腺素能受体、α1B-肾上腺素能受体、α1D-肾上腺素能受体、α2A-肾上腺素能受体、α2B-肾上腺素能受体、α2C-肾上腺素能受体、β1-肾上腺素能受体、β2-肾上腺素能受体、β3-肾上腺素能受体、C3a、C5a、C5L2、AT1、AT2、APJ、GPBA、BB1、BB2、BB3、B1、B2、CB1、CB2、CCR1、CCR2、CCR3、CCR4、CCR5、CCR6、CCR7、CCR8、CCR9、CCR10、CXCR1、CXCR2、CXCR3、CXCR4、CXCR5、CXCR6、CXCR7、CX3CR1、XCR1、CCK1、CCK2、D1、D2、D3、D4、D5、ETA、ETB、GPER、FPR1、FPR2/ALX、FPR3、FFA1、FFA2、FFA3、GPR42、GAL1、GAL2、GAL3、生长激素释放肽、FSH、LH、TSH、GnRH、GnRH2、H1、H2、H3、H4、HCA1、HCA2、HCA3、吻素、BLT1、BLT2、CysLT1、CysLT2、OXE、FPR2/ALX、LPA1、LPA2、LPA3、LPA4、LPA5、S1P1、S1P2、S1P3、S1P4、S1P5、MCH1、MCH2、MC1、MC2、MC3、MC4、MC5、MT1、MT2、胃动素、NMU1、NMU2、NPFF1、NPFF2、NPS、NPBW1、NPBW2、Y1、Y2、Y4、Y5、NTS1、NTS2、δ、κ、μ、NOP、OX1、OX2、P2Y1、P2Y2、P2Y4、P2Y6、P2Y11、P2Y12、P2Y13、P2Y14、QRFP、PAF、PKR1、PKR2、PRRP、DP1、DP2、EP1、EP2、EP3、EP4、FP、IP1、TP、PAR1、PAR2、PAR3、PAR4、RXFP1、RXFP2、RXFP3、RXFP4、sst1、sst2、sst3、sst4、sst5、NK1、NK2、NK3、TRH1、TA1、UT、V1A、V1B、V2、OT、CCRL2、CMKLR1、GPR1、GPR3、GPR4、GPR6、GPR12、GPR15、GPR17、GPR18、GPR19、GPR20、GPR21、GPR22、GPR25、GPR26、GPR27、GPR31、GPR32、GPR33、GPR34、GPR35、GPR37、GPR37L1、GPR39、GPR42、GPR45、GPR50、GPR52、GPR55、GPR61、GPR62、GPR63、GPR65、GPR68、GPR75、GPR78、GPR79、GPR82、GPR83、GPR84、GPR85、GPR87、GPR88、GPR101、GPR119、GPR120、GPR132、GPR135、GPR139、GPR141、GPR142、GPR146、GPR148、GPR149、GPR150、GPR151、GPR152、GPR153、GPR160、GPR161、GPR162、GPR171、GPR173、GPR174、GPR176、GPR182、GPR183、LGR4、LGR5、LGR6、LPAR6、MAS1、MAS1L、MRGPRD、MRGPRE、MRGPRF、MRGPRG、MRGPRX1、MRGPRX2、MRGPRX3、MRGPRX4、OPN3、OPN5、OXGR1、P2RY8、P2RY10、SUCNR1、TAAR2、TAAR3、TAAR4、TAAR5、TAAR6、TAAR8、TAAR9、CCPB2、CCRL1、FY、CT、降钙素受体样受体、CRF1、CRF2、GHRH、GIP、GLP-1、GLP-2、胰高血糖素、分泌素、PTH1、PTH2、PAC1、VPAC1、VPAC2、BAI1、BAI2、BAI3、CD97、CELSR1、CELSR2、CELSR3、ELTD1、EMR1、EMR2、EMR3、EMR4P、GPR56、GPR64、GPR97、GPR98、GPR110、GPR111、GPR112、GPR113、GPR114、GPR115、GPR116、GPR123、GPR124、GPR125、GPR126、GPR128、GPR133、GPR143、GPR144、GPR157、LPHN1、LPHN2、LPHN3、CaS、GPRC6、GABAB1、GABAB2、mGlu1、mGlu2、mGlu3、mGlu4、mGlu5、mGlu6、mGlu7、mGlu8、GPR156、GPR158、GPR179、GPRC5A、GPRC5B、GPRC5C、GPRC5D、卷曲受体、FZD1、FZD2、FZD3、FZD4、FZD5、FZD6、FZD7、FZD8、FZD9、FZD10、SMO等。
作为转运子,可以列举例如ABC1、ABC2、ABC3、ABCR、ABCA5、ABCA6、ABCA7、ABCA8、ABCA9、ABCA10、ABCA12、ABCA13、ABCB1、ABCB2、ABCB3、ABCB4、ABCB5、ABCB6、ABCB7、ABCB8、ABCB9、ABCB10、ABCB11、ABCC1、ABCC2、ABCC3、ABCC4、ABCC5、ABCC6、ABCC7、ABCC8、ABCC9、ABCC10、ABCC11、ABCC12、ABCD1、ABCD2、ABCD3、ABCG1、ABCG2、ABCG4、ABCG5、ABCG8、F型ATP酶α亚基、F型ATP酶β亚基、F型ATP酶γ亚基、F型ATP酶δ亚基、F型ATP酶ε亚基、F型ATP酶A亚基、F型ATP酶B亚基、F型ATP酶C亚基、F型ATP酶D亚基、F型ATP酶E亚基、F型ATP酶F2亚基、F型ATP酶F6亚基、F型ATP酶G2亚基、F型ATP酶8亚基、V型ATP酶V1马达A亚基、V型ATP酶V1马达B1亚基、V型ATP酶V1马达B2亚基、V型ATP酶V1马达C1亚基、V型ATP酶V1马达D亚基、V型ATP酶V1马达E1亚基、V型ATP酶V1马达E2亚基、V型ATP酶V1马达F亚基、V型ATP酶V1马达G1亚基、V型ATP酶V1马达G2亚基、V型ATP酶V1马达G3亚基、V型ATP酶V1马达H亚基、V型ATP酶V0马达a1亚基、V型ATP酶V0马达a2亚基、V型ATP酶V0马达a3亚基、V型ATP酶V0马达a4亚基、V型ATP酶V0马达b亚基、V型ATP酶V0马达c亚基、V型ATP酶V0马达d1亚基、V型ATP酶V0马达d2亚基、V型ATP酶V0马达e1亚基、V型ATP酶V0马达e2亚基、钠/钾离子转运ATP酶亚基α-1、钠/钾离子转运ATP酶亚基α-2、钠/钾离子转运ATP酶亚基α-3、钠/钾离子转运ATP酶亚基α-4、钠/钾离子转运ATP酶亚基β-1、钠/钾离子转运ATP酶亚基β-2、钠/钾离子转运ATP酶亚基β-3、钠/钾离子转运ATP酶亚基γ、SERCA1、SERCA2、SERCA3、PMCA1、PMCA2、PMCA3、PMCA4、SPCA1、SPCA2、ATP4A、ATP12A、ATP4B、ATP7A、ATP7B、ATP8A1、ATP8A2、ATP8B1、ATP8B2、ATP8B3、ATP8B4、ATP9A、ATP9B、ATP10A、ATP10B、ATP10D、ATP11A、ATP11B、ATP11C、突触小泡糖蛋白2A、EAAT1、EAAT12、EAAT3、EAAT4、EAAT5、ASCT1、ASCT2、GLUT1、GLUT2、GLUT3、GLUT4、GLUT5、GLUT6、GLUT7、GLUT8、GLUT9、GLUT10、GLUT11、GLUT12、HMIT、rBAT、4F2hc、CAT1、CAT2、CAT3、CAT4、可能的阳离子氨基酸转运蛋白、LAT1、LAT2、y+LAT1、y+LAT2、b0、+AT、Asc-1、xCT、AGT1、AE1、AE2、AE3、AE4、NBCe1、NBCe2、NBCn1、NBCn2、NDCBE、BTR1、SGLT1、SGLT2、SGLT3、SGLT4、SGLT5、CHT、NIS、SMVT、SMCT1、SMCT2、SMIT1、SMIT2、NET、DAT、GAT1、GAT2、GAT3、BGT1、TauT、CT1、GlyT1、GlyT2、ATB0、PROT、B0AT1、B0AT2、B0AT3、NTT4、NTT5、SIT1、NCX1、NCX2、NCX3、NHE1、NHE2、NHE3、NHE4、NHE5、NHE6、NHE7、NHE8、NHE9、NHA1、NHA2、Sperm-NHE、NHE11、NTCP、ASBT、P3、P4、P5、SOAT、P7、NRAMP1、DMT1、NKCC2、NKCC1、NCC、KCC1、KCC2、KCC3、KCC4、CCC9、CCC6、NaS1、NaS2、NaC1、NaC2、NaC3、UT-A、UT-B、PepT1、PepT2、PHT1、PHT2、MCT1、VMCT2、MCT3、MCT4、MCT5、MCT6、MCT7、MCT8、MCT9、MCT11、MCT12、MCT13、MCT14、TAT1、NPT1、NPT3、NPT4、钠/磷酸盐共转运蛋白同系物、AST、VGLUT1、VGLUT2、VGLUT3、VNUT、VMAT1、VMAT2、VAChT、溶质载体家族18成员B1、FOLT、ThTr1、ThTr2、PiT1、PiT2、OCT1、OCT2、OCT3、OCTN1、OCTN2、CT2、OAT1、OAT2、OAT3、OAT4、OAT5、有机阴离子转运蛋白4、URAT1、ORCTL3、ORCTL4、FLIPT1、BOIT、ORCTL2、OAT6、SLC22A23、SLC22A24、UST6、溶质载体家族22成员31。
另外,作为转运子,可以列举例如SVCT1、SVCT2、SVCT3、SNBT1、NKCX1、NKCX2、NKCX3、NKCX4、NKCX5、NKCX6、CIC、DIC、OGC、ODC、SLC25A34、SLC25A35、溶质载体家族25成员47、溶质载体家族25成员48、AGC1、AGC2、GC1、GC2、ORC1、ORC2、CAC、ORNT3、SLC25A38、CGI-69、MCFP、SLC25A44、SLC25A45、PHC、ANT1、ANT2、ANT3、ANT4、GDC、PMP34、DNC、SAMC1、SLC25A42、APC1、APC2、APC3、MFTC、PNC1、PNC2、SCaMC-3L、SLC25A43、UCP1、UCP2、UCP3、UCP4、UCP5、KMCP1、线粒体载体1、线粒体载体2、溶质载体家族25成员51、溶质载体家族25成员52、溶质载体家族25成员53、线粒体铁蛋1、线粒体铁蛋白2、SLC25A46、精脒/精胺N1-乙酰基转移酶1(Sat-1)、DTDST、DRA、潘蛋白(Pendrin)、PAT-1、SLC26A7、SLC26A9、压力素(Prestin)、Tat1、SLC26A10、KBAT、FATP1、FATP2、FATP3、FATP4、FATP5、FATP6、CNT1、CNT2、CNT3、ENT1、ENT2、ENT3、PMAT、ZnT1、ZnT2、ZnT3、ZnT4、ZnT5、ZnT6、ZnT7、ZnT8、ZnT9、ZnT10、CTR1、CTR2、VIAAT、ACATN1、NaPi-IIa、NaPi-IIb、NaPi-IIc、CMP-唾液酸转运蛋白、UDP-半乳糖转运蛋白、UDP-N-乙酰氨基葡萄糖转运蛋白、MGC2541、FLJ11130、UGTREL1、PAPS转运蛋白1、PAPS转运蛋白2、YEA、GDP-岩藻糖转运蛋白、OVCOV1、UDP-葡萄糖醛酸/UDP-N-乙酰半乳糖胺转运蛋白、HFRC1、FRCL1、溶质载体家族35成员E1、溶质载体家族35成员E2、溶质载体家族35成员E2B、溶质载体家族35成员E3、溶质载体家族35成员E4、溶质载体家族35成员F1、溶质载体家族35成员F2、溶质载体家族35成员F3、溶质载体家族35成员F4、溶质载体家族35成员F5、溶质载体家族35成员F6、溶质载体家族35成员G1、溶质载体家族35成员G2、溶质载体家族35成员G3、溶质载体家族35成员G4、溶质载体家族35成员G5、溶质载体家族35成员G6、PAT1、PAT2、PAT3、PAT4、SPX1、SPX2、SPX3、SPX4、SNAT1、SNAT2、SNAT3、SNAT4、SNAT5、SNAT6、SNAT7、推测的钠偶联中性氨基酸转运蛋白8、推测的钠偶联中性氨基酸转运蛋白9、PP1744、AVT2、ZIP1、ZIP2、ZIP3、ZIP4、ZIP5、ZIP6、ZIP7、ZIP8、ZIP9、ZIP10、ZIP11、ZIP12、ZIP13、ZIP14、IREG1、MgtE、溶质载体家族41成员2、溶质载体家族41成员3、RhAG、RhBG、RhCG、LAT3、LAT4、EEG1、CTL1、CTL2、CTL3、CTL4、CTL5、质子相关糖转运蛋白A、膜相关转运蛋白、溶质载体家族45成员3、溶质载体家族45成员4、PCFT、TSCOT、SLC46A3、MATE1、MATE2-K、HRG1、FLVCR1、FLVCR2、MFSD7、DIRC2、RAG1AP1、OSTα、OSTβ、RFVT1、RFVT2、RFVT3、OATP1A2、OATP1B1、OATP1B3、OATP1C1、OATP2A1、OATP2B1、OATP3A1、OATP4A1、OATP4C1、OATP5A1、OATP6A1等。
在制作BRIL融合蛋白质时,目标蛋白质中的BRIL的***位置、BRIL融合蛋白质的N末端与C末端的氨基酸序列的长度等能够适当调整以通过对BRIL融合蛋白质进行实施例中后述的FSEC等的筛选,得到所希望的单分散性和稳定性等。
作为本发明的抗体或其抗原结合片段,可以列举与BRIL特异性结合的抗体(抗BRIL抗体)或其抗原结合片段。
抗体分子由被称为重链(Heavy chain,以下记作H链)和轻链(Light chain,以下记作L链)的多肽构成。另外,H链从N末端侧起由H链可变区(也记作VH)、H链恒定区(也记作CH)构成,L链从N末端侧起由L链可变区(也记作VL)、L链恒定区(也记作CL)的各区域构成。
CH在每个亚类中,分别已知有α、δ、ε、γ和μ链。CH从N末端侧起还由CH1结构域、铰链区、CH2结构域、CH3结构域的各结构域构成。结构域是指构成抗体分子的各多肽的功能性结构单位。另外,CH2结构域与CH3结构域一起称为Fc区域或简称为Fc。CL已知有Cλ链和Cκ链。
本发明中的CH1结构域、铰链区、CH2结构域、CH3结构域和Fc区域根据EU指数[Kabat et al.,Sequences of Proteins of Immunological Interest,US Dept.Healthand Human Services(1991)],以从N末端起的氨基酸残基的编号来规定。具体而言,CH1规定为EU指数第118~215位的氨基酸序列,铰链规定为EU指数第216~230位的氨基酸序列,CH2规定为EU指数第231~340位的氨基酸序列,CH3规定为EU指数第341~447位的氨基酸序列。
作为本发明的抗体,还包括特别是基因工程学制作的重组小鼠抗体、重组大鼠抗体、重组兔抗体、小鼠型嵌合抗体、大鼠型嵌合抗体、人型嵌合抗体(以下,也仅简记作嵌合抗体)、人源化抗体[也被称为人源互补决定区(Complementarity Determining Region;CDR)移植抗体]和人抗体等的基因重组抗体。
嵌合抗体是指例如由人以外的动物(非人类动物)的抗体的VH和VL与人抗体的CH和CL构成的抗体。另外,还包含不同种类动物间的VH/VL和CH/CL重组得到的嵌合抗体。作为非人类动物,例如小鼠、大鼠、仓鼠、兔等只要能够制作杂交瘤,则可以使用任何来源。
杂交瘤是指使对非人类动物免疫抗原所取得的B细胞与源自小鼠等的骨髓瘤细胞进行细胞融合而得到的、产生具有所希望的抗原特异性的单克隆抗体的细胞。因此,构成杂交瘤所产生的抗体的可变区由非人类动物抗体的氨基酸序列构成。
人型嵌合抗体能够通过生产单克隆抗体的源自非人类动物细胞的杂交瘤,取得编码该单克隆抗体的VH和VL的cDNA,分别***到具有编码人抗体的CH和CL的DNA的动物细胞用表达载体中,构建人嵌合抗体表达载体,导入动物细胞,使其表达并制造。
人源化抗体是指将非人类动物抗体的VH和VL的CDR的氨基酸序列移植到与人抗体的VH和VL对应的CDR上的抗体。VH和VL的CDR以外的区域被称为骨架区(以下记作FR)。
人源化抗体能够通过构建编码由非人类动物抗体的VH的CDR的氨基酸序列和任意的人抗体的VH的FR的氨基酸序列构成的VH的氨基酸序列的cDNA和编码由非人类动物抗体的VL的CDR的氨基酸序列和任意的人抗体的VL的FR的氨基酸序列构成的VL的氨基酸序列的cDNA,分别***到具有编码人抗体的CH和CL的DNA的动物细胞用表达载体中,构建人源化抗体表达载体,并导入动物细胞,来表达并制造。
人抗体原本是指在人体内天然存在的抗体,但也包括由于最近的基因工程学、细胞工程、发育工程的技术进步所制作的人抗体噬菌体库和由人抗体产生转基因动物得到的抗体等。
人抗体能够通过对保有人免疫球蛋白基因的小鼠(Tomizuka K.et.al.,ProcNatl Acad Sci U S A.97,722-7,2000)免疫所希望的抗原来取得。另外,通过使用由源自人的B细胞扩增抗体基因得到的噬菌体展示文库,选择具有所希望的结合活性的人抗体,能够不进行免疫而取得人抗体(Winter G.et.al.,Annu Rev Immunol.12:433-55.1994)。此外,通过使用EB病毒使人B细胞永生,制作生产具有所希望的结合活性的人抗体的细胞,能够取得人抗体(Rosen A.et.al.,Nature 267,52-54.1977)。
存在于人体内的抗体例如能够通过使从人末梢血分离的淋巴细胞感染EB病毒等而永生后,克隆,能够得到产生该抗体的淋巴细胞,能够由培养淋巴细胞得到的培养物中纯化该抗体。
人抗体噬菌体库是通过将由人B细胞制备的抗体基因***噬菌体基因使Fab、scFv等的抗体片段在表面表达的噬菌体的文库。通过该文库,能够回收表达以对将抗原固定化的底物的结合活性为指标而具有所希望的抗原结合活性的抗体片段的噬菌体。该抗体片段进一步通过基因工程学的方法,也能够变成由2条完全的H链和2条完全的L链构成的人抗体分子。
人抗体产生转基因动物是指将人抗体基因重组入宿主动物的染色体内的动物。具体而言,能够在小鼠ES细胞导入人抗体基因,将该ES细胞移植到其他小鼠的初期胚后,使其发育,制作人抗体产生转基因动物。由人抗体产生转基因动物制作人抗体的方法能够利用通常的人以外的哺乳动物所进行的杂交瘤制作方法取得人抗体产生杂交瘤进行培养,由此在培养物中产生并积累人抗体。
作为本发明的抗体的VH和VL的氨基酸序列,可以是将人抗体的VH和VL的氨基酸序列、非人类动物抗体的VH和VL的氨基酸序列、或者非人类动物抗体的CDR移植到任意的人抗体的骨架得到的人源化抗体的VH和VL的氨基酸序列的任意一种。
作为本发明的抗体中的CL的氨基酸序列,可以是人抗体的氨基酸序列或非人类动物抗体的氨基酸序列的任意一种,优选为人抗体的氨基酸序列的Cκ或Cλ。
作为本发明的抗体的CH,可以是属于免疫球蛋白的任何CH,优选使用属于IgG类的亚类、γ1(IgG1)、γ2(IgG2)、γ3(IgG3)、γ4(IgG4)的任意一种。
作为本发明的抗体,Fc与抗体片段结合而成的Fc融合蛋白质、Fc与天然存在的配体或受体结合而成的Fc融合蛋白质(也称为免疫粘附素)、使得多个Fc区融合而成的Fc融合蛋白质等也包含在本发明。另外,为了使抗体稳定化以及控制血中半衰期,改变了氨基酸残基的Fc区等也能够用于本发明的抗体。
本发明的抗体或其抗原结合片段还包括包含翻译后修饰后所有的氨基酸残基的抗体。作为翻译后修饰,可以列举例如H链的C末端的赖氨酸残基的缺失[赖氨酸剪切(lysine clipping)]以及多肽的N末端的谷氨酰胺残基改变成焦谷氨酰胺(pyroGlu)等[Beck et al,Analytical Chemistry,85,715-736(2013)]。
在本发明中作为抗原结合片段(或者也称为抗体片段),可以列举Fab、Fab’、F(ab’)2、scFv、双抗体、dsFv、包含多个CDR的肽等。
Fab是将IgG抗体用蛋白质分解酶木瓜蛋白酶处理得到的片段中,(H链的第224位的氨基酸残基被切断)、H链的N末端侧约一半与L链全体由二硫键(S-S键)结合得到的分子量约5万的具有抗原结合活性的抗原结合片段。
F(ab’)2是将IgG用蛋白质分解酶胃蛋白酶处理得到的片段中,(H链的第234位的氨基酸残基被切断)、比Fab经由铰链区的S-S键结合的片段稍大、分子量约10万的具有抗原结合活性的抗原结合片段。
Fab’是将上述F(ab’)2的铰链区的S-S键切断得到的分子量约5万的具有抗原结合活性的抗原结合片段。
scFv是将1条VH和1条VL使用由4个Gly和1个Ser残基构成的接头(G4S)连接任意个数得到的接头肽等适当的肽接头(P)连结而成的VH-P-VL或VL-P-VH多肽且具有抗原结合活性的抗原结合片段。
双抗体(Diabody)是抗原结合特异性相同或不同的scFv形成二聚体得到的抗原结合片段、且具有对相同抗原的2价抗原结合活性或对不同抗原的特异性抗原结合活性的抗原结合片段。
dsFv是将VH和VL中的各自1个氨基酸残基取代为半胱氨酸残基后的多肽经由该半胱氨酸残基间的S-S键结合而成的片段。
包含CDR的肽包含VH或VL的CDR的至少1个区域以上而构成。多个包含CDR的肽能够将CDR彼此直接或经由适当的肽接头而结合。
构建编码本发明的改变抗体的VH和VL的CDR的DNA,将该DNA***原核生物用表达载体或真核生物用表达载体,将该表达载体导入原核生物或真核生物,由此使其表达进行制造。另外,包含CDR的肽能够通过Fmoc法或tBoc法等的化学合成法制造。
作为本发明的抗BRIL抗体或其抗原结合片段,具体可以列举选自以下的(a)~(о)中的任意一种。
(a)与BRIL的螺旋结构结合的抗体或其抗原结合片段、
(b)与BRIL的第1~4螺旋结构的任意1个结合的抗体或其抗原结合片段、
(c)与BRIL的第3螺旋结构和第4螺旋结构的至少任意一者结合的抗体或其抗原结合片段、
(d)与BRIL的第3螺旋结构至第4螺旋结构的至少一部分结合的抗体或其抗原结合片段、
(e)与BRIL的第3螺旋结构和第4螺旋结构结合的抗体或其抗原结合片段、
(f)与BRIL的选自从N末端起第67位的Ile(I)、第71位的Gln(Q)、第74位的Asp(D)、第77位的Lys(K)、第78位的Leu(L)、第83位的Lys(K)、第85位的Lys(K)、第86位的Glu(E)、第88位的Gln(Q)、第89位的Ala(A)、第90位的Ala(A)、第92位的Glu(E)、第93位的Gln(Q)、第96位的Thr(T)、第97位的Thr(T)、第99位的Asn(N)和第100位的Ala(A)的氨基酸残基中的至少1个氨基酸残基结合的抗体或其抗原结合片段、
(g)与BRIL的选自从N末端起第74位的Asp(D)、第92位的Glu(E)、第96位的Thr(T)、第97位的Thr(T)和第99位的Asn(N)的氨基酸残基中的至少1个氨基酸残基结合的抗体或其抗原结合片段、
(h)与BRIL的从N末端起第74位的Asp(D)结合的抗体或其抗原结合片段、
(i)与BRIL的选自从N末端起第92位的Glu(E)、第96位的Thr(T)、第97位的Thr(T)和第99位的Asn(N)的氨基酸残基中的至少1个氨基酸残基结合的抗体或其抗原结合片段、
(j)与BRIL的从N末端起第92位的Glu(E)结合的抗体或其抗原结合片段、
(k)与BRIL的从N末端起第96位的Thr(T)结合的抗体或其抗原结合片段、
(l)与BRIL的从N末端起第97位的Thr(T)结合的抗体或其抗原结合片段、
(m)与BRIL的从N末端起第99位的Asn(N)结合的抗体或其抗原结合片段、
(n)与BRIL的从N末端起第96位的Thr(T)、第97位的Thr(T)和第99位的Asn(N)的氨基酸残基结合的抗体或其抗原结合片段、
(o)与BRIL的第92位的Glu(E)、第96位的Thr(T)、第97位的Thr(T)和第99位的Asn(N)的氨基酸残基结合的抗体或其抗原结合片段。
在本发明中作为构成BRIL的螺旋结构的氨基酸序列,序列编号9所示的氨基酸序列中,作为构成第1螺旋结构的氨基酸序列可以列举从N末端起第4位的M至第19位的K的氨基酸序列,作为构成第2螺旋结构的氨基酸序列可以列举从N末端起第23位的A至42位的K的氨基酸序列,作为构成可以列举第3螺旋结构的氨基酸序列从N末端起59位的K至81位的E的氨基酸序列,以及作为构成第4螺旋结构的氨基酸序列可以列举从N末端起第84位的V至第105位的Y的氨基酸序列。
另外,作为本发明的抗体或该抗体片段更具体而言,可以列举选自以下的(i)~(vii)中的任意一种。
(i)与抗体的VH的CDR1~3分别包含序列编号1~3所示的氨基酸序列、且抗体的VL的CDR1~3分别包含序列编号4~6所示的氨基酸序列的抗体竞争性结合的抗体或其抗原结合片段、
(ii)与抗体的VH的CDR1~3分别包含序列编号1~3所示的氨基酸序列、且抗体的VL的CDR1~3分别包含序列编号4~6所示的氨基酸序列的抗体所结合的表位结合的抗体或其抗原结合片段、
(iii)与和抗体的VH的CDR1~3分别包含序列编号1~3所示的氨基酸序列、且抗体的VL的CDR1~3分别包含序列编号4~6所示的氨基酸序列的抗体所结合的表位相同的表位结合的抗体或其抗原结合片段、
(iv)抗体的VH的CDR1~3分别包含与序列编号1~3所示的氨基酸序列以以下顺序显示90%以上、91%以上、92%以上、93%以上、94%以上、更优选95%以上、96%以上、97%以上、98%以上、99%以上的相同性的氨基酸序列,且抗体的VL的CDR1~3分别包含与序列编号4~6所示的氨基酸序列优选以以下顺序显示90%以上、91%以上、92%以上、93%以上、94%以上、更优选95%以上、96%以上、97%以上、98%以上、99%以上的相同性的氨基酸序列的抗体及其抗原结合片段、
(v)抗体的VH的CDR1~3分别包含序列编号1~3所示的氨基酸序列、且抗体的VL的CDR1~3分别包含序列编号4~6所示的氨基酸序列的抗体或其抗原结合片段、
(vi)抗体的VH包含与序列编号7所示的氨基酸序列优选以以下的顺序显示90%以上、91%以上、92%以上、93%以上、94%以上、更优选95%以上、96%以上、97%以上、98%以上、99%以上的相同性的氨基酸序列,且抗体的VL包含与序列编号8所示的氨基酸序列优选以以下的顺序显示90%以上、91%以上、92%以上、93%以上、94%以上、更优选95%以上、96%以上、97%以上、98%以上、99%以上的相同性的氨基酸序列的抗体或其抗原结合片段、
(vii)抗体的VH包含序列编号7所示的氨基酸序列、且抗体的VL包含序列编号8所示的氨基酸序列的抗体或其抗原结合片段。
本发明的抗体中还包括在本发明的抗体或其抗原结合片段上融合了荧光物质、放射性同位元素等结构分析所需要的分子后的衍生物。另外,本发明的抗体或其抗原结合片段能够用于BRIL融合蛋白质的检测或测定。例如作为免疫学的检测或测定,为使用实施了标记的抗原或抗体或者其抗原结合片段,检测或测定抗体或其抗原结合片段量或抗原量的方法。
作为免疫学的检测或测定方法,可以列举放射性物质标记免疫抗体法(RIA)、酶免疫测定法(EIA或ELISA)、荧光免疫测定法(FIA)、发光免疫测定法(luminescentimmunoassay)、免疫印迹法或物理化学的方法等。
根据上述方法,不仅能够进行BRIL融合蛋白质的检测或测定,而且在BRIL融合蛋白质的利用电子显微镜的结构解析以及利用X射线的晶体结构解析中,还能够将融合于目标蛋白质的BRIL部分用抗BRIL抗体标记化,或确定三维下的分子的方向性。
以下,具体说明本发明的抗BRIL抗体的制造方法、以及使用抗BRIL抗体的BRIL融合蛋白质的稳定化方法、BRIL融合蛋白质的晶体结构解析方法等。
1.抗体的制造方法
(1)抗原的制备
在作为抗原的BRIL蛋白质或目标蛋白质上融合BRIL得到的BRIL融合蛋白质能够通过将包含编码蛋白质的全长或其一部分长度的cDNA的表达载体导入大肠杆菌、酵母、昆虫细胞或动物细胞等来获得。
另外,也能够通过Fmoc法或tBoc法等的化学合成法制备具有BRIL的部分序列的合成肽,用于抗原。BRIL或BRIL融合蛋白质也可以在C末端或N末端添加FLAG或His等公知的标签。
本发明中使用的BRIL或BRIL融合蛋白质能够通过使用Molecular Cloning,ALaboratory Manual,Second Edition,Cold Spring Harbor Laboratory Press(1989)或Current Protocols In Molecular Biology,John Wiley&Sons(1987-1997)等中记载的方法等,例如通过以下的方法,将编码该BRIL或BRIL融合蛋白质的DNA在宿主细胞中表达来制造。
首先,将包含编码BRIL或BRIL融合蛋白质的部分的全长cDNA***适当的表达载体的启动子的下游,由此制作重组载体。将所得到的该重组载体导入适合该表达载体的宿主细胞,由此能够得到生产多肽的转化体。
作为表达载体,只要能够在使用的宿主细胞中自我复制或重组到染色体中,且在能够转录编码多肽的DNA的位置含有适当的启动子的载体,则可以任意使用。
作为宿主细胞,只要是大肠杆菌等的属于埃希氏菌属等的微生物、PichiaPastoris酵母、Sf9等的昆虫细胞、或CHO细胞等的动物细胞等能够表达目标基因的细胞则可以任意使用。
在使用大肠杆菌等的原核生物作为宿主细胞的情况下,重组载体优选为能够在原核生物中自我复制,同时包含启动子、核糖体结合序列、包含编码BRIL或BRIL融合蛋白质的部分的DNA以及转录终止序列的载体。另外,该重组载体中也不一定需要转录终止序列,但优选在结构基因的正下方配置转录终止序列。进一步,在该重组载体中也可以包含控制启动子的基因。作为该重组载体,优选使用将作为核糖体结合序列的Shine-Dalgarno序列(也称为SD序列)与起始密码子之间调节为适当距离(例如6~18碱基)的质粒。
另外,作为编码该BRIL或BRIL融合蛋白质的DNA的碱基序列,能够以成为对宿主内的表达最适合的密码子的方式取代碱基,由此能够提高目标BRIL或BRIL融合蛋白质的生产率。
作为表达载体,只要能够在使用的宿主细胞中发挥功能则可以任意使用,可以列举例如:pBTrp2、pBTac1、pBTac2(以上、Roche Diagnostics公司制)、pKK233-2(Pharmacia公司制)、pSE280(Invitrogen公司制)、pGEMEX-1(Promega公司制)、pQE-8(Qiagen公司制)、pKYP10(日本特开昭58-110600号公报)、pKYP200[Agricultural BiologicalChemistry,48,669(1984)]、pLSA1[Agric.Biol.Chem.,53,277(1989)]、pGEL1[Proc.Natl.Acad.Sci.USA,82,4306(1985)]、pBluescript II SK(-)(Stratagene公司制)、pTrs30[由大肠杆菌JM109/pTrS30(FERM BP-5407)制备]、pTrs32[由大肠杆菌JM109/pTrS32(FERM BP-5408)制备]、pGHA2[由大肠杆菌IGHA2(FERM BP-400)制备、日本特开昭60-221091号公报]、pGKA2[由大肠杆菌IGKA2(FERM BP-6798)制备、日本特开昭60-221091号公报]、pTerm2(US4686191、US4939094、US5160735)、pSupex、pUB110、pTP5、pC194、pEG400[J.Bacteriol.,172,2392(1990)]、pGEX(Pharmacia公司制)、pET***(Novagen公司制)、pME18SFL3、或pFastBac1(Invitrogen公司制)等。
作为宿主细胞,可以列举例如大肠杆菌XL1-Blue、大肠杆菌XL2-Blue、大肠杆菌DH1、大肠杆菌MC1000、大肠杆菌KY3276、大肠杆菌W1485、大肠杆菌JM109、大肠杆菌HB101、大肠杆菌No.49、大肠杆菌W3110、大肠杆菌NY49或大肠杆菌DH5α等。
作为向宿主细胞导入重组载体的方法,只要是向使用的宿主细胞导入DNA的方法则能够使用任意的方法,可以列举例如使用钙离子的方法[Proc.Natl.Acad.Sci.USA,69,2110(1972)、Gene,17,107(1982)、Molecular&General Genetics,168,111(1979)]。
在使用动物细胞作为宿主的情况下,作为表达载体,只要为能够在动物细胞中发挥功能,则能够任意使用,可以列举例如pcDNAI、pCDM8(Funakoshi公司制)、pAGE107[日本特开平3-22979号公报;Cytotechnology,3,133(1990)]、pAS3-3(日本特开平2-227075号公报)、pCDM8[Nature,329,840(1987)]、pcDNAI/Amp(Invitrogen公司制)、pcDNA3.1(Invitrogen公司制)、pREP4(Invitrogen公司制)、pAGE103[J.Biochemistry,101,1307(1987)]、pAGE210、pME18SFL3、pKANTEX93(国际公开第97/10354号)、N5KG1val(美国专利第6,001,358号说明书)、INPEP4(Biogen-IDEC公司制)和转座子载体(国际公开第2010/143698号)等。
作为宿主细胞,可以列举人白血病细胞Namalwa细胞、猴细胞COS细胞、中国仓鼠卵巢细胞CHO细胞[Journal of Experimental Medicine,108,945(1958);Proc.Natl.Acad.Sci.USA,60,1275(1968);Genetics,55,513(1968);Chromosoma,41,129(1973);Methods in Cell Science,18,115(1996);Radiation Research,148,260(1997);Proc.Natl.Acad.Sci.USA,77,4216(1980);Proc.Natl.Acad.Sci.,60,1275(1968);Cell,6,121(1975);Molecular Cell Genetics,Appendix I,II(pp.883-900)]、二氢叶酸还原酶基因(以下记作dhfr)缺失了的CHO细胞(CHO/DG44细胞)[Proc.Natl.Acad.Sci.USA,77,4216(1980)]、CHO-K1(ATCC CCL-61)、DUkXB11(ATCC CCL-9096)、Pro-5(ATCC CCL-1781)、CHO-S(Life Technologies、Cat#11619)、Pro-3、大鼠骨髓瘤细胞YB2/3HL.P2.G11.16Ag.20(或也称为YB2/0)、小鼠骨髓瘤细胞NSO、小鼠骨髓瘤细胞SP2/0-Ag14、叙利亚仓鼠细胞BHK或HBT5637(日本特开昭63-000299号公报)等。
作为重组载体的导入方法,只要是能够在动物细胞导入DNA的方法就可以任意使用,可以列举例如电穿孔法[Cytotechnology,3,133(1990)]、磷酸钙法(日本特开平2-227075号公报)、或脂质转染法[Proc.Natl.Acad.Sci.USA,84,7413(1987)]等。
将具有如上得到的导入了编码BRIL或BRIL融合蛋白质的DNA的重组载体的微生物、酵母、昆虫细胞或动物细胞等的来源的转化体在培养基中培养,在培养液中生成并积累该BRIL或BRIL融合蛋白质,从该培养液中收集,由此能够制造BRIL或BRIL融合蛋白质。将该转化体在培养基中培养的方法能够按照宿主的培养中使用的通常的方法进行。
作为编码BRIL或BRIL融合蛋白质的基因的表达方法,除了直接表达以外,还能够使用分泌生产或融合蛋白质表达等的方法[Molecular Cloning,A Laboratory Manual,Second Edition,Cold Spring Harbor Laboratory Press(1989)]。作为BRIL或BRIL融合蛋白质的生产方法,有在宿主细胞内生产的方法、在宿主细胞外分泌的方法、或在宿主细胞的外膜上生产的方法,通过改变使用的宿主细胞、生产的BRIL或BRIL融合蛋白质的结构,能够选择适当的方法。
(2)动物的免疫和融合用抗体产生细胞的制备
对3~20周龄的小鼠、免疫不全小鼠(MRL/MpJJms slc-lpr/lpr)、大鼠或仓鼠等的动物免疫(1)中得到的抗原,采集该动物的脾、***、末梢血中的抗体产生细胞。
免疫通过在动物的皮下或静脉内或腹腔内例如与弗氏完全佐剂、氢氧化铝凝胶与百日咳菌疫苗、或蛋白脂质体等的适当的佐剂一起投予抗原来进行。在抗原为部分肽的情况下,制作与BSA(牛血清白蛋白)、或KLH(Keyhole Limpet hemocyanin)等的载体蛋白质的缀合物,将其作为免疫原使用。
抗原的投予在第1次投予之后,每隔1~2周进行5~10次。各投予后第3~7天通过眼底静脉丛采血,使用酶免疫测定法[Antibodies-A Laboratory Manual,Cold SpringHarbor Laboratory(1988)]等测定其血清的抗体效价。将对免疫中使用的抗原,其血清显示足够的抗体效价的动物作为融合用抗体产生细胞的供给源。
在抗原的最终投予后第3~7天,从免疫了的动物摘出脾脏等包含抗体产生细胞的组织,采集抗体产生细胞。在使用脾脏细胞的情况下,将脾脏粉碎,分散后,离心,进而除去红细胞,取得融合用抗体产生细胞。
(3)骨髓瘤细胞的制备
作为骨髓瘤细胞,使用从小鼠得到的株化细胞,可以使用例如8-氮鸟嘌呤耐性小鼠(BALB/c由来)骨髓瘤细胞株P3-X63Ag8-U1(P3-U1)[Current Topics inMicrobiology and Immunology,18,1(1978)]、P3-NS1/1-Ag41(NS-1)[EuropeanJ.Immunology,6,511(1976)]、SP2/0-Ag14(SP-2)[Nature,276,269(1978)]、P3-X63-Ag8653(653)[J.Immunology,123,1548(1979)]、或P3-X63-Ag8(X63)[Nature,256,495(1975)]等。
该骨髓瘤细胞用正常培养基[添加了谷氨酰胺、2-巯基乙醇、庆大霉素、FBS和8-氮鸟嘌呤的RPMI1640培养基]传代,在细胞融合的第3~4天前用正常培养基传代,确保融合当日2×10 7个以上的细胞数。
(4)细胞融合和单克隆抗体产生杂交瘤的制备
将(2)中得到的融合用抗体产生细胞和(3)中得到的骨髓瘤细胞用MinimumEssential Medium(MEM)培养基或PBS(磷酸氢二钠1.83g、磷酸二氢钾0.21g、食盐7.65g、蒸留水1升、pH7.2)充分清洗,以细胞数成为融合用抗体产生细胞:骨髓瘤细胞=5~10:1的方式混合,离心后,除去上清。
将沉淀的细胞群充分分散后,在37℃一边搅拌一边添加聚乙二醇-1000(PEG-1000)、MEM培养基和二甲亚砜的混合液。进而每1~2分钟添加MEM培养基1~2mL数次后,加入MEM培养基,使总量为50mL。离心后,除去上清。将沉淀的细胞群缓慢分散后,对融合用抗体产生细胞中在HAT培养基[添加了次黄嘌呤、胸腺嘧啶核苷和氨基蝶呤的正常培养基]中缓慢悬浮细胞。
将该悬浊液在5%CO 2培养箱中在37℃培养7~14天。培养后,取出培养上清的一部分,通过后述的结合试验等杂交瘤的选择方法,与包含BRIL或BRIL融合蛋白质的抗原反应,选择与不与不含BRIL或BRIL融合蛋白质的抗原反应的细胞群。然后,通过极限稀释法进行克隆,选择稳定并确认到强的抗体效价的细胞作为单克隆抗体产生杂交瘤。
(5)纯化单克隆抗体的制备
对进行了姥鲛烷(Pristane)处理[在腹腔内投予2,6,10,14-四甲基十六烷(Pristane)0.5mL,饲养2周]的8~10周龄的小鼠或裸小鼠,在腹腔内注射(4)中得到的单克隆抗体产生杂交瘤。以10~21天,杂交瘤发生腹水癌化。从该小鼠采集腹水,离心并将固体成分除去后,用40~50%硫酸铵进行盐析,进行利用辛酸沉淀法、DEAE-琼脂糖柱、蛋白质A-柱或凝胶过滤柱的纯化,收集IgG或IgM组分,作为纯化单克隆抗体。
另外,将(4)中得到的单克隆抗体产生杂交瘤用添加了10%FBS的RPMI1640培养基等培养后,通过离心将上清去除,悬浮在Hybridoma SFM培养基中,培养3~7天。将所得到的细胞悬浮液离心,利用所得到的上清,进行利用蛋白质A-柱或蛋白质G-柱的纯化,收集IgG组分,也能够得到纯化单克隆抗体。此外,也能够在Hybridoma SFM培养基中添加5%Daigo GF21。
抗体的亚类的确定通过使用亚类分型试剂盒利用酶免疫测定法进行。蛋白质量的定量通过Lowry法或280nm时的吸光度计算。
(6)单克隆抗体的选择
单克隆抗体的选择如以下所示,通过使用binding ELISA、脂质体ELISA和流式细胞仪,测定抗体与BRIL或BRIL融合蛋白质表达细胞的的结合性等来进行。BRIL或BRIL融合蛋白质表达细胞只要为在细胞表面上表达BRIL或BRIL融合蛋白质即可可以为任意细胞,可以列举例如Sf9细胞、Pichia Pastoris细胞、人细胞株和(1)中得到的BRIL融合蛋白质强制表达细胞株等。
将BRIL融合蛋白质、该脂质体或BRIL融合蛋白质表达细胞注入96孔板等的板后,注入作为第1抗体的血清、杂交瘤的培养上清或纯化单克隆抗体等的被测物质,使其反应。
将反应后的细胞用包含1~10%牛血清白蛋白(BSA)的PBS(以下记作BSA-PBS)等充分清洗后,注入作为第2抗体的用荧光试剂等标记过的抗免疫球蛋白抗体使其反应。用BSA-PBS等充分清洗后,使用流式细胞仪测定标记化抗体的荧光量,由此选择对BRIL融合蛋白质、BRIL融合蛋白脂质体、或BRIL融合蛋白质表达细胞进行特异性反应的单克隆抗体。
另外,与本发明的抗体竞争性地结合BRIL融合蛋白质、BRIL融合蛋白脂质体或BRIL融合蛋白质表达细胞的抗体,能够通过在使用上述的binding ELISA、脂质体ELISA或流式细胞仪的测定体系中添加被测抗体使其反应而取得。
即,在添加被测抗体时,筛选抑制本发明的抗体与BRIL融合蛋白质、BRIL融合蛋白脂质体或BRIL融合蛋白质表达细胞的结合的抗体,由此,能够取得关于与BRIL或BRIL融合蛋白质的氨基酸序列,或者BRIL或BRIL融合蛋白质的立体结构的结合,能够与本发明的抗体竞争性与BRIL结合的单克隆抗体。
另外,与包含本发明的BRIL或BRIL融合蛋白质结合的单克隆抗体所结合的表位的表位结合的抗体能够通过用公知的方法鉴定上述的筛选方法所取得的抗体的表位,制作包含鉴定的表位的合成肽或模拟表位的立体结构的合成肽等,进行免疫,由此取得。
此外,与和结合于本发明的BRIL或BRIL融合蛋白质的单克隆抗体所结合的表位相同的表位结合的抗体能够通过鉴定由上述的筛选方法取得的抗体的表位,制作鉴定的表位的部分合成肽或模拟表位的立体结构的合成肽等,进行免疫,而取得。
2.基因重组抗体的制作
作为基因重组抗体的制作例,以下表示人型嵌合抗体的制作方法。基因重组的小鼠抗体、大鼠抗体和兔抗体等也能够用同样的方法制作。
(1)基因重组抗体表达用载体的构建
基因重组抗体表达用载体为导入了编码小鼠、大鼠或人等各种抗体的CH和CL的DNA的动物细胞用表达载体,能够通过在动物细胞用表达载体中分别克隆编码所希望种类的抗体的CH和CL的DNA的来构建。
抗体的C区域能够使用任意的小鼠、大鼠、兔、人等任意抗体的CH和CL。例如使用人抗体的γ1亚类的CH和κ类的CL等。编码人抗体的CH和CL的DNA使用cDNA,但也能够使用包含外显子和内含子的染色体DNA。
动物细胞用表达载体只要是能够重组表达编码人抗体的C区域的基因的载体则可以任意使用。例如使用pAGE107[Cytotechnol.,3,133(1990)]、pAGE103[J.Biochem.,101,1307(1987)]、pHSG274[Gene,27,223(1984)]、pKCR[Proc.Natl.Acad.Sci.USA,78,1527(1981)]、pSG1bd2-4[Cytotechnol.,4,173(1990)]或pSE1UK1Sed1-3[Cytotechnol.,13,79(1993)]等。
动物细胞用表达载体中启动子和增强子中使用SV40的早期启动子[J.Biochem.,101,1307(1987)]、莫洛尼(氏)小鼠白血病病毒LTR[Biochem.Biophys.Res.Commun.,149,960(1987)]或免疫球蛋白H链的启动子[Cell,41,479(1985)]和增强子[Cell,33,717(1983)]等。
从基因重组抗体表达载体的构建的容易度、向动物细胞导入的容易度、动物细胞内的抗体H链和L链的表达量的平衡均衡等的观点出发,基因重组抗体表达用载体使用抗体H链和L链存在于同一载体上的类型(串联型)的基因重组抗体表达用载体[J.Immunol.Methods,167,271(1994)],但也能够使用抗体H链和L链存在于不同的载体上的类型。串联型的基因重组抗体表达用载体使用pKANTEX93(国际公开第97/10354号)、pEE18[Hybridoma,17,559(1998)]等。
(2)编码源自人或人以外的动物的抗体的V区域的cDNA的取得和氨基酸序列的解析
例如,编码非人抗体的VH和VL的cDNA的取得和氨基酸序列的解析能够如下进行。
由产生非人抗体的杂交瘤细胞提取mRNA,合成cDNA。将合成的cDNA克隆到噬菌体或质粒等的载体上制作cDNA文库。通过该文库,例如使用编码小鼠抗体的C区部分或V区部分的DNA作为探针,分别分离具有编码VH或VL的cDNA的重组噬菌体或重组质粒。分别确定重组噬菌体或重组质粒上的作为目标的小鼠抗体的VH或VL的全碱基序列,由碱基序列分别推测VH或VL的全氨基酸序列。
制作产生非人抗体的杂交瘤细胞的人以外的动物使用小鼠、大鼠、仓鼠或兔等,但只要能够制作杂交瘤细胞,则也能够使用任何动物。
将所选择的cDNA用适当的内切酶等切断后,克隆到pBluescript SK(-)(Stratagene公司制)等的质粒上,通过通常使用的碱基序列分析方法等确定该cDNA的碱基序列。碱基序列分析方法例如进行双脱氧法[Proc.Natl.Acad.Sci.USA,74,5463(1977)]等反应后,使用ABI PRISM3700(PE Biosystems公司制)或A.L.F.DNA测序仪(Pharmacia公司制)等的碱基序列自动分析装置等。
由所确定的碱基序列分别推测VH和VL的全氨基酸序列,通过与已知的抗体的VH和VL的全氨基酸序列[Sequences of Proteins of Immunological Interest,USDept.Health and Human Services(1991)]进行比较,分别确认取得的cDNA是否编码包含分泌信号序列的抗体的VH和VL的完整的氨基酸序列。
关于包含分泌信号序列的抗体的VH和VL的完整的氨基酸序列,通过与已知的抗体的VH和VL的全氨基酸序列[Sequences of Proteins of Immunological Interest,USDept.Health and Human Services(1991)]进行比较,能够推测分泌信号序列的长度和N末端氨基酸序列,进而能够得知它们所属的亚组。另外,关于VH和VL的各CDR的氨基酸序列,也能够通过与已知的抗体的VH和VL的氨基酸序列[Sequences of Proteins ofImmunological Interest,US Dept.Health and Human Services(1991)]进行比较来找出。
(3)基因重组抗体表达载体的构建
在编码(1)中得到的基因重组抗体表达用载体的非人或人抗体的CH或CL的各个基因的上游,分别克隆分别编码非人或人抗体的VH或VL的cDNA,由此能够构建小鼠、大鼠、兔或人型嵌合抗体等的基因重组抗体表达载体。
为了将编码非人或人抗体的VH或VL的cDNA的3’末端侧与非人或人抗体的CH或CL的5’末端侧连结,制作以连结部分的碱基序列编码适当氨基酸且成为适当的内切酶识别序列的方式设计的VH和VL的cDNA。
将所制作的VH和VL的cDNA分别克隆到(1)所得到的基因重组抗体表达用载体的编码非人或人抗体的CH或CL的各个基因的上游,以使它们以适当的形式表达,构建小鼠、大鼠、兔或人型嵌合抗体等的基因重组抗体表达载体。
所构建的基因重组抗体表达载体能够通过导入到上述的适当的宿主细胞使其表达,来制作基因重组抗体。
3.与BRIL或BRIL融合蛋白质结合的抗体的用途
本发明的抗体利用与BRIL或BRIL融合蛋白质特异性结合的性质,可以在免疫学的方法、目标蛋白质的稳定化方法、结晶制造方法、晶体结构分析方法、电子显微镜结构分析等的用途中使用。免疫学的方法是指使用实施了标记的抗原或抗体,检测或测定抗体量或抗原量的方法。可以列举例如放射性物质标记免疫抗体法、酶免疫测定法、荧光免疫测定法、发光免疫测定法、免疫印迹法或物理化学的方法等。
另外,在结晶制造方法、电子显微镜结构分析、晶体结构分析等的结构分析中,能够通过使用非标记抗体将BRIL融合蛋白质稳定化来使用。另外,在本结构分析中,通过抗BRIL抗体本身与BRIL或BRIL融合蛋白质特异性结合,能够作为复合体中的标记物识别,因此有用。
放射性物质标记免疫抗体法例如使抗原或表达抗原的细胞等与本发明的抗体或该抗体片段反应,进而使实施了放射线标记的抗免疫球蛋白抗体或该抗体片段反应后,用闪烁计数器等来测定。
酶免疫测定法例如使抗原或表达抗原的细胞等与本发明的抗体或该抗体片段反应,进而与用酶等实施了标记的抗免疫球蛋白抗体或结合片段反应后,添加底物用吸光光度计测定反应液的吸光度。作为酶免疫测定法中使用的标记体,能够使用公知[酶免疫测定法、医学書院(1987)]的酶标记。作为标记酶使用碱性磷酸酶标记、过氧化物酶标记、荧光素酶标记、或生物素标记等。
荧光免疫测定法用文献[Monoclonal Antibodies-Principles and practice,Third edition,Academic Press(1996)、单克隆抗体实验手册、KODANSHA SCIENTIFICLTD.(1987)]等中记载的方法测定。作为荧光免疫测定法中使用的标记体,能够使用公知[荧光抗体法、Soft-science公司(1983)]的荧光标记。例如使用FITC或RITC等。发光免疫测定法用文献[生物发光和化学发光临床检查42、广川书店(1998)]等中记载的方法测定。作为发光免疫测定法中使用的标记体,可以列举公知的发光体标记,使用吖啶酯、洛粉碱(LOPHINE)等。
另外,也能够通过使荧光标记的抗体与细胞反应,用流式细胞仪分析的荧光抗体染色法[Monoclonal Antibodies-Principles and practice,Third edition,AcademicPress(1996)、单克隆抗体实验手册、KODANSHA SCIENTIFIC LTD.(1987)]进行检测。另外,荧光抗体染色法中,使用FMAT8100HTS***(Applied Biosystems公司制)等的情况下,能够不分离所形成的抗体-抗原复合体与参与抗体-抗原复合体的形成的游离的抗体或抗原,来测定抗原量或抗体量。
作为使用本发明的抗BRIL抗体的使BRIL融合蛋白质稳定化的方法、结晶制造方法、晶体结构分析方法,例如能够制备与BRIL特异性结合的抗体或该抗体片段,使其与BRIL融合蛋白质以适当的摩尔比反应后,使用液相色谱,纯化包含BRIL融合蛋白质和抗BRIL抗体的复合体的峰进行结晶化,通过抗BRIL抗体与BRIL融合蛋白质结合,能够得到稳定化后的BRIL融合蛋白质/抗BRIL抗体的共结晶。
所得到的BRIL融合蛋白质被稳定地结晶化,能够用于X射线晶体结构分析。
另外,作为使用本发明的抗BRIL抗体使BRIL融合蛋白质在溶液中稳定化的方法,例如在负染色电子显微镜解析、或冷冻电子显微镜解析等的结构解析中,在作为试样的BRIL融合蛋白质中添加抗BRIL抗体进行电子显微镜解析,由此使溶液中的BRIL融合蛋白质稳定化且作为结构复合体的标记物利用,能够赋予三维的分子的方向性。作为抗BRIL抗体不论是上述的标签化的抗体,还是非标签化的抗体都可以使用。负染色电子显微镜解析和冷冻电子显微镜解析均为进行液相中的目标蛋白质的结构解析的方法,能够使用染色电子显微镜进行结构解析的样品同样在冷冻电子显微镜中也能够用于结构解析。
以下,利用实施例具体说明本发明,但本发明不限于下述实施例。
实施例
[实施例1]BRIL融合人ChemR23蛋白质的制作
根据已经报告的GPCR晶体结构分析结果,可知通过在GPCR的从第5个跨膜螺旋上保守的脯氨酸起第16~24位的氨基酸区域与从第6个跨膜螺旋上保守的脯氨酸起第-24~-28位的氨基酸区域重叠的部分融合BRIL,GPCR的结构稳定性提高,结晶化概率提高(Eugene Chun et al.Structure,2012;20:967-976)。因此,在本实施例中也在人ChemR23(以下,也简称为hChemR23。)的第5~6个跨膜螺旋之间的环部分***BRIL,构建人ChemR23-BRIL融合蛋白质。
具体而言,在制作了在hChemR23的氨基酸序列(序列编号10)中,从N末端起第247位的亮氨酸与第248位的谷氨酰胺之间***了BRIL的变异体、在第248位的谷氨酰胺与第249位的精氨酸之间***了BRIL的变异体、在第249位的精氨酸与第250位的天冬酰胺之间***了BRIL的变异体、在第250位的天冬酰胺与第251位的精氨酸之间***了BRIL的变异体、在第251位的精氨酸与第252位的亮氨酸之间***了BRIL的变异体、在第252位的亮氨酸与第253位的丙氨酸之间***了BRIL的变异体、在第253位的丙氨酸与第254位的赖氨酸之间***了BRIL的变异体、在第254位的赖氨酸与第255位的苏氨酸之间***了BRIL的变异体、削除第248位的谷氨酰胺至第254位的赖氨酸且在第247位的亮氨酸与第255位的苏氨酸之间***了BRIL的变异体、削除第248位的谷氨酰胺至第253位的丙氨酸且在第247位的亮氨酸与第254位的赖氨酸之间***了BRIL的变异体、削除第248位的谷氨酰胺至第252位的亮氨酸且在第247位的亮氨酸与第253位的丙氨酸之间***了BRIL的变异体、削除第248位的谷氨酰胺至第251位的精氨酸且在第247位的亮氨酸与第252位的亮氨酸之间***了BRIL的变异体、削除第248位的谷氨酰胺至第250位的天冬酰胺且在第247位的亮氨酸与第251位的精氨酸之间***了BRIL的变异体、削除第248位的谷氨酰胺至第249位的精氨酸且在第247位的亮氨酸与第250位的天冬酰胺之间***了BRIL的变异体、削除第248位的谷氨酰胺且在第247位的亮氨酸与第249位的精氨酸之间***了BRIL的变异体、削除第249位的精氨酸至第254位的赖氨酸且在第248位的谷氨酰胺与第255位的苏氨酸之间***了BRIL的变异体、削除第249位的精氨酸至第253位的丙氨酸且在第248位的谷氨酰胺与第254位的赖氨酸之间***了BRIL的变异体、削除第249位的精氨酸至第252位的亮氨酸且在第248位的谷氨酰胺与第253位的丙氨酸之间***了BRIL的变异体、削除第249位的精氨酸至第251位的精氨酸且在248位的谷氨酰胺与252位的亮氨酸之间***了BRIL的变异体、削除第249位的精氨酸至第250位的天冬酰胺且在第248位的谷氨酰胺与第251位的精氨酸之间***了BRIL的变异体、削除第249位的精氨酸且在248位的谷氨酰胺与第250位的天冬酰胺之间***了BRIL的变异体、削除第250位的天冬酰胺至第254位的赖氨酸且在第249位的精氨酸与第255位的苏氨酸之间***了BRIL的变异体、削除第250位的天冬酰胺至第253位的丙氨酸且在第249位的精氨酸与第254位的赖氨酸之间***了BRIL的变异体、削除第250位的天冬酰胺至第252位的亮氨酸且在第249位的精氨酸与253位的丙氨酸之间***了BRIL的变异体、削除第250位的天冬酰胺至第251位的精氨酸且在第249位的精氨酸与第252位的亮氨酸之间***了BRIL的变异体、削除第250位的天冬酰胺且在第249位的精氨酸与第251位的精氨酸之间***了BRIL的变异体、削除第251位的精氨酸至第254位的赖氨酸且在第250位的天冬酰胺与第255位的苏氨酸之间***了BRIL的变异体、削除第251位的精氨酸至第253位的丙氨酸且在第250位的天冬酰胺与第254位的赖氨酸之间***了BRIL的变异体、削除第251位的精氨酸至第252位的亮氨酸且在第250位的天冬酰胺与第253位的丙氨酸之间***了BRIL的变异体、削除第251位的精氨酸且在第250位的天冬酰胺与第252位的亮氨酸之间***了BRIL的变异体、削除第252位的亮氨酸至第254位的赖氨酸且在第251位的精氨酸与第255位的苏氨酸之间***了BRIL的变异体、削除第252位的亮氨酸至第253位的丙氨酸且在第251位的精氨酸与第254位的赖氨酸之间***了BRIL的变异体、削除第252位的亮氨酸且在第251位的精氨酸与第253位的丙氨酸之间***了BRIL的变异体、削除第253位的丙氨酸至第254位的赖氨酸且在第252位的亮氨酸与第255位的苏氨酸之间***了BRIL的变异体、削除第253位的丙氨酸且在第252位的亮氨酸与第254位的赖氨酸之间***了BRIL的变异体、以及削除第254位的赖氨酸且在第253位的丙氨酸与第255位的苏氨酸之间***了BRIL的变异体的合计32种BRIL融合蛋白质。
使用酿酒酵母(Saccharomyces cerevisiae)中将片段化载体(在p426GAL1***了TEV protease识别序列、GFP和His8标签序列的载体)和基因片段用同源重组反应连结的体系(Nat.Protoc.2008;784-98),使其表达在人ChemR23的C末端融合了绿色荧光蛋白(GFP)和His8标签序列的BRIL融合蛋白质。
将表达的hChemR23-BRIL融合蛋白质供于荧光尺寸排阻色谱(Fluorescent SizeExclusion Chromatography;FSEC),实施FSEC筛选。将与凝集体峰相比,所希望的主峰更高、单分散性高的样品判断为作为单一的BRIL融合蛋白质表达的试样,选择为BRIL***到最适合的***位置的BRIL融合蛋白质。
进而制作改变BRIL融合蛋白质的N末端和C末端的氨基酸序列的长度的hChemR23-BRIL融合蛋白质,通过FSEC筛选确定最适合的N末端和C末端的氨基酸序列的长度,取得稳定的hChemR23-BRIL融合蛋白质。图1表示hChemR23-BRIL融合蛋白质的利用FSEC的柱形图。
FSEC筛选的结果,选择hChemR23的第1~31位的氨基酸和第343~373位的氨基酸残基缺失,削除第252位的亮氨酸,而且在hChemR23的第251位的精氨酸与第253位的丙氨酸之间连结有BRIL的BRIL融合蛋白质(序列编号11)。
[实施例2]hChemR23-BRIL融合蛋白质的制备
对于选出的变异体,用以下的步骤构建杆状病毒表达体系。首先,将编码序列编号10所示的hChemR23的氨基酸序列中,在编码第32位至第342位的氨基酸序列的cDNA序列(削除第252位的亮氨酸且***BRIL)的C末端上添加了组氨酸标签的氨基酸序列且将第192位的谷氨酰胺取代为谷氨酰胺酸的序列构成的cDNA重组到改变型的pFastBac1(Invitrogen公司制),构建Sf9细胞表达用载体(pFastBac1-hChemR23-BRIL)。
按照Bac to Bac Baculovirus Expression System(Invitrogen公司制)的手册,将构建的pFastBac1-hChemR23-BRIL载体转化到DH10Bac感受态细胞,取得hChemR23-BRIL表达用的杆粒(Bacmid)。将该杆粒转染到Sf9细胞,制作重组杆状病毒。按照手册,使制作得到的杆状病毒转染到Sf9细胞,由此制备在细胞膜表达hChemR23-BRIL的Sf9细胞。
从在细胞膜表达ChemR23-BRIL的Sf9细胞中,用以下的方法制备细胞膜组分。将Sf9细胞冻结融解,用低渗缓冲液[10mmol/L HEPES pH7.5、20mmol/L KCl、10mM MgCl2、protein inhibitor cocktail tablet Complete(商标)EDTA free]悬浮后,移到超离心用管中,在4℃进行45,000rpm、30分钟超离心。
将沉淀用高渗缓冲液[10mmol/L HEPES pH7.5、10mmol/LmgCl 2、20mmol/L KCl、1M NaCl、protein inhibitor cocktail tablet Complete(商标)EDTA free]悬浮,用Dounce型匀浆器(Nippon Genetics株式会社)进行悬浮,再次以45,000rpm进行30分钟超离心。将沉淀用高渗缓冲液悬浮,用Dounce型匀浆器悬浮,再次以45,000rpm进行30分钟超离心。
将沉淀悬浮于包含40%甘油的高渗缓冲液,作为Sf9细胞膜组分以-80℃冷冻保存。将包含hChemR23-BRIL的Sf9细胞膜在冰上解冻后,将膜组分用溶解缓冲液[50mmol/LHEPES pH7.5、500mmol/L NaCl、10%甘油、2%正十二烷基(注册商标)-D-麦芽糖苷(DDM)、0.03%胆固醇半琥珀酸酯(CHS)、protein inhibitor cocktail tablet Complete(商标)EDTA free(Roche公司制)]悬浮后,以4℃用旋转器(rotator)缓慢混合2小时左右,由此将膜溶解。
溶解后,以45,000rpm进行40分钟超离心,将上清回收。在其中加入用清洗缓冲液(50mmol/L HEPES pH7.5、500mmol/L NaCl、10%甘油、2%DDM、0.03%CHS、20mmol/L咪唑)平衡化后的TALON金属亲和树脂(Clontech公司制)10mL,在4℃用批式法使蛋白质吸附2小时。
将树脂填充在空柱中,用清洗缓冲液进行5CV(柱体积)清洗后,用盐浓度提高到800mmol/L的清洗缓冲液进行5CV清洗后,用洗脱缓冲液(50mmol/L HEPES pH7.5、500mmol/L NaCl、10%甘油、2%DDM、0.03%CHS、500mmol/L咪唑)进行3CV洗脱。
将洗脱后的样品用超滤浓缩到10mL,使用PD-10柱置换为清洗缓冲液w/o咪唑(50mmol/L HEPES pH7.5、500mmol/L NaCl、10%甘油、2%DDM、0.03%CHS),加入需要量的Tabacco Etch Virus Protease(TEV,烟草蚀刻病毒蛋白酶)蛋白酶,在4℃静置过夜。
第二天,确认用TEV蛋白酶的切断后,加入用清洗缓冲液w/o咪唑平衡化后的NiSepharose 6Fast Flow(GE Healthcare Japan公司制)6mL,在4℃用批式法使蛋白质吸附2小时。在柱中装入树脂,回收通过液,使用Amicon Ultra(100kDa截止大小、MerckMillipore公司制)浓缩到1mL左右后,通过BCA测试(Smith,P.K.et al.Anal.Biochem.,1985:150;76-85)和UV280测定,算出蛋白质浓度,以后的浓缩通过监测UV280,来计算浓度。最终浓缩到30mg/mL左右,作为纯化hChemR23-BRIL样品。
[实施例3]免疫和抗体产生杂交瘤的亚克隆
为了作为抗原使用,制备将纯化hChemR23-BRIL用以下的方法再构成为脂质体的样品。
在L-α-磷脂酰胆碱(EggPC)溶液(10mg/mL EggPC、0.8w/v%胆酸钠、0.5mg/mL脂质A的PBS)中,将纯化后的hChemR23-BRIL以相对于脂质10mg而蛋白质1mg的比例混合。加入与液量基本等量的Bio-Beads SM-2(Bio-Rad Laboratories制)缓慢颠倒混合,由此将表面活性剂除去后,进行超声波匀浆,由此制备免疫用hChemR23-BRIL蛋白脂质体。
就ELISA用的脂质体抗原而言,在包含EggPC的生物素-PE溶液(10mg/mL EggPC、25μg/mL生物素PE(Avanti Polar Lipids)、0.8w/v%胆酸钠in PBS)中,以相对于EggPC10mg而蛋白质1mg的比例混合,以与免疫用脂质体抗原的制备同样的方法,制备ELISA用hChemR23-BRIL蛋白脂质体。
免疫中使用5周龄的雌性免疫不全小鼠(MRL/MpJJms slc-lpr/lpr、日本SLC株式会社)。在初次免疫中,将上述的免疫用hChemR23-BRIL蛋白脂质体用PBS缓冲液稀释后的稀释液作为抗原液,通过腹腔注射对小鼠免疫。
在第2次以后的追加免疫中,将用PBS缓冲液稀释的脂质体抗原和等量的ImjectAlum(Thermo Fisher Scientific)混合得到的液体作为抗原液。实施初次免疫(100μg/小鼠),在初次免疫7天后实施1次追加免疫(50μg/小鼠),在初次免疫第21天后实施第2次追加免疫(50μg/小鼠)。
使用在第2次免疫后第7天分别采集的血液通过离心操作制备血清样品,用脂质体ELISA法进行抗体效价的测定。在第3次免疫后第7天进行全采血、脾脏摘出。采集的全血通过离心操作制备血清样品。从摘出的脾脏提取脾脏细胞,通过PEG法使其与小鼠骨髓瘤细胞(P3/NS1/1-Ag4-1、独立行政法人医药基盤研究所JCRB细胞库)融合。
用在500mL的RPMI1640(Nacalai Tesque公司制)中添加了HAT Media Supplement(50x)Hybri-Max(SIGMA-ALDRICH公司制)1瓶得到的培养基悬浮杂交瘤,在96孔中各注入300μL,在37℃、5%CO 2的条件下静置1周。
HAT筛选后第7天将各孔的培养上清中的抗hChemR23-BRIL抗体利用脂质体ELISA法进行1次筛选。将确认了抗体的产生的孔悬浮并移到24孔在37℃静置培养。这里使用的脂质体ELISA法使用的是将hChemR23-BRIL包埋生物素化脂质体经由链霉亲和素固定在96孔板中进行的方法(日本特愿2009-110994)。
具体而言,将hChemR23-BRIL包埋生物素化脂质体用PBS稀释成1-10μg/mL,分注如96孔的链霉亲和素板后,在室温静置1.5小时,由此将hChemR23-BRIL包埋生物素化脂质体固相化。除去固相抗原溶液,在每一个孔中加入包含1%BSA的PBS(以下记作BSA-PBS)200μL,在室温静置2小时。
将BSA-PBS除去,作为一次抗体将杂交瘤培养上清在每孔中加入50μL,在室温静置2小时左右。除去杂交瘤培养上清,用洗板机实施清洗。作为二次抗体将抗小鼠IgG-HRP缀合物用0.5-1%的BSA-PBS稀释,每孔加入50μL,在室温静置1.5小时左右。除去二次抗体液,用洗板机清洗。然后,以450nm的吸光度检测HRP反应底物四甲基联苯胺(TMB)的产物。
在24孔扩大培养后第2天进行2次筛选。用脂质体ELISA法检测各孔的培养上清中的抗hChemR23-BRIL抗体。确认对hChemR23-BRIL、hCCR10-BRIL(第1~39位的氨基酸和第316~362位的氨基酸缺失且第236位~第243位的氨基酸削除后与BRIL连结而成的变异体)(序列编号12)、空脂质体和改性hChemR23-BRIL的结合性,选出产生向hChemR23-BRIL的结合性高而与其他样品的结合性低的抗体的细胞。将确认了产生抗体的孔悬浊,移到24个孔中在37℃静置培养。
此外,使hCCR10-BRIL在Pichia pastoris(毕赤巴斯德酵母)的细胞膜上表达,培养后,将菌体冻结融解,在其中添加所需量的Zymolyase(注册商标)100T(Nacalai Tesque公司制),在30℃以100rpm左右的低速度振荡1小时,由此进行细胞壁的消化反应。然后,进行超声波破碎,以7,000rpm高速离心20分钟,回收上清。
将回收的上清进一步以45,000rpm进行40分钟超离心,将沉淀用高盐缓冲液(10mmol/L HEPES pH7.5、10mmol/LmgCl 2、20mmol/L KCl、1M NaCl)悬浮,用Dounce型匀浆器悬浮,再次以45,000rpm进行30分钟超离心。将沉淀用Membrane buf.(50mmol/L HEPESpH7.5、120mmol/L NaCl、20%甘油)悬浮后,添加适当的配体使其成为100μmol/L,将其作为膜组分,纯化与实施例2中记载的方法同样地实施。
将2次筛选中选出的培养细胞上清中的抗hChemR23-BRIL抗体用与实施例1同样的FSEC法实施3次筛选。将使hChemR23-BRIL表达了的Pichia pastoris细胞膜和表达了hCCR10-BRIL的Pichia pastoris细胞膜分别用1%DDM可溶化,进行超离心,并使用上清。
选出产生虽然对hChemR23-BRIL和hCCR10-BRIL的两者观察到了结合,但相比于hCCR10-BRIL,明显对于hChemR23-BRIL的结合强的抗体的杂交瘤,作为杂交瘤SRP2070。确认杂交瘤SRP2070生产的抗BRIL小鼠单克隆抗体SRP2070的亚类,结果为小鼠IgG2a类。
[实施例4]纯化抗体的制备
将取得的抗BRIL抗体产生杂交瘤SRP2070用10cm培养皿进行扩大培养,将每1个培养皿的细胞对1只裸小鼠(BALB/cSlc-nu/nu、日本SLC株式会社)进行腹腔内给药。小鼠在杂交瘤的腹腔内给药的7天前将500μL的弗氏不完全佐剂(Freund’s IncompleteAdjuvant)(FIA、DIFCO公司制)进行腹腔内给药。细胞接种后采集腹水。腹水通过离心,将细胞和残渣除去。然后,用填充脱脂棉的针筒过滤,进而将残渣过滤。
制备将390g的硫酸铵溶解于1L的PBS缓冲液的饱和硫酸铵溶液,将腹水和饱和硫酸铵溶液以体积比为1比2混合,在4℃搅拌1小时以上。然后,用一晚透析置换为PBS缓冲液。
单克隆抗体纯化使用AKTA pure色谱***(GE Healthcare Japan公司制),用HiTrap protein G(GE Healthcare Japan公司制)进行。洗脱用1mol/L甘氨酸盐酸缓冲液进行,在洗脱用管中预先添加洗脱量的10分之一的1mol/L Tris-HCl,由此与洗脱的同时进行洗脱液的中和。
取得的纯化单克隆抗体用PBS缓冲液置换后,用在NHS-activated Sepharose 4Fast Flow(GE Healthcare Japan公司制)上固定了木瓜蛋白酶(Nacalai Tesque公司制)的树脂进行处理,由此进行Fab片段化。然后,供于Protein A Sepharose 4 Fast Flow(GEHealthcare Japan公司制),将通过液回收,由此制备Fab片段。将所得到的Fab片段样品作为结构解析用Fab抗体SRP2070Fab。
[实施例5]抗BRIL抗体SRP2070抗体的序列解析
从由构建的SRP2070产生杂交瘤提取的mRNA制作cDNA,进行抗体的重链和轻链的氨基酸序列以及编码其的基因序列的解析。
其结果得知,SRP2070抗体的VH区域由序列编号7所示的氨基酸序列构成,SRP2070抗体的VH区域的CDR1~3由序列编号1~3所示的氨基酸序列构成。得知编码序列编号7所示的氨基酸序列的基因由序列编号13表示。得知包含信号序列的氨基酸序列由序列编号15表示,编码其的基因由序列编号17表示。
[化学式1]
序列编号7:
/>
SS(下划线为CDR部分)
序列编号1:
序列编号2:
序列编号3:
另外得知,SRP2070抗体的VL区域由序列编号8所示的氨基酸序列构成,VL区域的CDR1~3由序列编号4~6所示的氨基酸序列构成。得知编码序列编号8所示的氨基酸序列的基因由序列编号14表示。得知包含信号序列的氨基酸序列由序列编号16表示,编码其的基因由序列编号18表示。
[化学式2]
序列编号8:
(下划线为CDR部分)
序列编号4:
序列编号5:
序列编号6:
[实施例6]hChemR23-BRIL/apo/SRP2070Fab复合体的制备和结构解析
在以实施例2所记载的方法制备的hChemR23-BRIL样品中以摩尔比计约1.2倍量的SRP2070Fab,在4℃静置1小时。样品的纯化通过组合AKTA Pure色谱***(GE HealthcareJapan公司制)和Superdex 200 Increase10/300 GL(GE Healthcare Japan公司制)来实施。
分离精制hChemR23-BRIL/apo/SRP2070Fab复合体的峰,浓缩至约50mg/mL,作为结晶化用样品。
所得到的结晶化样品通过LCP(Lipidic cubic phase)法[Martin Caffrey etal.,NATURE PROTOCOLS 2009;4(5):706-31]实施共结晶。具体而言,将hChemR23-BRIL/apo/SRP2070Fab复合体结晶化用样品、1-油酰基-rac-甘油和胆固醇以40%、54%、6%的比率在针筒内混合,由此制作LCP。
结晶化使用LCP结晶化用玻璃夹层板,对LCP 50nL注入结晶化溶液800 nL并用玻璃盖板密封。
以作为沉淀剂的20-50v/v%聚乙二醇300、20-50v/v%聚乙二醇400、20-50v/v%聚乙二醇单甲醚500或20-50v/v%聚乙二醇二甲醚550;作为缓冲液的100mM MES-NaOH pH6-6.5、100mM Hepes-NaOH pH7-7.5或100mM Tris-HCl pH8-8.5;作为有机溶剂的添加剂的0.5-2v/v%甲基-2,4-戊二醇、0.5-2v/v%2,5-己二醇、0.5-2v/v%1,2,3-己三醇或0.5-2v/v%异丙醇;作为盐的50-400mM乙酸铵、氯化铵、磷酸二氢铵、氟化铵、甲酸铵、柠檬酸二铵、磷酸氢二铵、硝酸铵、硫酸铵、酒石酸氢铵、水合醋酸钙、二水合氯化钙、二水合乙酸锂、氯化锂、四水合柠檬酸锂、硝酸锂、一水合硫酸锂、四水合乙酸镁、六水合氯化镁、无水甲酸镁、六水合硝酸镁、水合硫酸镁、六水合二氯化镍(II)、乙酸钾、氯化钾、一水合柠檬酸钾、磷酸二氢钾、氟化钾、甲酸钾、磷酸一氢钾、硝酸钾、四水合酒石酸钾钠、硫酸钾、硫氰酸钾、三水合乙酸钠、氯化钠、无水柠檬酸钠、磷酸二氢钠、甲酸钠、无水磷酸一氢钠、丙二酸钠pH 7.0、硝酸钠、十水合硫酸钠、无水酒石酸二钠、硫氰酸钠、琥珀酸pH 7.0、无水乙酸锌、十水合硫酸锌的组合,实施结晶化。
上述条件中,以作为沉淀剂的36-47v/v%聚乙二醇300或32-43.5v/v%聚乙二醇单甲醚500;作为缓冲液的100mM MES-NaOH pH6-6.5、有机溶剂的添加剂的0.5-2v/v%甲基-2,4-戊二醇或0.5-2v/v%2,5-己二醇;作为盐的125-190mM琥珀酸二钠、75-150mM柠檬酸三钠的组合,生成hChemR23-BRIL/apo/SRP2070Fab的结晶。
此外,在抗体非存在下进行了hChemR23-BRIL融合蛋白质的结晶化,但在任何条件下都没能取得结晶,无法实施hChemR23的结构解析。另一方面,在抗BRIL抗体存在下,生成了结晶(表1)。
由LCP法取得的结晶用液氮冻结,在高辉度光科学研究中心SPring-8Beam lineBL32XU中,进行X射线衍射实验。结合来自合计81个结晶的部分数据,得到了衍射功率4.0的结晶,以及分辨率4.5埃的完整数据,实施hChemR23-BRIL/apo/SRP2070Fab的复合体的结构解析的结果,得到了图3所示的蛋白质立体结构。图2表示X射线衍射像的结果,图3表示结构解析的结果。另外,表1表示利用抗BRIL抗体的BRIL融合蛋白质的结晶纯化和结构解析的结果。
[表1]
抗BRIL抗体的BRIL融合蛋白质的结晶纯化和结构解析
由以上的结果可知,在抗BRIL抗体非存在下无法取得的BRIL融合蛋白质的结晶在抗BRIL抗体存在下才能够结晶化,并能够将目标蛋白质进行结构解析。
[实施例7]5HT 1B-BRIL和SRP2070Fab的复合体制备和结构解析
5HT 1B-BRIL用与已经报道的(Wang et al.,Science 2013;340:610-614)相同的构建方法制备。低分子配体的麦角胺在将表达5HT 1B-BRIL融合蛋白质的Sf9细胞膜可溶化时以100μM添加,并且在以后的各纯化阶段的缓冲液中添加100μM进行纯化,由此稳定地纯化5HT 1B-BRIL融合蛋白质。将用与实施例6同样的方法制备得到的包含5HT 1B-BRIL/SRP2070Fab的凝胶过滤组分浓缩至约30mg/mL,与实施例6记载的方法同样地以LCP法进行结晶化。
其结果,在从结晶化起1周以内,生成了能够在衍射数据取得中利用的结晶(表1)。与实施例6同样地在高辉度光科学研究中心SPring-8Beam line BL32XU中进行X射线衍射实验,得到了分辨率3埃的完整数据,实施了5HT 1B-BRIL/Ergotamine/SRP2070Fab的复合体的结构解析。将结果表示于图4和表1。
由以上的结果可知,与实施例6同样地在抗BRIL抗体存在下能够得到良好的结晶,因此结晶化中抗BRIL抗体不会抑制BRIL融合蛋白质的结晶化,反而通过使抗BRIL抗体共存,能够简便地发现结晶化条件,且能够有效地进行结晶化。因此可知,本发明的抗BRIL抗体能够使融合了BRIL的目标蛋白质稳定地结晶化,在BRIL融合蛋白质的结构解析中是非常有用的工具。
[实施例8]BRIL/SRP2070Fab的制备和结晶化
将在BRIL蛋白质的氨基酸序列的N末端添加了TEV蛋白酶识别氨基酸的变异体基因利用内切酶位点BamHI和HindIII***pET28a载体(Novagen公司制),作为His标签融合体表达。表达样品通过Ni Sepharose 6Fast Flow(GE Healthcare Japan公司制)纯化,然后用TEV蛋白酶将His标签切断。
再次、供于Ni Sepharose 6Fast Flow,将回收的通过液用阴离子交换柱纯化。对其样品,添加摩尔比约1.2倍量的SRP2070Fab,在4℃静置1小时后,进行凝胶过滤,分离纯化BRIL/SRP2070Fab复合体的峰,浓缩至15mg/mL,使用该样品,用蒸汽扩散法实施结晶化。
具体而言,将100nL的BRIL/SRP2070Fab复合体蛋白质溶液和100nL的结晶化溶液混合,作为结晶化内液,与50μL的结晶化溶液(结晶化外液)一起密封,在4℃静置,由此在一周内取得结晶。
作为结晶化溶液,例如由18w/v%聚乙二醇8000、180mmol/L氟化铵、50mmol/LCHES pH9.5生成结晶。取得结晶用液氮冻结,实施X射线衍射实验,结果得到分辨率2.0埃的完整数据,成功进行了BRIL/SRP2070Fab的复合体结构解析。
SRP2070Fab与BRIL的结合方式与实施例6的hChemR23-BRIL融合蛋白质和实施例7的5HT1B-BRIL融合蛋白质的结合方式相同。通过所得到的BRIL和SRP2070Fab的复合体结构解析结果,确定SRP2070Fab的表位和互补位。
确认BRIL与抗BRIL抗体SRP2070的复合体结构,得知抗BRIL抗体SRP2070识别并结合BRIL的第3螺旋结构至第4螺旋结构。
另外,为了解析详细的表位,选择抗BRIL抗体SRP2070的CDR和以内相互作用的BRIL蛋白质内的氨基酸残基,结果得知本发明的抗BRIL抗体SRP2070与BRIL蛋白质的立体结构中的第3螺旋结构至第4螺旋结构中存在的氨基酸残基结合,识别BRIL氨基酸序列的N末端起第67位的Ile(I)、第71位的Gln(Q)、第74位的Asp(D)、第77位的Lys(K)、第78位的Leu(L)、第83位的Lys(K)、第85位的Lys(K)、第86位的Glu(E)、第88位的Gln(Q)、第89位的Ala(A)、第90位的Ala(A)、第92位的Glu(E)、第93位的Gln(Q)、第96位的Thr(T)、第97位的Thr(T)、第99位的Asn(N)和第100位的Ala(A)的氨基酸残基。
此外可知,上述表位中第74位的Asp(D)、第92位的Glu(E)、第93位的Gln(Q)、第96位的Thr(T)、第97位的Thr(T)和第99位的Asn(N)与抗体形成氢键,因此是构成抗BRIL抗体SRP2070的表位的氨基酸残基中最重要的氨基酸残基。
[实施例9]hChemR23-BRIL/apo/SRP2070Fab的负染色电子显微镜解析
用实施例1中记载的方法制备hChemR23-BRIL融合蛋白质。然后,用实施例6记载的方法制备hChemR23-BRIL/apo/SRP2070Fab的复合体,作为负染色电子显微镜的样品,调至约2mg/mL的浓度。将该样品稀释至100倍,在4℃以18000转速离心15分钟。将2.5μL的上清样品上样至样品载网上,在室温静置1分钟,使样品渗透至载网上。
然后,从载网去除样品液,用水清洗3次。将2.5μL的负染色用的试剂NanoW(Methylamine Tungstate,from Nanoprobes)加到样品载网上,在室温静置1分钟,将蛋白质颗粒染色。擦去剩余的染色试剂,在撮影前使样品载网干燥。使TF20电子显微镜在室温以200kV工作,在100,000倍的倍率(像素大小/pixel)、焦点距离1.8~2.5μm的条件下拍摄电子显微镜照片。
实施二维图像的分类,将取得5种代表性平均像的结果表示于图5。如图5所示,箭头(实线)所示的部分为SRP2070Fab,箭头(虚线)所示的部分为GPCR部分,能够识别SRP2070Fab的取向。由以上的结果可知,通过对BRIL融合蛋白质使用本发明的抗BRIL抗体,能够识别液相中三维结构中的GPCR蛋白质部分、BRIL部分,其结果能够鉴定BRIL融合蛋白质分子的方向性。
[实施例10]5HT 1B-BRIL/Ergotamine/SRP2070Fab的负染色电子显微镜解析
用实施例7记载的方法制备5HT 1B-BRIL/麦角胺/SRP2070Fab。作为变更之处,将最终的缓冲液组成中的表面活性剂DDM和CHS的浓度设为0.025%。作为负染色电子显微镜用样品,调至约0.75mg/mL的浓度。将该样品稀释至50倍,在4℃以18,000转速离心15分钟。将2.5μL的上清样品上样至样品载网上,在室温静置10秒钟,使样品渗透至载网上。
然后,从载网去除样品液,用水清洗3次。将2.5μL的负染色用的试剂Nano-W(Methylamine Tungstate,from Nanoprobes)加到样品载网上,在室温静置1分钟,将蛋白质颗粒染色。擦去剩余的染色试剂,在撮影前使样品载网干燥。使TF20电子显微镜在室温以200kV工作,以80,000倍的倍率(像素大小/pixel)、焦点距离1.8~2.5μm的条件下拍摄电子显微镜照片。
实施二维图像的分类,将取得10种代表性平均像的结果表示于图6。如图6所示,箭头(实线)所示的部分为SRP2070Fab,箭头(虚线)所示的部分为GPCR部分,能够识别SRP2070Fab的取向。由以上的结果可知,不仅是之前实施例的ChemR23-BRIL融合蛋白质,而且其他BRIL融合蛋白质也同样,通过使用本发明的抗BRIL抗体,都能够识别液相中三维结构中的GPCR蛋白质部分、BRIL部分,其结果能够鉴定BRIL融合蛋白质分子的方向性。
参照特定的方式详细说明了本发明,但在不脱离本发明的精神和范围内能够进行各种变更和修正,对于本领域技术人员来说是不言而喻的。此外,本申请基于在2017年7月13日申请的日本专利申请(日本特愿2017-137269),将其整体通过引用援用。另外,这里所引用的所有参照作为整体引入。
序列编号9-人工序列的说明:BRIL蛋白质的氨基酸序列
序列编号10-人工序列的说明:人ChemR23的氨基酸序列
序列编号11-人工序列的说明:人ChemR23-BRIL融合蛋白质的氨基酸序列
序列编号12-人工序列的说明:人CCR10-BRIL融合蛋白质的氨基酸序列。
序列表
<110> 协和麒麟株式会社
<120> 抗BRIL抗体以及使用了该抗体的BRIL融合蛋白质的稳定化方法
<130> W525092
<150> JP2017-137269
<151> 2017-07-13
<160> 18
<170> PatentIn version 3.3
<210> 1
<211> 5
<212> PRT
<213> 小家鼠(Mus musculus)
<400> 1
Asp Phe Tyr Ile Asn
1 5
<210> 2
<211> 17
<212> PRT
<213> 小家鼠(Mus musculus)
<400> 2
Trp Ile Phe Pro Gly Ser Gly Asn Thr His Tyr Asn Glu Lys Phe Lys
1 5 10 15
Gly
<210> 3
<211> 10
<212> PRT
<213> 小家鼠(Mus musculus)
<400> 3
Pro Val Ser Tyr Tyr Tyr Asp Phe Asp Tyr
1 5 10
<210> 4
<211> 11
<212> PRT
<213> 小家鼠(Mus musculus)
<400> 4
Arg Ala Ser Gln Ser Val Ser Asn Tyr Leu His
1 5 10
<210> 5
<211> 7
<212> PRT
<213> 小家鼠(Mus musculus)
<400> 5
Tyr Ala Ser Gln Ser Ile Ser
1 5
<210> 6
<211> 9
<212> PRT
<213> 小家鼠(Mus musculus)
<400> 6
Gln Gln Ser Asn Ser Trp Pro Leu Thr
1 5
<210> 7
<211> 119
<212> PRT
<213> 小家鼠(Mus musculus)
<400> 7
Gln Ile Gln Leu Gln Gln Ser Gly Pro Glu Leu Val Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp Phe
20 25 30
Tyr Ile Asn Trp Met Lys Gln Arg Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Ser Gly Asn Thr His Tyr Asn Glu Lys Phe
50 55 60
Lys Gly Lys Ala Thr Leu Ile Val Asp Thr Ser Ser Ser Thr Ala Phe
65 70 75 80
Met Gln Leu Asn Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
85 90 95
Thr Arg Pro Val Ser Tyr Tyr Tyr Asp Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Thr Leu Thr Val Ser Ser
115
<210> 8
<211> 107
<212> PRT
<213> 小家鼠(Mus musculus)
<400> 8
Asp Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Val Thr Pro Gly
1 5 10 15
Asp Arg Val Ser Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Asn Tyr
20 25 30
Leu His Trp Tyr Gln Gln Lys Ser His Glu Ser Pro Arg Leu Leu Ile
35 40 45
Lys Tyr Ala Ser Gln Ser Ile Ser Gly Ile Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Ser Ile Asn Ser Val Glu Thr
65 70 75 80
Glu Asp Phe Gly Met Tyr Phe Cys Gln Gln Ser Asn Ser Trp Pro Leu
85 90 95
Thr Phe Gly Ala Gly Thr Lys Leu Glu Leu Arg
100 105
<210> 9
<211> 106
<212> PRT
<213> 人工(Artificial)
<220>
<223> Description of the artificial sequence: amino acid sequence of
BRIL
<400> 9
Ala Asp Leu Glu Asp Asn Trp Glu Thr Leu Asn Asp Asn Leu Lys Val
1 5 10 15
Ile Glu Lys Ala Asp Asn Ala Ala Gln Val Lys Asp Ala Leu Thr Lys
20 25 30
Met Arg Ala Ala Ala Leu Asp Ala Gln Lys Ala Thr Pro Pro Lys Leu
35 40 45
Glu Asp Lys Ser Pro Asp Ser Pro Glu Met Lys Asp Phe Arg His Gly
50 55 60
Phe Asp Ile Leu Val Gly Gln Ile Asp Asp Ala Leu Lys Leu Ala Asn
65 70 75 80
Glu Gly Lys Val Lys Glu Ala Gln Ala Ala Ala Glu Gln Leu Lys Thr
85 90 95
Thr Arg Asn Ala Tyr Ile Gln Lys Tyr Leu
100 105
<210> 10
<211> 373
<212> PRT
<213> 人(Homo sapiens)
<400> 10
Met Arg Met Glu Asp Glu Asp Tyr Asn Thr Ser Ile Ser Tyr Gly Asp
1 5 10 15
Glu Tyr Pro Asp Tyr Leu Asp Ser Ile Val Val Leu Glu Asp Leu Ser
20 25 30
Pro Leu Glu Ala Arg Val Thr Arg Ile Phe Leu Val Val Val Tyr Ser
35 40 45
Ile Val Cys Phe Leu Gly Ile Leu Gly Asn Gly Leu Val Ile Ile Ile
50 55 60
Ala Thr Phe Lys Met Lys Lys Thr Val Asn Met Val Trp Phe Leu Asn
65 70 75 80
Leu Ala Val Ala Asp Phe Leu Phe Asn Val Phe Leu Pro Ile His Ile
85 90 95
Thr Tyr Ala Ala Met Asp Tyr His Trp Val Phe Gly Thr Ala Met Cys
100 105 110
Lys Ile Ser Asn Phe Leu Leu Ile His Asn Met Phe Thr Ser Val Phe
115 120 125
Leu Leu Thr Ile Ile Ser Ser Asp Arg Cys Ile Ser Val Leu Leu Pro
130 135 140
Val Trp Ser Gln Asn His Arg Ser Val Arg Leu Ala Tyr Met Ala Cys
145 150 155 160
Met Val Ile Trp Val Leu Ala Phe Phe Leu Ser Ser Pro Ser Leu Val
165 170 175
Phe Arg Asp Thr Ala Asn Leu His Gly Lys Ile Ser Cys Phe Asn Asn
180 185 190
Phe Ser Leu Ser Thr Pro Gly Ser Ser Ser Trp Pro Thr His Ser Gln
195 200 205
Met Asp Pro Val Gly Tyr Ser Arg His Met Val Val Thr Val Thr Arg
210 215 220
Phe Leu Cys Gly Phe Leu Val Pro Val Leu Ile Ile Thr Ala Cys Tyr
225 230 235 240
Leu Thr Ile Val Cys Lys Leu Gln Arg Asn Arg Leu Ala Lys Thr Lys
245 250 255
Lys Pro Phe Lys Ile Ile Val Thr Ile Ile Ile Thr Phe Phe Leu Cys
260 265 270
Trp Cys Pro Tyr His Thr Leu Asn Leu Leu Glu Leu His His Thr Ala
275 280 285
Met Pro Gly Ser Val Phe Ser Leu Gly Leu Pro Leu Ala Thr Ala Leu
290 295 300
Ala Ile Ala Asn Ser Cys Met Asn Pro Ile Leu Tyr Val Phe Met Gly
305 310 315 320
Gln Asp Phe Lys Lys Phe Lys Val Ala Leu Phe Ser Arg Leu Val Asn
325 330 335
Ala Leu Ser Glu Asp Thr Gly His Ser Ser Tyr Pro Ser His Arg Ser
340 345 350
Phe Thr Lys Met Ser Ser Met Asn Glu Arg Thr Ser Met Asn Glu Arg
355 360 365
Glu Thr Gly Met Leu
370
<210> 11
<211> 416
<212> PRT
<213> 人工(Artificial)
<220>
<223> Description of the artificial sequence: hChemR23-BRIL fusion
protein
<400> 11
Ser Pro Leu Glu Ala Arg Val Thr Arg Ile Phe Leu Val Val Val Tyr
1 5 10 15
Ser Ile Val Cys Phe Leu Gly Ile Leu Gly Asn Gly Leu Val Ile Ile
20 25 30
Ile Ala Thr Phe Lys Met Lys Lys Thr Val Asn Met Val Trp Phe Leu
35 40 45
Asn Leu Ala Val Ala Asp Phe Leu Phe Asn Val Phe Leu Pro Ile His
50 55 60
Ile Thr Tyr Ala Ala Met Asp Tyr His Trp Val Phe Gly Thr Ala Met
65 70 75 80
Cys Lys Ile Ser Asn Phe Leu Leu Ile His Asn Met Phe Thr Ser Val
85 90 95
Phe Leu Leu Thr Ile Ile Ser Ser Asp Arg Cys Ile Ser Val Leu Leu
100 105 110
Pro Val Trp Ser Gln Asn His Arg Ser Val Arg Leu Ala Tyr Met Ala
115 120 125
Cys Met Val Ile Trp Val Leu Ala Phe Phe Leu Ser Ser Pro Ser Leu
130 135 140
Val Phe Arg Asp Thr Ala Asn Leu His Gly Lys Ile Ser Cys Phe Asn
145 150 155 160
Asn Phe Ser Leu Ser Thr Pro Gly Ser Ser Ser Trp Pro Thr His Ser
165 170 175
Gln Met Asp Pro Val Gly Tyr Ser Arg His Met Val Val Thr Val Thr
180 185 190
Arg Phe Leu Cys Gly Phe Leu Val Pro Val Leu Ile Ile Thr Ala Cys
195 200 205
Tyr Leu Thr Ile Val Cys Lys Leu Gln Arg Asn Arg Ala Asp Leu Glu
210 215 220
Asp Asn Trp Glu Thr Leu Asn Asp Asn Leu Lys Val Ile Glu Lys Ala
225 230 235 240
Asp Asn Ala Ala Gln Val Lys Asp Ala Leu Thr Lys Met Arg Ala Ala
245 250 255
Ala Leu Asp Ala Gln Lys Ala Thr Pro Pro Lys Leu Glu Asp Lys Ser
260 265 270
Pro Asp Ser Pro Glu Met Lys Asp Phe Arg His Gly Phe Asp Ile Leu
275 280 285
Val Gly Gln Ile Asp Asp Ala Leu Lys Leu Ala Asn Glu Gly Lys Val
290 295 300
Lys Glu Ala Gln Ala Ala Ala Glu Gln Leu Lys Thr Thr Arg Asn Ala
305 310 315 320
Tyr Ile Gln Lys Tyr Leu Ala Lys Thr Lys Lys Pro Phe Lys Ile Ile
325 330 335
Val Thr Ile Ile Ile Thr Phe Phe Leu Cys Trp Cys Pro Tyr His Thr
340 345 350
Leu Asn Leu Leu Glu Leu His His Thr Ala Met Pro Gly Ser Val Phe
355 360 365
Ser Leu Gly Leu Pro Leu Ala Thr Ala Leu Ala Ile Ala Asn Ser Cys
370 375 380
Met Asn Pro Ile Leu Tyr Val Phe Met Gly Gln Asp Phe Lys Lys Phe
385 390 395 400
Lys Val Ala Leu Phe Ser Arg Leu Val Asn Ala Leu Ser Glu Asp Thr
405 410 415
<210> 12
<211> 376
<212> PRT
<213> 人工(Artificial)
<220>
<223> Description of the artificial sequence: hCCR10-BRIL fusion
protein
<400> 12
Ser Arg Ala Phe Gln Pro Ser Val Ser Leu Thr Val Ala Ala Leu Gly
1 5 10 15
Leu Ala Gly Asn Gly Leu Val Leu Ala Thr His Leu Ala Ala Arg Arg
20 25 30
Ala Ala Arg Ser Pro Thr Ser Ala His Leu Leu Gln Leu Ala Leu Ala
35 40 45
Asp Leu Leu Leu Ala Leu Thr Leu Pro Phe Ala Ala Ala Gly Ala Leu
50 55 60
Gln Gly Trp Ser Leu Gly Ser Ala Thr Cys Arg Thr Ile Ser Gly Leu
65 70 75 80
Tyr Ser Ala Ser Phe His Ala Gly Phe Leu Phe Leu Ala Cys Ile Ser
85 90 95
Ala Asp Arg Tyr Val Ala Ile Ala Arg Ala Leu Pro Ala Gly Pro Arg
100 105 110
Pro Ser Thr Pro Gly Arg Ala His Leu Val Ser Val Ile Val Trp Leu
115 120 125
Leu Ser Leu Leu Leu Ala Leu Pro Ala Leu Leu Phe Ser Gln Asp Gly
130 135 140
Gln Arg Glu Gly Gln Arg Arg Cys Arg Leu Ile Phe Pro Glu Gly Leu
145 150 155 160
Thr Gln Thr Val Lys Gly Ala Ser Ala Val Ala Gln Val Ala Leu Gly
165 170 175
Phe Ala Leu Pro Leu Gly Val Met Val Ala Cys Tyr Ala Leu Leu Gly
180 185 190
Arg Thr Leu Leu Ala Ala Asp Leu Glu Asp Asn Trp Glu Thr Leu Asn
195 200 205
Asp Asn Leu Lys Val Ile Glu Lys Ala Asp Asn Ala Ala Gln Val Lys
210 215 220
Asp Ala Leu Thr Lys Met Arg Ala Ala Ala Leu Asp Ala Gln Lys Ala
225 230 235 240
Thr Pro Pro Lys Leu Glu Asp Lys Ser Pro Asp Ser Pro Glu Met Lys
245 250 255
Asp Phe Arg His Gly Phe Asp Ile Leu Val Gly Gln Ile Asp Asp Ala
260 265 270
Leu Lys Leu Ala Asn Glu Gly Lys Val Lys Glu Ala Gln Ala Ala Ala
275 280 285
Glu Gln Leu Lys Thr Thr Arg Asn Ala Tyr Ile Gln Lys Tyr Leu Arg
290 295 300
Arg Ala Leu Arg Val Val Val Ala Leu Val Ala Ala Phe Val Val Leu
305 310 315 320
Gln Leu Pro Tyr Ser Leu Ala Leu Leu Leu Asp Thr Ala Asp Leu Leu
325 330 335
Ala Ala Arg Glu Arg Ser Cys Pro Ala Ser Lys Arg Lys Asp Val Ala
340 345 350
Leu Leu Val Thr Ser Gly Leu Ala Leu Ala Arg Cys Gly Leu Asn Pro
355 360 365
Val Leu Tyr Ala Phe Leu Gly Leu
370 375
<210> 13
<211> 357
<212> DNA
<213> 小家鼠(Mus musculus)
<400> 13
cagatccagc tgcagcagtc tggacctgag ctggtgaagc ctggggcttc agtgaagata 60
tcctgcaagg cttctggcta caccttcact gacttctata taaactggat gaagcagagg 120
cctggacagg gacttgagtg gattggatgg atttttcctg gaagcggtaa tactcactac 180
aatgagaagt tcaagggcaa ggccacattg attgtagaca catcctccag cacagccttc 240
atgcagctca acagcctgac ctctgaggac tctgcggtct atttctgtac aagaccggtc 300
tcttattact acgattttga ctactggggc caaggcacca ctctcacagt ctcctca 357
<210> 14
<211> 321
<212> DNA
<213> 小家鼠(Mus musculus)
<400> 14
gatattgtgc taactcagtc tccagccacc ctgtctgtga ctccaggaga tagagtcagt 60
ctttcctgca gggccagcca aagtgttagc aactacctac actggtatca acaaaaatca 120
catgagtctc caaggcttct catcaagtat gcttcccagt ccatctctgg gatcccctcc 180
aggttcagtg gcagtggatc agggacagat ttcactctca gtatcaacag tgtggagact 240
gaagattttg gaatgtattt ctgtcaacag agtaacagct ggccgctcac gttcggtgct 300
gggaccaagc tggagctgag a 321
<210> 15
<211> 138
<212> PRT
<213> 小家鼠(Mus musculus)
<400> 15
Met Gly Trp Ser Trp Ile Phe Leu Phe Leu Leu Ser Gly Thr Ala Gly
1 5 10 15
Val His Cys Gln Ile Gln Leu Gln Gln Ser Gly Pro Glu Leu Val Lys
20 25 30
Pro Gly Ala Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe
35 40 45
Thr Asp Phe Tyr Ile Asn Trp Met Lys Gln Arg Pro Gly Gln Gly Leu
50 55 60
Glu Trp Ile Gly Trp Ile Phe Pro Gly Ser Gly Asn Thr His Tyr Asn
65 70 75 80
Glu Lys Phe Lys Gly Lys Ala Thr Leu Ile Val Asp Thr Ser Ser Ser
85 90 95
Thr Ala Phe Met Gln Leu Asn Ser Leu Thr Ser Glu Asp Ser Ala Val
100 105 110
Tyr Phe Cys Thr Arg Pro Val Ser Tyr Tyr Tyr Asp Phe Asp Tyr Trp
115 120 125
Gly Gln Gly Thr Thr Leu Thr Val Ser Ser
130 135
<210> 16
<211> 127
<212> PRT
<213> 小家鼠(Mus musculus)
<400> 16
Met Val Phe Thr Pro Gln Ile Leu Gly Leu Met Leu Phe Trp Ile Ser
1 5 10 15
Ala Ser Arg Gly Asp Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser
20 25 30
Val Thr Pro Gly Asp Arg Val Ser Leu Ser Cys Arg Ala Ser Gln Ser
35 40 45
Val Ser Asn Tyr Leu His Trp Tyr Gln Gln Lys Ser His Glu Ser Pro
50 55 60
Arg Leu Leu Ile Lys Tyr Ala Ser Gln Ser Ile Ser Gly Ile Pro Ser
65 70 75 80
Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Ser Ile Asn
85 90 95
Ser Val Glu Thr Glu Asp Phe Gly Met Tyr Phe Cys Gln Gln Ser Asn
100 105 110
Ser Trp Pro Leu Thr Phe Gly Ala Gly Thr Lys Leu Glu Leu Arg
115 120 125
<210> 17
<211> 414
<212> DNA
<213> 小家鼠(Mus musculus)
<400> 17
atgggatgga gctggatctt tcttttcctc ctgtcaggaa ctgcaggtgt ccattgccag 60
atccagctgc agcagtctgg acctgagctg gtgaagcctg gggcttcagt gaagatatcc 120
tgcaaggctt ctggctacac cttcactgac ttctatataa actggatgaa gcagaggcct 180
ggacagggac ttgagtggat tggatggatt tttcctggaa gcggtaatac tcactacaat 240
gagaagttca agggcaaggc cacattgatt gtagacacat cctccagcac agccttcatg 300
cagctcaaca gcctgacctc tgaggactct gcggtctatt tctgtacaag accggtctct 360
tattactacg attttgacta ctggggccaa ggcaccactc tcacagtctc ctca 414
<210> 18
<211> 381
<212> DNA
<213> 小家鼠(Mus musculus)
<400> 18
atggttttca cacctcagat tcttggactt atgcttttct ggatttcagc ctccagaggt 60
gatattgtgc taactcagtc tccagccacc ctgtctgtga ctccaggaga tagagtcagt 120
ctttcctgca gggccagcca aagtgttagc aactacctac actggtatca acaaaaatca 180
catgagtctc caaggcttct catcaagtat gcttcccagt ccatctctgg gatcccctcc 240
aggttcagtg gcagtggatc agggacagat ttcactctca gtatcaacag tgtggagact 300
gaagattttg gaatgtattt ctgtcaacag agtaacagct ggccgctcac gttcggtgct 360
gggaccaagc tggagctgag a 381
Claims (5)
1.一种使BRIL融合蛋白质稳定化的方法,其中,所述BRIL融合蛋白质是使BRIL与目标蛋白质融合而成的,该方法使用与BRIL结合的抗原结合片段,通过使与BRIL结合的抗原结合片段与BRIL融合蛋白质的BRIL结合,使BRIL融合蛋白质稳定化;
其中,与BRIL结合的抗原结合片段的VH的CDR1~3分别包含序列编号1~3所示的氨基酸序列,且该抗原结合片段的VL的CDR1~3分别包含序列编号4~6所示的氨基酸序列;其中所述抗原结合片段是Fab。
2.根据权利要求1所述的方法,其中,BRIL融合蛋白质为目标蛋白质的2个相邻的螺旋结构通过BRIL融合而成的蛋白质。
3.根据权利要求1或2所述的方法,其中,目标蛋白质为膜表达蛋白质。
4.根据权利要求3所述的方法,其中,膜表达蛋白质为选自G蛋白偶联受体(GPCR)、离子通道和转运子中的任意一种。
5.一种抗BRIL抗原结合片段,
其中,所述抗原结合片段的VH的CDR1~3分别包含序列编号1~3所示的氨基酸序列,且所述抗原结合片段的VL的CDR1~3分别包含序列编号4~6所示的氨基酸序列;其中所述抗原结合片段是Fab。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017137269 | 2017-07-13 | ||
JP2017-137269 | 2017-07-13 | ||
PCT/JP2018/026408 WO2019013308A1 (ja) | 2017-07-13 | 2018-07-12 | 抗bril抗体及び該抗体を用いたbril融合タンパク質の安定化方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110914430A CN110914430A (zh) | 2020-03-24 |
CN110914430B true CN110914430B (zh) | 2023-11-21 |
Family
ID=65001382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201880046011.XA Active CN110914430B (zh) | 2017-07-13 | 2018-07-12 | 抗bril抗体以及使用了该抗体的bril融合蛋白质的稳定化方法 |
Country Status (5)
Country | Link |
---|---|
US (2) | US11091545B2 (zh) |
EP (1) | EP3653713A4 (zh) |
JP (2) | JP6577691B2 (zh) |
CN (1) | CN110914430B (zh) |
WO (1) | WO2019013308A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114276460B (zh) * | 2022-03-04 | 2022-06-24 | 水木未来(北京)科技有限公司 | 改造型gpr75及其用途 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6107035A (en) * | 1997-03-14 | 2000-08-22 | University Of Guelph | Method for determining predisposition to boar taint |
WO2006112445A1 (ja) * | 2005-04-15 | 2006-10-26 | Eisai R & D Management Co., Ltd. | チトクロムcの免疫化学的測定方法及び測定キット |
CN103874711A (zh) * | 2011-05-13 | 2014-06-18 | 瑞塞普托斯公司 | 用于结晶g-蛋白偶联受体目的的新的融合伴体 |
CN106232626A (zh) * | 2014-03-27 | 2016-12-14 | 鸟石生物公司 | 结合人***素1(cb1)受体的抗体 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58110600A (ja) | 1981-12-25 | 1983-07-01 | Kyowa Hakko Kogyo Co Ltd | ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド |
JPS60221091A (ja) | 1983-12-21 | 1985-11-05 | Kyowa Hakko Kogyo Co Ltd | 新規プロモ−タ− |
JP2564268B2 (ja) | 1985-08-28 | 1996-12-18 | 協和醗酵工業株式会社 | 融合抗原ポリペプチド |
ZA872705B (en) | 1986-04-22 | 1987-10-05 | Immunex Corporation | Human g-csf protein expression |
JP2928287B2 (ja) | 1988-09-29 | 1999-08-03 | 協和醗酵工業株式会社 | 新規ポリペプチド |
JPH0322979A (ja) | 1989-06-19 | 1991-01-31 | Kyowa Hakko Kogyo Co Ltd | 新規プラスミノーゲン活性化因子 |
CN1241944C (zh) | 1995-09-11 | 2006-02-15 | 协和发酵工业株式会社 | 抗人白介素-5受体α链的抗体 |
US6001358A (en) | 1995-11-07 | 1999-12-14 | Idec Pharmaceuticals Corporation | Humanized antibodies to human gp39, compositions containing thereof |
JP4835573B2 (ja) | 2007-10-26 | 2011-12-14 | パナソニック株式会社 | 基板搬送装置および基板搬送方法 |
DK2441831T3 (en) | 2009-06-11 | 2018-12-03 | Inter Univ Research Institute Corporation Research Organization Of Information And Systems | PROCEDURE FOR PRODUCING PROTEIN |
WO2012148586A1 (en) | 2011-03-15 | 2012-11-01 | The Board Of Trustees Of The Leland Stanford Junior University | Gpcr fusion protein containing an n-terminal autonomously folding stable domain, and crystals of the same |
WO2015134607A1 (en) * | 2014-03-04 | 2015-09-11 | Yale University | Cell penetrating anti-guanosine antibody based therapy for cancers with ras mutations |
JP6677954B2 (ja) | 2016-02-05 | 2020-04-08 | 御木本製薬株式会社 | ヒアルロン酸合成酵素遺伝子発現促進剤 |
-
2018
- 2018-07-12 CN CN201880046011.XA patent/CN110914430B/zh active Active
- 2018-07-12 WO PCT/JP2018/026408 patent/WO2019013308A1/ja unknown
- 2018-07-12 US US16/630,181 patent/US11091545B2/en active Active
- 2018-07-12 JP JP2019515561A patent/JP6577691B2/ja active Active
- 2018-07-12 EP EP18832377.8A patent/EP3653713A4/en active Pending
-
2019
- 2019-08-21 JP JP2019151308A patent/JP2019203019A/ja active Pending
-
2021
- 2021-04-09 US US17/226,312 patent/US11773161B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6107035A (en) * | 1997-03-14 | 2000-08-22 | University Of Guelph | Method for determining predisposition to boar taint |
WO2006112445A1 (ja) * | 2005-04-15 | 2006-10-26 | Eisai R & D Management Co., Ltd. | チトクロムcの免疫化学的測定方法及び測定キット |
CN103874711A (zh) * | 2011-05-13 | 2014-06-18 | 瑞塞普托斯公司 | 用于结晶g-蛋白偶联受体目的的新的融合伴体 |
CN106232626A (zh) * | 2014-03-27 | 2016-12-14 | 鸟石生物公司 | 结合人***素1(cb1)受体的抗体 |
Non-Patent Citations (7)
Title |
---|
"A new scaffold for binding haem in the cytochrome domain of the extracellular flavocytochrome cellobiose dehydrogenase";Hallberg, BM等;《Structure》;20000115;第8卷(第1期);第79-88页 * |
"Alternate protein frameworks for molecular recognition";Ku,J等;《PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA》;19951231;第92卷;第6552-6556页 * |
"Crystal structure of the adenosine A(2A) receptor bound to an antagonist reveals a potential allosteric pocket";Sun, BF等;《PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA》;20170228;第114卷;第2066-第2071页 * |
"GABAB受体表达和纯化及膜转运蛋白YajR结构和功能研究";姜道华;《中国博士学位论文全文数据库 基础科学辑》;20150715(第7期);A006-57 * |
"Menbrane Protein Crystallization using Antibodies";IWATA,S 等;《Program and abstracts of 10th annual conference of protein science society of Japan》;20101231;第53页 * |
"Structural insight into allosteric modulation of protease-activated receptor 2";Cheng等;《Nature》;20170504;第545卷(第7652期);第112-115页 * |
"Structure of a nanobody-stabilized active state of the .beta.2 adrenoceptor";Rasmussen 等;《Nature》;20110113;第469卷(第7329期);第175-180页 * |
Also Published As
Publication number | Publication date |
---|---|
JPWO2019013308A1 (ja) | 2019-08-08 |
US11091545B2 (en) | 2021-08-17 |
JP6577691B2 (ja) | 2019-09-18 |
EP3653713A4 (en) | 2021-03-31 |
JP2019203019A (ja) | 2019-11-28 |
EP3653713A1 (en) | 2020-05-20 |
US20200157211A1 (en) | 2020-05-21 |
US20210309738A1 (en) | 2021-10-07 |
CN110914430A (zh) | 2020-03-24 |
US11773161B2 (en) | 2023-10-03 |
WO2019013308A1 (ja) | 2019-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2814155C (en) | Anti-tim-3 antibody | |
US20200239586A1 (en) | Fn14 Binding Proteins and Uses Thereof | |
US20210340249A1 (en) | Muscarinic acetylcholine receptor binding agents and uses thereof | |
JP7099709B2 (ja) | ヒト化抗ベイシジン抗体およびその使用 | |
JP7311425B2 (ja) | CD40とEpCAMに結合するバイスペシフィック抗体 | |
JP6687525B2 (ja) | オピオイド受容体結合剤およびその使用 | |
WO2021002312A1 (ja) | 抗EphA4抗体 | |
CN113574072A (zh) | 靶向C5aR的抗体 | |
CN110914430B (zh) | 抗bril抗体以及使用了该抗体的bril融合蛋白质的稳定化方法 | |
AU2014203658B2 (en) | FN14 binding proteins and uses thereof | |
KR20240046239A (ko) | 항-vegfr1 항체 및 이들의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |